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ABSTRACT
In vitro and in vivo toxicological evaluation of emissions from the
fused filament fabrication three-dimensional printing
Mariana T. Farcas
Fused filament fabrication (FFF), a three-dimensional (3-D) printing process, is an emerging
technology that has recently gained wide popularity among both consumers and manufacturers.
As filament is heated to above its glass transition temperature in a 3-D printer, a portion may
undergo thermal decompostion, which releases ultrafine particles (UFP) and volatile organic
compounds (VOCs) with potential adverse respiratory health effects are released into the air. This
study's central hypotheses is that emissions generated during 3-D printing are toxic and exposure
to these emissions induces pulmonary and systemic adverse health effects. Considering that
currently, limited understanding is available on the health impact of the FFF 3-D printer exposures,
the overall goal of this research was to fill the knowledge gap by pursuing the following three
studies.
The aim of the first study was to assess acrylonitrile butadiene styrene (ABS) and
polycarbonate (PC) filaments 3-D printer emissions-induced cell toxicity. In this study, the
particles and vapors released during printing were collected directly into the cell culture medium
and delivered to the small airway epithelial cells at six concentrations. At 24 h, various endpoints,
such as cellular uptake, cell viability, cell membrane damage, ROS production, total antioxidant
capacity, glutathione peroxidase levels in cell lysates, cell death mechanisms (apoptosis and
necrosis), and cytokines and chemokines released in cell supernatants were measured. To
analyze the data, mixed model regression analyses were performed on these endpoints using
particle numbers as the independent variable. The regression lines illustrated a significant doseresponse relationship between a decrease in cell viability and the number of emitted particles,
which correlated with a significant dose-dependent increase in the LDH activity, and all other
endpoints evaluated.
The aim of the second study was to assess pulmonary and systemic toxicity in rats following
whole-body inhalation exposure to ABS filament 3-D printer emissions. In this study, male
Sprague Dawley rats were exposed to filtered air or ABS emissions for 1, 4, 8, 15, or 30 days (4
h/day, 4 days/week). The average mass concentration and number of particulate generated
during 4-h real-time printing of three desktop 3-D printers operating simultaneously was 240 µg/m3
and 8.84 x 10⁴ particles/m³. At the start of the exposure (day 1), a predominant pro-inflammatory
response was seen in BALF, represented by an increase in IFN-γ and TNF-α Th1-type cytokines
followed by a switch to an anti-inflammatory response by day 15 of exposure represented by a
rise in IL-10 Th2-type cytokine. The Th1/Th2 switch could be responsible for the initial “delayed”
influx of the alveolar macrophages and its peak occurrence at 15 days of exposure, which
corresponded with a significant increase in blood monocytes and platelet counts. Other systemic
changes noted were that initially (day 1), a significant increase in both hepatic and renal
biomarkers was found; however, at day 15 of exposure, only renal biomarkers were increased. At
the longest exposure duration (day 30), all the endpoints evaluated returned to the control levels.
Neither pulmonary oxidative stress responses nor histopathological changes of the lungs and
nasal passages were found among the treatments.
The aim of the third study was to evaluate the pulmonary effects of FFF 3-D printer
emissions using a relevant human ALI organotypic airway tissue model to mimic the respiratory
behavior upon exposure. Primary normal, human-derived bronchial epithelial cells (NHBEs) were
directly exposed for 4 h to ABS filament emissions. NHBEs epithelium integrity and differentiation
changes, cytotoxicity, tissue injury, and inflammatory and immune system regulation markers
were evaluated following exposure and 24 h after the end of the exposure. Overall, at the
conditions applied, exposure of NHBEs to ABS emissions did not affect epithelium integrity,
ii

ciliation, mucus production, or induce cytotoxicity. At 24 h after the exposure, significant increases
in IL-12p70, IFN-γ, TNF-α, IL-17A, VEGF, and MIP-1α were noted in the basal cell culture medium
of ABS-exposed cells compared to chamber control cells.
Overall, toxicological evaluation of FFF 3-D printer emissions was conducted in three
different conditions, 1) traditional submerged culture of human small airway epithelial cells, 2)
repeated whole-body inhalation exposure of rats to freshly generated aerosols, and 3) advanced
human ALI organotypic airway tissue model. At the experimental conditions applied, in both in
vitro models and in vivo, 3-D printer emissions produced minimal to moderate pulmonary toxicity.
Furthermore, these findings were consistent with results observed in the physiologically relevant
in vivo-like in vitro model cultured at ALI. In conclusion, these studies indicate that the FFF 3-D
printer emissions could induce moderate toxicological effects. These studies are significant as
they are amongst the first and comprehensive studies published to evaluate the pulmonary and
systemic toxicity of 3-D printer emissions. Further studies are needed to establish a more broad
exposure-dose-response relationships and integration of in vivo and in vitro responses.
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW
1.1.

ADDITIVE MANUFACTURING
Based on the approach by which a product is created, there are three types of

manufacturing processes: subtractive, formative, and additive [1]. Additive manufacturing
(AM) is a layer-based automated fabrication process of joining materials to make scaled
3-dimensional physical objects without using part-dependent tools [2, 3]. AM provides the
next series of major expertise of the entire manufacturing technology due to flexibility in
design, conception, and customization, which also explain the phenomenal expansion
and evolution in recent years [4].
There are primarily eight process steps [5, 6] in AM:
•

Step 1 – 3-dimensional (3-D) model creation (conceptualization): a 3-D computeraided design (CAD) data set or model is created representing the part being produced
using CAD design software or a 3-D object scanner or other imaging technologies
such as computerized tomography scanning (CT-Scanning).

•

Step 2 – STL file creation (tessellation): the 3-D data set is converted to an STL/AMF
file format and sliced into digital layers using a computer and special software,
resulting in a set of contoured virtual slices with even thickness.

•

Step 3 – STL file transfer: the STL file is transferred to the AM machine, where it is
manipulated to ensure the correct size, position, and orientation of virtual slices for
building.

•

Step 4 – Machine set up: consumables are loaded, and the AM machine is
appropriately set up prior to the build process (build parameters like the material
constraints, energy source, layer thickness, and timings).

•

Step 5 – Building the part: this is an automated process; however, monitoring is
needed to ensure no errors have taken place like running out of material, power, or
software glitches.

•

Step 6 – Removal of the build part: this part requires interaction with the machine as
the part is removed from the build platform and its support structure.

•

Step 7 – Post-processing: the part is cleaned up before use which requires careful,
experienced manual manipulation.
1

•

Step 8 – Part is ready to be used: parts may also require additional treatment before
they are acceptable for use, such as priming and painting to give an acceptable
surface texture and finish, or may also be required to be assembled together with
other mechanical or electronic components to form a final model or product.
The major AM processes were classified in 2010, as per the American Society for

Testing and Materials (ASTM) group “ASTM F42 – Additive Manufacturing”, into seven
categories. The classification was done based on the type of materials used, the
deposition technique, and how the material is fused or solidified. These categories are:
1) Vat Photopolymerization (VP)
2) Material Jetting (MJ)
3) Binder Jetting (BJ)
4) Material Extrusion (ME)
5) Powder Bed Fusion (PBF)
6) Sheet Lamination (SL)
7) Directed Energy Deposition (DED).
Table 1.1. includes details about these technologies, processes, the material used, a
brief description, and advantages and disadvantages [7]. However, one should consider
that AM is continuously expanding; therefore, new technologies could develop in the
future along with a broader range of materials.
Some believe that we are experiencing a new industrial revolution due to the
complexity of AM and its impact [8]. Additive manufacturing has been found to have many
benefits [9-12], such as:
1) The direct translation of design to the component, with the capability of printing fully
functional items without any assembly operations.
2) Generation of parts with greater customization with no additional tooling or
manufacturing cost, thus reducing or even eliminating tool investment costs.
3) Functional design allows the manufacturing of complex geometrical parts with internal
features, variable thicknesses, and irregular shapes.
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Example

Materials

category

Technology

(printed “ink”)

Vat photopolymerization (VP)

Process

Stereolithography
(SLA)
Photopolymers
Ceramics

Brief description

Advantages

Uses ultraviolet (UV) light to

•

High build speed

initiate a chain reaction on a

•

High level of

layer of resin or monomer

accuracy and good

solution. The monomers are

finish

UV-active and instantly convert

•

Large build areas

Disadvantages
•

Limited to
photopolymers

•

High cost for supplies
and materials

•

Lengthy post-

to polymer chains after

processing time and

activation by photoinitiators in

removal from resin

Digital Light

resin. After polymerization, a

Processing

pattern inside the resin layer is

support structures

solidified in order to hold the

and post-curing

(DLP)

•

Often requires

subsequent layers.
The material is pumped and

•

Material jetting (MJ)

deposited in the form of

Multi-Jet
Modeling
(MJM)

Multi-material
printing

Polymers

droplets via the injection nozzle

•

Multicolor

Ceramics

onto the substrate. The droplets

•

High accuracy of

Composites

then form a continuous pattern

deposition of

Wax

which solidifies to sufficient

droplets

Metals

strength in order to hold

Biologicals

subsequent layers of printed
materials.
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•

•

Low waste

Support material is
often required

•

Low-strength material

The material is selectively
joined together using a liquid

Powder bed and

binding agent (e.g., glue). Inks

inkjet head

Binder jetting (BJ)

printing

Polymers
Ceramics
Glass
Metals
Hybrid

3-D printing

Full-color object

•

printing
•

may also be deposited in order
Waxes
Composites

Plaster-based

•

Wide material

Not always suitable
for structural parts

•

selection

High porosities on
finished parts

to impart color. Once a layer is

•

Faster than others

•

formed, a new one is created

•

Allows for a large

processing adds time

by spreading powder over the

number of different

to the overall process

top of the object, and the

binder-powder

process is repeated until the

combinations and

object is formed. Unbound

various mechanical

material is used to support the

properties

Additional post-

object being produced, thus
reducing the need for support

Material extrusion (ME)

systems.
A continuous filament¹ of a

•

Widespread use

•

Vertical anisotropy

thermoplastic polymer is heated

•

Inexpensive

•

Accuracy and speed

at the nozzle to reach a semi-

•

Scalable

are low when

liquid state and then extruded

•

Multi-material

compared to other

printing

processes, and

Can build fully

accuracy of the final

functional parts

model is limited to

on the platform or on top of
Fused filament
fabrication
(FFF)

Thermoplastics

previously printed layers.

Composites
Biologics

1.

•

The feedstock can contain

material nozzle

additives such as metals,

thickness

flame retardants,

•

nanomaterials, etc.

resolution
•
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Limited part

Poor surface finish

Thin layers of very fine

Powder bed fusion (PBF)

Selective Laser
Melting
(SLM)

Sheet lamination (SL)

Manufacturing
(LOM)

•

Relatively slow speed

inexpensive

•

Size limitations

High accuracy and

•

High power required

details

•

Powder handling and

Composites

closely packed on a platform,

Metals

are fused together with a laser

Glass

beam or a binder. Subsequent

•

Fully dense parts

Ceramic

layers of powders are rolled on

•

High specific

Metals

•

top of previous layers and fused

strength, and

together until the final 3D part is

stiffness

built.

•

recycling
•

Support and anchor
structure

•

Large range of

Finish is dependent
on powder grain size

material options

(EBM)

Laminated Object

Relatively

powders, which are spread and

Electron Beam
Melting

•

Thermoplastics

Is based on layer-by-layer

•

Fast

cutting and lamination of sheets

•

Low cost

depending on paper

Plastics

or rolls of materials. Successive

•

Ease of material

or plastic material but

Metals

layers are cut precisely using a

handling

may require post-

Ceramics

mechanical cutter or laser.

processing to achieve

Wood

They are then bonded together

the desired effect

(form-then-bond) or vice versa
(bond then-form).
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•

•

Finishes can vary

Limited material use

Directed energy deposition (DED)

Uses a source of energy (laser

Electron Beam
AM (EBAM)

Metals
Ceramics
Hybrid

•

Ability to control the

•

Finishes can vary

or electron beam), which is

grain structure to a

depending on paper

directly focused on a small

high degree, which

or plastic material but

region of the substrate and is

lends the process to

may require post-

also used to melt a feedstock

repair work of high

processing to achieve

material (powder or wire)

quality

the desired effect
•

Low shelf life

material is then deposited and

•

Limited material use

fused into the melted substrate

•

Expensive precursors

simultaneously. The melted

•

Functional parts

and solidified after the
movement of the laser beam.

Table 1.1. Classification of seven additive manufacturing processes categorized by ASTM International, materials
types, short description, advantages, and disadvantages. Adapted from [5-7].
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4) Flexible and lightweight component manufacturing with hollow or lattice structures
facilitating application for a specific function and specific characteristics, thus providing
substantial benefits in various industrial sectors.
5) The ability of direct manufacturing of components to their final or near-final shape with
minimal to no additional processing.
6) Potential to approach zero waste manufacturing by optimizing and maximizing
material usage.
7) A significant reduction in overall product development, validation, and manufacturing
time, leading to quicker market launch.
8) Smaller operational footprint towards manufacturing a large variety of parts.
9) On-demand manufacturing and flexibility in responding to the continuous changes in
market demand and moving away from projection-based manufacturing.
10) Excellent scalability from the prototype to full-scale production.
11) Reduced environmental impact and increased sustainability (generation of less waste,
reduce material consumption, and reduction in transportation in the supply chain).
1.1.1. Fused filament fabrication
Fused filament fabrication (FFF, also known as Filament Freeform Fabrication) is
derived from Fused Deposition Modeling (FDM™ technology). It is an extrusion-based
technology and one of the most popular additive manufacturing processes. FFF has
applications in many types of manufacturing sectors, such as biomedical [13-21],
pharmaceutical [22-28], aerospace [29-31], automobile [32-34], construction [35-39],
electrical and electronics [40-43], food [44-48], textile [49-52], jewelry [53], toys [54-56],
sports [57-59], and many others [60-66]. Also, 3-D printed devices such as oxygen valves,
mask frames, ventilators, nasal swabs, and door openers have been designed and
manufactured to fight against the spread of the Covid-19 virus and assist hospitalized
patients [67].
FFF is conceptually the simplest, affordable, and most readily available AM
technology that offers industries and consumers alike the possibility to build objects using
a spool of filament-based material (thermoplastic). This makes FFF unique compared to
other AM technologies. As the 3-D printer releases the thermoplastic filament, this is fed
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into a heating chamber in the printer's extruder assembly, where it is heated above its
glass transition temperature. Once it becomes more viscous, it can flow out the printer's
head through a nozzle as the extruder assembly moves. The FFF 3-D printer extruder
assesmbly can move horizontally and vertically (X,Y and Z axis), tracing a path
programmed into the 3-D object file. The extruder assembly releases the molten plastic
onto the print bed to create the physical object by adding thin layers, one on top of
another. Once the filament cools, it hardens, and then the object can be released from
the print bed. Prior to printing, slicing software defines how to break the 3-D digital model
into layers that the printer can print, as described in steps 1 through 3 at the beginning of
this section [5, 64, 67].
Efforts have been made on evaluating the effects of various parameters on the
precise control of the extrusion process and the quality and performance of the printed
parts. It had been determined that FFF is a complex process that is dependent on a
significant number of parameters, such as machine parameters (printing speed, raster
angle, melt flow rate through the nozzle, airgap, layer thickness, infill density, build
orientation, and temperature) and material parameters (thermal and mechanical) [67-72].
More importantly, the composition of the toxic pollutants released during 3-D printing
varies with different reaction temperatures, residence times, oxygen or additive contents,
and, obviously, filament type [73], indicating that these parameters may influence
potential health outcomes resulting from exposure. Therefore, a literature review of FFF
3-D printer emissions composition and characterization serves as the focus of section
1.4.
1.1.2. Thermoplastics used in fused filament fabrication
Thermoplastics, also called thermosoftening plastics, are plastic polymers that
become soft and moldable when heated above a specific temperature called the glass
transition temperature and solidify again as they cool, making them reusable nearly
indefinitely [74]. Thermoplastics have the simplest molecular structure, consisting of
chemically independent macromolecule chains that associate through intermolecular
forces. This facilitates thermoplastics to be remolded as the intermolecular interactions
increase upon cooling, restoring the bulk properties [75]. Above its glass transition
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temperature and below its melting point, a thermoplastic can change its physical
properties drastically without an associated phase change. Most thermoplastics are
rubbery within this temperature range due to alternating rigid crystalline and elastic
amorphous regions, approximating random coils [76]. For aesthetic purposes, pigments
can be added to thermoplastics. Also, additives or fillers can be added to the
thermoplastic to improve specific properties such as thermal or chemical stability and UV
resistance [77].
Acrylonitrile-Butadiene-Styrene (ABS) and polycarbonate (PC) filaments are the
most common filaments used in industrial settings and in offices, schools, universities,
libraries, and homes [78]. Examples of other filaments popular on the market are nylon,
high impact polystyrene (HIPS), polylactic acid (PLA), polyethylene terephthalate (PET),
taulman T-glase (PETT), and thermoplastic elastomer (TPE) [79].
1.1.2.1.

Manufacturing and uses of Acrylonitrile-Butadiene-Styrene

Acrylonitrile-butadiene-styrene (ABS) polymer is the largest volume engineering
thermoplastic used in the US. It is produced by graft polymerization of acrylonitrile and
styrene monomers onto an elastomer, such as polybutadiene or a butadiene copolymer
[80]. This graft terpolymer's property advantages include excellent toughness, resistance,
good dimensional stability, and processability [80].
ABS was introduced in the US in the late 1940s. In the 1950' s, the technique of
grafting styrene and acrylonitrile onto polybutadiene rubber was perfected, thus
introducing the acrylonitrile-butadiene-styrene copolymers in use today [81]. Acrylonitrile
provides heat resistance, chemical resistance, and surface hardness. The butadiene
supplies toughness and impact resistance, while the styrene component promotes
processability, rigidity, and strength. ABS contains over 50% styrene and varying
amounts of butadiene and acrylonitrile [80]. Two USA commercial copolymer samples
examined were found to contain 30 and 50 mg/kg (ppm) residual, unreacted acrylonitrile
monomer [81].
ABS is used in piping, automotive components (instrument panels, armrests,
interior trim panels, seat belt retainers, glove compartment doors, lift gates, wheel covers,
9

grilles, headlight, mirror housings, and decorative trim), appliance components (door
liners and food compartments of household refrigerators, fans and bases of blenders),
components of business machines, telephones and electrical and electronic equipment,
pipe fittings, recreational vehicle components (e.g., snowmobile components, canoes,
and interiors of small and large boats) [82]. Other uses of ABS copolymers include
packaging (margarine tubs), luggage and cases, toys and sporting goods, and furniture.
1.1.2.2.

Manufacturing and uses of Polycarbonate

Polycarbonate (PC) is an amorphous engineering thermoplastic material. The term
polycarbonate applies to several types of polymeric materials, which contain repeating
carbonate linkages [78]. To increase melt strength for extrusion and blow molding
applications, trifunctional monomers are added to the reaction process. PC is
characterized by higher thermal stability, higher rigidity, and higher glass transitions
compared to ABS [83].
The two chemical synthesis routes of PC are interfacial and melt reactions. Both
interfacial and melt-reaction pathways for PC synthesis use Bisphenol A (BPA) as a
monomer. PC is synthesized by reacting acetone and phenol via an acid-catalyzed
reaction recrystallized to a high purity with a suitable solvent [84].
Since the discovery in the 1950s, the two-common types of polycarbonates are:
1) Aromatic polycarbonates (the most common type of polycarbonates), and
2) Aliphatic polycarbonates (prepared with similar synthesis methods as aromatic
polycarbonates but based on aliphatic building block).
Aromatic polycarbonates are the largest portion of this class of materials. Most often, the
generic term polycarbonate refers to BPA polycarbonate.
PC’s unique combination of transparency, rigidity, ductility, heat resistance, and
processability made the polymer successful in many applications such as automotive (tail
and headlights, signal light lenses and housings, runway markers, blow-molded spoilers,
instrument panels, and seat backs), appliances (food processors, electrical kitchen
components, power tool housings, refrigerator drawers, and vacuum cleaner
components), electronic and business equipment (computer parts and peripherals,
connectors, terminal blocks, and telecommunication components), medical products
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(tubing connectors, dialysis components, and devices, blood oxygenators, filter housings,
lenses, gamma sterilization appliances, and surgical staplers), safety and sports (sports
helmets, recreational vehicle hoods, windshields, headlights, boat propellers, and
sunglass lenses) [78, 83].

1.2.

FUSED FILAMENT FABRICATION EMISSIONS CHARACTERIZATION
Considerable evidence shows that the FFF process using thermoplastics as

feedstock releases a significant number of nanoparticles (NPs) and various organic
compounds [73, 85-103]. Concerning the health hazards, there is growing recognition
that the biological activity and adverse health effects of toxicants depend on their
physicochemical characteristics [104]. This represents an area of interest to both the
public and manufacturers, toxicologists, regulatory decision-makers, and risk assessors
[105]. Identifying the contributors to health risk among the complex physical-chemical
components found in FFF 3-D printer emissions is an important matter, representing this
section’s focus.
1.2.1. Nanoparticles
There is no clear understanding of the relationship between NPs toxicity and their
physicochemical properties except for size. Oberdörster et al. [106] suggested that some
other key characteristics that might be important to understand include agglomeration
state, shape, chemical composition, surface area, surface chemistry, surface charge, and
porosity.
A PubMed and Google scholar literature search was performed to include relevant
publications from 2000 up to December 2020 that evaluated and characterized the FFF
printer-emitted particulates. As a result, this section will review the following: 1) particle
number emissions rates (PNERs) and particle number concentrations (PNCs), 2) the
particle temporal pattern, 3) particle size distribution, 4) particle mass, 5) morphology,
6) particle agglomeration and volatility, and 7) elemental characteristics.
Published studies have found that the PNERs from 3-D printing are estimated to
range from approximately 107 to 1012 particles/min and that the printing materials and
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printing conditions can influence the emission of particulate matter [91-93, 95, 101].
Across the literature, it is generally observed that the emissions characteristics vary
significantly, and some filaments produce higher particle numbers than others. Azimi et
al. [93] characterized the PNERs from a total of 16 unique combinations of five popular
commercially available makes and models of desktop 3-D printers and nine filaments,
including ABS, PLA, HIPS, semitransparent nylon, laybrick (an imitation brick material of
unknown chemical composition), laywood (an imitation wood material of unknown
chemical composition), transparent PC, a semitransparent nylon-based plasticized
copolyamide thermoplastic elastomer (PCTPE), and a transparent polyester resin
filament called T-Glase. It has been determined that ABS filament generates highest
PNERs, particles/min median values ranging from 2 × 1010 to 9 × 1010, followed by PC
filament (4 × 1010), PCTPE (2 × 1010), T-Glase (5 × 109), HIPS (4 × 109), nylon (2 × 108),
PLA (108), laywood (8 × 107), and laybrick (6 × 107).
Kwon et al. [88] classified the printer filaments as high, medium, and low emitters
according to their PNERs. Under manufacturer-recommended and at consistenttemperature conditions, filaments with PNERs >1011 particle/min were defined as high
emitters, filaments with PNERs between 109 and <1011 particle/min were defined as
medium emitters, and lastly, filaments with PNERs less than the medium emitters were
considered low emitters. For instance, high emitters included HIPS (PNERs = 2.13 × 1011
- 5.75 × 1011 particle/min) and nylon (PNERs = 1.05 × 1011 - 4.34 × 1011 particle/min);
medium emitters included ABS (PNERs = 6.91 × 109 - 5.56 × 1010 particle/min), and low
emitters included PVA (PNERs = 7.97 × 107 - 1.23 × 109 particle/min), laywood (PNERs
= 6.83 × 107 - 7.71 × 108 particle/min), and PLA (PNERs = 1.98 × 107 - 7.92 × 108
particle/min).
The PNCs were reported to range from approximately 103 to 105 particles/cm3 for
room measurements [89-91, 101] and approximately 104 to 106 particles/cm3 for chamber
measurements [88, 90, 91, 93, 95, 96, 107]. PNCs over the printing time are direct
measurements of particle counts per unit volume (cubic centimeter) and do not depend
on the assumptions of potential particle losses to tubing (as a function of length, curves,
and material - conductive vs. non-conductive tubing) in a system. Increases in PNCs
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value can, in the same way as PNERs, indicate a greater potential for a particles'
inhalation.
The size distribution and the temporal pattern of PNCs have raised concerns
regarding NPs exposure during FFF 3-D printing [88-91, 94, 95, 97-99]. A typically large
peak of particles in the range of 20 to 100 nm occurs during the initial heating and first
layer printing, followed by an exponential decay of PNCs (Figure 1.1) [95]. It is
hypothesized that it is due to the pre-heating of the filament in the 3-D printer nozzle
and/or the printing of solid layers for the objects' solid exterior [94, 95, 108, 109]. The
PNCs reached the maximum during the first four minutes when initial heating occurred
(0–2 min), and when the solid layer was printed (2–4 min). For example, when comparing
ABS, PLA, PVA, HIPS, PCABS, nylon, bronzePLA, and PET, the average initial peak
concentration was between 1.1 × 106 particle/cm3 (PLA & HIPS) and 4.8 × 106
particle/cm3 (PVA) [95]. After the initial particle burst, a decline in the particle
concentration is observed, indicating a lower emission rate than the ventilation rate when
printing the 50% infilled density layer, compared with the solid exterior layers. Also, the
decline in the particle concentration for each filament shows slightly diﬀerent decay
trends, which could be due to different particle emission rates for each filament (Figure
1.1). When the solid exterior is printed during the end of the printing (last two minutes),
the particle counts increase again. Based on these findings, Floyd et al. [95] concluded
that when printing the first and last layers (solid hard-shell), particle emission rates are
higher compared with printing the middle layers (50% infilled density core).
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Figure 1.1. Particle number concentration (PNCs, #/cm3) in the sub-halfmicron size range (16.8 – 532.8 nm) as a function of time (min) for ABS, PLA, PVA,
HIPS, PCABS, nylon, bronzePLA, and PET filaments. Reproduced from Floyd, E.L.,
et al. [95], Fume emissions from a low-cost 3-D printer with various filaments. Journal of
Occupational and Environmental Hygiene, 2017. 14(7): p. 523-533 with permission from
the Taylor & Francis Group. https://doi.org/10.1080/15459624.2017.1302587.
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To study the nanoparticle formation, Youn et al. [110] recorded real-time
measurement of the PNCs as a function of particle diameter and time during printing with
PLA (Figure 1.2). For a 3 h sampling time, they assigned five measurement periods or
phases as such: (1) background, (2) phase 1: a single 3-D printer operation, (3) phase 2:
two 3-D printer operation, (4) phase 3: five 3-D printer operation, and (5) background. To
confirm that the nanoparticle formation was inhibited, a 10 min break was taken between
the second and third phases. They measured the room's size-resolved PNCs
representing the background reading, showing a unimodal distribution with a peak at 90
nm. Once they turned on the first 3-D printer, phase 1, a bimodal distribution was
distinguished with peaks at 15 and 90 nm. At this phase, they observed the formation of
<20 nm NPs, while the 70 - 100 nm NPs increased slightly. When a second printer was
turned on, phase 2, the PNCs with sizes ranging from 10 and 230 nm increased. An
interesting pattern was noticed for the PNCs of 70 - 100 nm particles: at the beginning of
phase 2, it was the same as that observed in phase 1; however, it progressively increased
as a function of time. This could be explained by the agglomeration of the 10 - 30 nm NPs
emitted during both phase 1 and phase 2 and the continuous emission of the 70 - 100 nm
large single NPs. This theory is supported when during the break time (between phases
1 and 2), the 10 - 30 nm particle number concentration decreased, but the 70 - 100 nm
particles remained similar to that measured in phase 2 [111]. During phase 3, when five
printers were operated simultaneously, the 10 - 30 nm PNCs dramatically increased
initially with the highest concentration of all sampling periods. After phase 3, when the
printer was off, nanoparticle sampling was conducted to obtain an after-background
reading. At this phase, inhibition of 10 - 30 nm particle emissions was confirmed, whereas
the 70 - 100 nm particles remained at similar number concentrations during the afterbackground measurement due to nanoparticle agglomeration. This suggests that caution
should be used after the print run and not only when the printer is operating, considering
the particles are <100 nm and potentially have higher toxicity due to high surface area
compared to their larger counterparts [106].
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Figure 1.2. TEM images of fume particles on scales of: (a)100 nm, (b) 250 nm,
and (c) 2 µm. Reproduced from Floyd, E.L., et al. [95], Fume emissions from a low-cost
3-D printer with various filaments. Journal of Occupational and Environmental Hygiene,
2017. 14(7): p. 523-533 with permission from the Taylor & Francis Group.
https://doi.org/10.1080/15459624.2017.1302587.
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Gu et al. [86] studied particle volatility by measuring particle number size
distribution at room temperature using a Fast Mobility Particle Sizer (FMPS) and after the
particles passed through a thermo-denuder with a second FMPS. The temperature in the
thermo-denuder increased stepwise by 50 °C from room temperature to 300 °C. Overall,
PNCs size decreased at increased thermo-denuder temperatures suggesting that the
emitted particles are volatile and start to evaporate from 150 °C. Concerning particles
emitted from 3-D printing with ABS, particle sizes and concentrations did not change very
much at 100 °C; however, at 150 °C, the number of particles over 50 nm decreased, and
at 200 °C, the particle mode around 30 nm decreased significantly. Particles with a
diameter of around 10 nm showed little change, even at 300 °C. Similarly, for HIPS, the
particle size and number concentrations gradually decreased with the increase of
temperature: from 60 - 70 nm at 23 °C to 34 - 39 nm at 150 °C, 29 nm at 200 °C, and 11
nm at 250 °C and 300 °C. At 250 °C, almost all particles over 60 nm had disappeared.
For PETG, PNCs decreased by 32%, 55%, and 73% at 150 °C, 200 °C, and 250 °C,
respectively. The major particle mode shifted greatly, from 70 nm at room temperature to
34 nm at 150 °C, and 11 nm at 250 °C. The authors conclude that the 3-D printer emitted
particles are composed of semi-volatile organic compounds (SVOC), though SVOCinvolved nucleation and condensation, as observed in previous studies [91, 98, 110] and
discussed in detail in the earlier paragraph. Additionally, using a volatility tandem
differential mobility analyzer, Mendes et al. [96] evaluated the volatility of emitted
nanoparticles and found that the emitted particles were composed of high and low
volatility compounds, consistent with the presence of organic compounds in the printer
aerosol emissions.
Traditionally, the mass dose is used to interpret the airborne fine particle
concentration, as the mass concentration usually corresponds with the traditionally used
occupational exposure levels. However, sampling of NP mass is a challenging task given
their small size, heterogeneity, and unique chemical/physical properties. Up to date, mass
concentration data of the particles released during 3-D printing is limited.
Chan et al. [112] measured total and respirable particulate concentrations in a
room (2.4 × 2.4 × 2.4 m) where three 3-D printers were operating with PLA filament, and
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the adjacent hallway (1.2 × 6.1 × 3.4 m) leading into the printing room. Sampling in the
printing room was performed at a height simulating the seated position of a facility user.
In the hallway just outside the printing room, air sampling was performed at the
approximate breathing height of 1.2 m. During the sampling, the door connecting the
printing room and hallway remained open because it is a usual practice at the facility. Two
scenarios were considered: a “typical-case” when the three printers run sequentially for
155 min, and a “worst-case” scenario when all three printers run concurrently for 97 min.
They found that the total particulate levels were higher in the worst-case scenario (0.7
mg/m3) than the typical-case scenario (0.3 mg/m3) in both settings. However, the printing
room's respirable particulate levels were lower in the worst-case scenario (0.4 mg/m3)
than the typical-case scenario (0.8 mg/m3).
In another study, Väisänen et al. [113] measured occupational particle mass
concentration generated during different AM processes: ME, VP, PBF, MJ, and MJM
processes. Samples were collected from the height of the breathing zone from the
beginning to the end of the manufacturing process, ranging from 70 to 150 min. The
particle concentrations were lower than reported by Chan et al. [112]. Dust concentration
generated during ME were ranging between 0.01 mg/m3 and 0.03 mg/m3 (0.01 mg/m3
mean, and standard deviation, SD, of 0.01). They also noted that printer malfunction
temporarily increased the particle concentrations by two orders of magnitude. To
summarize their other findings from testing other AM processes: VP generated dust
concentrations between 0.02 and 0.12 mg/m 3, PBF concentrations varied between 0.01
and 0.47 mg/m3, MJ concentrations were similar to ME, from 0.01 to 0.03 mg/m 3, and
during MJM the concentrations during manufacturing varied from 0.03 mg/m 3 to 0.07
mg/m3.
Characterizing emissions from desktop 3-D printers in laboratories and classrooms
on college campuses, McDonnell [114] found that half of all particles were <150 nm in
diameter, and particle size distribution was skewed towards a smaller average diameter.
PC (1.1 mg/m3) generated the maximum particle mass concentration followed by ABS
(0.2 - 0.6 mg/m3), nylon (0.25 mg/m3), and PLA (0.01 mg/m3) lastly. Using real-time
aerosol mass spectrometry, Katz et al. [87] determined fluctuations in particle size
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distribution and mass concentration throughout the printing period in a small office space.
Over the 3 hrs. print run, two distinct peaks were observed, one at 50 min and another
peak between 120 - 150 min after the printer started. Steinle [90] reported that a 165 min
print run in a small, unventilated room increased the ultrafine aerosol concentrations by
2,000 particles/cm3, and methyl methacrylate released during printing with PLA reached
a peak of 21 µg/m3 and was still detectable even 20 hrs. after printing. Based on SMPS
measurements inside a test chamber enclosure, Zontek et al. [115] found that the highest
number and mass aerosol concentration of particles was generated during heating (80
µg/m3) and printing (7.6 µg/m3). Additionally, keeping the 3-D printer door closed reduced
the number and mass concentration by 95%, thus proving the effectiveness of the
enclosure by reducing the particle count in the breathing zone. Similarly, Dunn et al. [116]
showed a 98% reduction in UFPs concentrations when an extruder head emission control
was installed during printing in a test chamber. Furthermore, when evaluated the
efficiency of this control in a simulated makerspace with 20 printers operating, it was found
that with the engineering controls in place, the particle counts were reduced significantly
to or at below background levels (< 1000 particles/cm3) compared to the 20,000
particles/cm3 without the engineering controls in places. Thus, this study showed that
including an engineering control to 3-D printers significantly reduces emissions to the
work environment.
Overall, in these findings [112-114], the particle mass concentration was lower
compared to American Conference of Governmental Industrial Hygienists' (ACGIH®)
Threshold Limit Values (TLV®) of 10 mg/m3 and 3 mg/m3, respectively [117]. There is a
need for sampling equipment able to sample physical characteristics such as surface
area, known to be a more appropriate metric for nanoparticle toxicity. Because NPs have
such low mass, gravimetric analysis alone might be insufficient for the expression of
exposure, and the number and/or surface area needs to be included to understand dose.
Also, it is important to distinguish between background levels of NPs and incidental 3-D
printer NPs. For example, Dunn et al. [118] reported free carbon nanotube (CNT) and
carbon nanofiber (CNF) at a 3-D printing shop using filament printers with unfilled and
CNT and/or CNF-infused polyetheletherketone (PEEK) filaments (these materials have
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never been used in the facility) raising the possibility that these materials are being
released from the matrix during 3-D printing.
The image analysis (Figure 1.2. and Figure 1.3) of emitted particle morphology
confirms the presence of two forms of 3-D printer particles: primary sub-half-micron
particles (<500 nm) and secondary super-half-micron particles (500 nm - 20 µm) [95,
110]. The majority of particles were agglomerated near-spherical NPs ranging from 10 20 nm size that tends to agglomerate to form larger particles approximately 100 nm in
size. The median primary particle size was ranging between 70 and 100 nm. The
deposition fraction and deposited areas in the human respiratory tract depend, in part, on
the aerodynamic particle size; therefore, the primary particle size is critical [106]. Floyd et
al. [95] reported the presence of micron-sized rod-shaped filament fragments. They
believe that these particles could play an important role in scavenging smaller particles
such as those in the sub-half-micron range. Additionally, the rod-shaped fragments can
pose more pulmonary risks due to the ability to be trapped in the small airways. The 3-D
printer particle morphology is also discussed in more detail above (page 9) in the context
of the nanoparticle formation when Youn et al. [110] recorded real-time measurement of
the PNCs as a function of particle diameter and time during printing with PLA (Figure
1.4).
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Figure 1.3. 3-D printer nanoparticle morphologies. Reproduced from Youn, J.S., et al. [110], Characteristics of nanoparticle formation and hazardous air pollutants
emitted by 3D printer operations: from emission to inhalation. RSC Advances, 2019.
9(34): p. 19606-19612 with permission from the Royal Society of Chemistry.
https://doi.org/10.1039/C9RA03248G.
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Figure 1.4. Real-time measurement of the particle number concentrations as
a function of particle diameter and time. Reproduced from Youn, J.-S., et al. [110],
Characteristics of nanoparticle formation and hazardous air pollutants emitted by 3D
printer operations: from emission to inhalation. RSC Advances, 2019. 9(34): p. 1960619612

with

permission

from

the

https://doi.org/10.1039/C9RA03248G.
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Royal

Society

of

Chemistry.

A variety of materials were detected from the elemental composition analysis of
particles emitted during 3-D printing [90, 103, 110, 119]. For ABS, the following elements
chromium (Cr, most abundant), nickel (Ni), silicon (Si), chlorine (Cl), calcium (Ca),
magnesium (Mg), sodium (Na), aluminum (Al), and sulfur (S) were also reported [119].
For PLA, particles mostly contain Fe, Al, and copper (Cu) [90, 103, 119], and other
studies also reported Si and potassium (K) [110]. It is believed that the presence of
transition metals in 3-D printer emitted particles could be due to the use of pigments and
additives added during filament manufacturing, residual catalysts from the polymerization
process, the equipment used to extrude plastic resin into filament, and the FFF 3-D printer
nozzle [119]. The transition metals could be linked to the reactive oxygen species (ROS)
formation, which is the major mechanism of nanoparticle toxicity, leading to potential
human health adverse effects.
Stephen et al. [101] compared the PNERs from the 3-D printer to ultrafine particle
(UFP) emission reported from cooking activities. They estimated that printing with PLA
has a similar UFP emission rate as cooking with an electric frying pan, and printing with
ABS has a similar emission rate estimate as grilling food on stoves at low power, but
approximately an order of magnitude lower than gas or electric stoves operating at high
power. The same study concluded that because the PNERs were greater than 1010
particles/min, 3-D printer emissions can be classified as “high emitters” according to
criteria set by He et al. [120]. Schripp et al. [121] found that the FFF 3-D printer particle
profiles (particle concentration and size distribution) were in the same range as laser-jet
printers.
1.2.2. Volatile organic compounds
To fully evaluate the potential health concerns from FFF 3-D printing, an
assessment of the complex mixture of gases released during printing that could
deteriorate indoor air quality (IAQ) is needed. Previous studies have found that gas-phase
emissions from 3-D printers may include odorants, irritants, and carcinogens [90, 93, 95,
119]. Commonly detected individual volatile organic compounds (VOCs) from 3-D printing
included styrene [73, 90, 93, 95, 119], lactide [93, 95], caprolactam [93, 95], ethylbenzene
[90, 93, 95, 119], xylenes [93, 95, 119], and aldehydes (acetaldehyde, formaldehyde) [95,
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119, 122]. Monomers or derivatives of filament material were the speciated VOCs
commonly detected [90, 93, 95].
A PubMed and Google scholar literature search was performed to include relevant
publications from 2000 up to December 2020 that evaluated and characterized the volatile
organic compounds released during FFF 3-D printing. As a result, this section will review
the following: 1) the total VOC emission rates (TVOC ERs), 2) the specific VOCs released
during the printing process, and 3) the relationship between VOCs and particle emissions.
Filament material type impacts the differences in the TVOC ERs and types of
VOCs emitted. Within the same filament, the printer make and model influence the
differences in the overall mass of the VOCs emitted [93]. For instance, ABS was found to
release more TVOC than PLA [91, 93, 95, 119, 122]. However, other studies reported
that TVOC ERs were higher for PLA than ABS [90]. The contrasting findings could be
explained on the method employed by each researcher, supporting the need to use a
defined test method so that comparative data can be obtained.
Azimi et al. [93] characterized the VOCs emissions from 16 unique combinations
of five popular commercially available makes and models of desktop 3-D printers and
nine filaments. The 3-D printer filaments were categorized in low emitters and high
emitters, respectively, based on the sum of the ten highest detectable VOCs normalized
by the mass of filament consumed (E∑VOC). The high emitters, with E∑VOC > 40 μg/min,
were nylon, followed by semitransparent nylon-based plasticized copolyamide
thermoplastic elastomer (PCTPE), ABS, laybrick (an imitation brick material of unknown
chemical composition), and laywood (an imitation wood material of unknown chemical
composition). The low emitters, with E∑VOC < 40 μg/min, were PLA, transparent PC, and
a transparent polyester resin filament called T-Glase.
To measure the 3-D printer TVOCs, the above-presented studies used the two
most common methods, based on photoionization detection and GC/MS principle,
respectively. On the other hand, Ding et al. [85] determined the TVOC mass yield per unit
mass of filaments (TVOCWL) via the total weight loss of organic compounds that were
released during printing per unit mass of filaments after extrusion (μg/g or %). It was noted
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that TVOCWL was 0.03% (0.29 mg/g) for PLA, 0.21% (2.14 mg/g) for ABS, and 2.14%
(21.38 mg/g) for PVA. Similar to previous findings [93, 95, 119], which used the semiquantitative methods mentioned above, the levels of TVOCWL were larger for ABS
compared to PLA. Furthermore, to support the emissions variance between the materials,
the relative stabilities were calculated based on the difference between the pyrolysis and
nozzle temperature. The relative stability of PVA was lower (45 °C - 150 °C) in comparison
to ABS (110 °C - 196 °C) and PLA2 (120 °C - 173 °C), which was consistent with the UFP
emissions pattern [85].
To investigate the effects of printer brand on VOCs emissions, two similar filaments
(ABS and PLA) were compared when using two different printers (printer A and E) [122].
It was has established that the printer brand had a significant effect on emissions yields
and TVOC ERs. For ABS, printer E emitted twice as much TVOCs and styrene as printer
A, while for PLA, the reverse was noticed. The particle numbers were influenced similarly
by the difference in printer brands.
Stefaniak et al. [119] evaluated the effect of color on TVOC ERs. It was found that
when printing with different filament types with the same color, the TVOC ERs were
significantly different. For example, ERs for blue ABS (2385 ± 82 μg/h) were higher
compared to transparent blue PLA (131 ± 37 μg/h) and below the limit of detection for
ocean blue PLA. Also, red ABS (2383 ± 357 μg/h) was significantly higher than true red
PLA (49 μg/h). Additionally, the color effect on the TVOC ERs within a given type of
filament varied. For ABS, the ERs for natural color were significantly higher than black.
At the same time, for PLA, there were no statistical differences among PLA filament colors
(ocean blue, transparent blue, true red, and army green) [119]. Similarly, for ABS, the
ERs decreased from red > green > white, while for PLA, there was no difference between
white, black, and natural filament [122].
The impact of nozzle and printer bed temperatures on TVOC ERs was also
explored [93, 119, 122], and conflicting data were discovered. While some studies [122]
suggest that an increase in nozzle temperature has a significant effect on the VOC and
particle emission, other studies found no clear relationship between TVOC ERs and either
bed or nozzle temperatures [93]. However, the PNERs are greatly affected by the nozzle
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temperature [119, 123], with ERs 100 - 10,000 times higher than the ERs at the lowest
temperature. Moreover, Davis et al. [122] suggest that an increase in nozzle temperature
has a greater impact on PNERs (increases by about 128%) and particle mass emissions
(increases by about 106%) than it does for VOC emissions.
The individual VOC information is more critical than the total TVOC ERs since
VOCs' toxicity varies for each chemical. As already mentioned, the VOC emission types
vary upon the filament used, therefore, depending on how the filament is formulated. It
was found [122] that between ABS, PLA, PVA, and HIPS filaments, ABS had the most
compounds detected with 177 individual VOCs, followed by 70 compounds from HIPS,
57 compounds from PLA, 49 compounds from PVA, and 47 compounds from nylon. As
anticipated, styrene and its derivatives, nitriles, and benzothiazole (chemicals with
nitrogen like acrylonitrile and ethylbenzene used in the production of styrene), were
emitted from ABS and HIPS filaments [93, 95, 119, 122]. The primary individual VOC
emitted from nylon, PCTPE, laybrick, laywood, polycarbonate, and T-Glase filaments was
caprolactam [93, 122]. Lactide was found as the primary individual VOC emitted from PLA
filaments [93].
A study to evaluate correlations between VOCs and particles emitted during
printing was conducted [122]. For ABS filament, an increase in styrene and benzothiazole
emission rates (ERs) was strongly associated with increased particle mass ER and
PNERs. For HIPS, because styrene is the main compound released during printing
(similar to ABS), the data point for PNERs versus styrene or TVOCs falls in the range of
ABS data points, however, not for the particle mass emission. HIPS total particle mass
was much higher than that of ABS, also due to larger particle sizes. For PLA, a weak
positive relationship was observed between lactide and total particle mass or PNERs, but
a strong positive relationship was observed between formaldehyde ER and particle mass
ER. Interestingly, lactide’s ER from a PLA with additives (Special PLA) was within the
range of other PLAs tested; however, it emitted more particles (mass and number), as
well as greater TVOC ER. This may indicate that this Special PLA's emissions were
associated with its additives rather than the bulk material. Emissions from PVA behaved
similarly to PLA and lower-emitting ABS for both gas and particle emissions. For Nylon
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filament, an inverse relationship between caprolactam emissions and particle emissions
was noted, where the higher VOC emitting nylon filament emitted fewer particles [122].
New studies indicate that ozone reacts with laser printer-generated VOCs to form
secondary organic aerosols [124, 125]. To test this hypothesis in regard to 3-D printing,
Stefaniak et al. [119] measured the ozone emissions rates and identified the carbonyl
compounds from ABS and PLA emissions. Indeed, compounds such as 4-oxopentanal,
glyoxal, methylglyoxal, and benzaldehyde were identified in both filament emissions
[119], confirming ozone-initiated reactions of alkene compounds from the 3-D printers’
emissions. Therefore, it is essential to identify these compounds as well, besides the
particles and VOCs, to understand the complete array of potential factors that could cause
respiratory or other health effects upon exposure to the 3-D printer emissions.
Studies have compared the 3-D printer TVOC ERs by filament material to those
from laser printers, copiers, and computers [119, 122]. On average, the TVOC ERs were
lower than those from laser printers and dry process copiers. However, some of the high
emitting filaments like ABS and nylon had similar TVOC ERs as lower-emitting laser
printers and personal computers. However, care should be taken considering that when
filaments include additives like bronze and nanotubes, VOC emissions may increase [95]
or decrease [73].
In conclusion, FFF printer emissions consist of complex mixtures, and several
reasons for the observed differences in emissions identified among studies, include
variables such as the printer brand, composition of the polymer filament, printer extrusion
temperatures, and sampling methods used by investigators. Therefore, it is critical to
characterize 3-D printing emissions consistently and accurately. This can be done using
a defined test method to obtain comparative data. The experimental setup (i.e., test
environment and exposure methods) and analysis techniques varied among studies [73,
90, 91, 93, 95, 119], making it difficult to compare data between studies or with other
emissions resources.
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1.3. HEALTH AND SAFETY CONSIDERATION OF FUSED FILAMENT
FABRICATION 3-D PRINTER EMISSIONS
As already mentioned in the previous section, during the thermal decomposition of
filaments, hazardous pollutants such as NPs and VOCs are released into the air [90, 93,
101, 108, 119, 122, 126]. In this section, potential toxicological effects from exposure to
these two components and possible mechanisms of toxicity will be reviewed.
1.3.1. Nanoparticles
1.3.1.1. Deposition behavior of nanoparticles emitted from 3-D printers
As with any emerging technology, the knowledge and research about health and
safety risks from exposure to FFF 3-D printer emissions is unclear and understudied.
Concerns have been raised regarding FFF 3-D printing, as the printer-emitted particles
are smaller than 100 nm, with the potential to penetrate deeper into the lower respiratory
tract upon inhalation, and infiltrating the extra-thoracic and conducting systems [127].
Although it is not the focus of our study, it is worth mentioning that the surface
contaminants of emitted particles can leach out of the parts [128] and potentially result in
enhanced toxicity.
Understanding the deposition behavior of NPs emitted from 3-D printers can help
estimate their potential toxicity in terms of human health perspective. Youn et al. [110],
using multiple-path particle dosimetry (MPPD) model, which evaluated deposition of 10
nm to 20 mm particles over the entire respiratory system, translated exposure to 3-D
printed NPs to inhaled deposited dose by determining the number of NPs that could be
deposited in the human respiratory tract as a function of airway generation number
(Figure 1.5). Based on the total particle number dose (#) per human airway generation
number, approximately 70% of the NPs are deposited in the human respiratory system
ranging in generation number from 16 to 28, with the maximum particle dose occurring (4
× 106 particles) at the 20th airway generation (Figure 1.5(a)), implying that the NPs
deposited in the pulmonary region which consists primarily of the alveolar region (AL)
[129]. Furthermore, examining the particle number dose as a function of both particle size
and airway generation number (Figure 1.5(b)), they estimated that the highest particle
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number dose (6.6 × 106 particles) was observed at the nanoparticle size of 15.1 nm and
the 19th airway generation. Overall, the 10-40 nm NPs showed the highest particle
number dose range, located between the airway generation number 16 and 22, indicating
that a large number of NPs were deposited in the lower respiratory tract compared to that
of the upper respiratory tract [110]. Moreover, when evaluating the total particle deposition
density (#/cm2) per human air generation number, the authors found that approximately
60% of the deposition density appeared in the airway number between 1 and 5, at the
starting point of the tracheobronchial region (TB) in the upper respiratory tract, with the
maximum deposition density occurring in the 3rd airways (3.7 × 104 #/cm2) (Figure
1.6(a)). This is likely because the surface areas of the airway generation number from 15 are approximately 2-530 times smaller than that of the surface areas of the airway
generation ranging from 6-28 [130]. Overall, based on both nanoparticle diameter and
airway generation number, the highest deposition densities were observed for particles
with diameters between 10-40 nm and were higher in the upper respiratory system due
to a smaller surface area (Figure 1.6(b)).
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Figure 1.5. (a) Total particle number dose (#) per human air generation
number and (b) particle number doses per human airway generation number and
nanoparticle diameter. Reproduced from Youn, J.-S., et al. [110], Characteristics of
nanoparticle formation and hazardous air pollutants emitted by 3D printer operations:
from emission to inhalation. RSC Advances, 2019. 9(34): p. 19606-19612.
https://doi.org/10.1039/C9RA03248G with permission from the Royal Society of
Chemistry.
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Figure 1.6. (a) Total particle deposition density (# cm2) per human air
generation number and (b) particle deposition density per human airway
generation number and nanoparticle diameter. Reproduced from Youn, J.-S. [110], et
al., Characteristics of nanoparticle formation and hazardous air pollutants emitted by 3D
printer operations: from emission to inhalation. RSC Advances, 2019. 9(34): p. 1960619612. https://doi.org/10.1039/C9RA03248G with permission from the Royal Society of
Chemistry.
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Using a different approach, Park et al. [131] used the International Commission on
Radiological Protection (ICRP) lung deposition model to estimate inhalation exposure
doses for a reference human during 3-D printing. They estimated that more than 95% (1.3
× 109 nano-sized particles/kgbw/g) of the total inhaled dose on a particle number basis
were inhaled when high emitters filaments (HIPS and nylon) were used for printing and
63%-72% (6.0 × 106 nano-sized particles/kgbw/g) when low emitters (PLA, PVA, or
Laywood) were used, respectively. For the particles larger than 1.0 μm, less than 0.1%
of emissions represented the inhaled dose. However, the mass of particles between 1.0
and 10 μm accounted for a larger proportion of the total inhaled dose (about 60%-90%).
Among the filament’s types, the high emitters produced an inhalation dose of about 82%91% of the total inhaled dose (150-230 ng/kgbw/g) compared to the low emitters 62%76% (10-30 ng/kgbw/g). The deposited fractions in the head airway (HA), the TB, and the
AL were further calculated. It was established that 63.6% (3.1 × 108 particles/kgbw/g)
from the total inhaled dose, deposited in the respiratory regions, with the AL accounting
for the largest proportion (23%-44%) of the total inhaled dose. Specifically, about 40% of
the inhaled dose, was released from the high emitters (5.8 × 106 particles/kgbw/g) and
about 27% (2.0 × 106 particles/kgbw/g) for the low emitters, respectively. Additionally, it
was found that a smaller proportion of emitted particles (16%-41%) deposited in the
respiratory regions on a mass basis than on a particle number basis. For instance, from
5.0-20.2 ng/kgbw/g to 27.7-43.3 ng/kgbw/g for the low emitters and the high emitters
filaments. Despite the large, inhaled dose on a mass basis from the high emitters (170280 ng/kgbw/g), only 17% was deposited, whereas the low emitters on a particle number
basis was 58.7%-70.3%. This could be explained by the larger particle size released by
the low emitters than the high emitters. These larger particles had a greater effect on the
total mass of the deposited dose. Interestingly, it was estimated that 3-D printers release
a higher number concentration of inhaled particles compared to consumer products such
as nano-enabled consumer spray products [132].
Using MPPD and ICRP66 models, Byrley et al. [133] modeled inhaled deposited
mass in different regions of the respiratory tract for different age groups (3 months, 23
months, 3 years, 9 years, 14 years, 18 years, and adults) and both sexes. The highest
predicted deposition mass per surface area in the pulmonary region was for age groups
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3 months through 9 years, whereas deposited mass alone (not normalized) in the
pulmonary region was predicted as highest in the 9-year-old through 18-year-old age
groups. It was predicted that the overall deposition to be lower in females than in males,
possibly due to the smaller tidal volume in females. However, the mass deposited per
pulmonary surface area in the female model was slightly higher than in the male model.
Clearance modeling predicted that most particles (84.9%) deposited in the pulmonary
region were retained after 30 days from a single 2-hr exposure. A simulation of four weeks
daily exposure with 2 hrs. of 3-D printer use every day predicted 67.9% retained mass in
the pulmonary region in male adults at five-month post-exposure period, raising concerns
about cumulative deposition for frequent 3-D printer users.
1.3.1.2. Mechanisms of nanoparticle induced-toxicity
Exposure to NPs poses a cause for concern as toxicity studies have shown that
pulmonary exposure to NPs produces a greater adverse inflammatory response than
larger particles of identical composition at equivalent mass concentrations [134]. The
enhanced toxicity of nano-sized materials compared to the respective bulk materials
arises from the fact that decreasing the size of the materials leads to an exponential
increase in surface area relative to volume, thereby making them highly reactive [135,
136].
Next, three main possible mechanisms underlying NPs-mediated toxicity will be
discussed: oxidative stress (OS), inflammation, and particle translocation. The molecular
mechanism of NPs-induced toxicity is not fully understood, as OS and inflammation are
interconnected [137].
1.3.1.2.1. Oxidative stress: concept and biomarkers
OS is one of the central mechanisms underlying the toxicity of NPs. OS results
from the imbalance of reactive oxygen species (ROS) generation and antioxidant
enzymes [138-141], and it plays a critical role in many diseases, such as pulmonary
diseases, cancer, and arteriosclerosis [142-151]. Particle size, along with shape and
surface area, play a decisive role in toxicity as the smaller the size, the more capable it is
of triggering ROS formation due to the higher number of reactive sites on its surface [15233

154]. It has been also noted that NP-induced biochemical catalysis is promoted by
significantly accelerated chemical reactions with NPs attributed to the dangling bonds
(immobilized free radicals) of the atoms located on the NP surface [155]. These free
radicals affect biological systems through the oxidation of proteins, lipids, and nucleic
acids. Therefore, the degree of OS can be measured indirectly by measuring the levels
of protein oxidation/nitration, lipid peroxidation, and DNA/RNA damage.
When a cell suffers OS, antioxidants present in the cell respond to reduce and
maintain the basal ROS generation. Total antioxidant capacity provides an overall
measure for the cumulative effect of antioxidant defense capacity, including enzymatic
and nonenzymatic systems [156, 157]. Hence, total antioxidant capacity has been
considered a useful indicator of a system’s total antioxidant status, considering that
various antioxidant enzymes, antioxidant vitamins, and micronutrients work in concert and
interact with each other to maintain cellular ROS balance [158, 159]. Previous in vivo and
in vitro studies reported a reduction in the antioxidant capacity following exposure to air
pollutants [160], and metal oxide NPs such as MgO [161], TiO2 and ZnO [162], selenium
(Se) NPs [163], indicating a reduction in antioxidant defense mechanisms.
Phase I and II metabolic enzymes regulate the balance between the
overproduction and destruction of ROS within the cell [164]. Glutathione peroxidase
(GPx) is a major front-line defense phase II enzyme (selenoenzyme antioxidant enzyme),
responsible for breaking down hydrogen peroxide and additional peroxides into less toxic
compounds and reduces the formation of free hydroxyl radicals [165, 166]. GPx has been
considered one of the most important antioxidant enzymes due to its higher affinity than
catalase to hydrogen peroxide, a central redox signaling molecule and contributor to OS
[167]. Animal studies have shown that neurons in mice lacking GPx were more
susceptible to hydrogen peroxide-mediated toxicity than the wild-type mice [168],
reinforcing that GPx is needed to deal with OS, and to eliminate ROS when exposed to
toxicants. Moreover, it has been shown that deletion of the genes regulating glutathioneS-transferase activity, a large family of Phase II enzymes, influenced the level of DNA
adducts and the development of lung cancer [169].
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Protein carbonyl is a major marker of oxidative modification of proteins. Protein
carbonylation results in irreversible protein dysfunction generated via metal-catalyzed
oxidation or from the cleavage of peptide bonds by the α-amidation pathway or by
oxidation of glutamyl residues [170, 171]. Introduction of carbonyl groups such as
aldehyde, ketone, and lactam into the proline, arginine, lysine, and threonine amino acid
side chains of proteins, and subsequent accumulation of protein carbonyl have been
found after exposure to NPs [172, 173], indicating cellular injury and suggesting their
potential role in disease pathogenesis [174]. The use of protein carbonyl as a potential
marker for assessing OS is advantageous compared to the measurement of other
oxidation products because of the relative early formation and carbonylated proteins'
relative stability [175, 176].
Lipids are susceptible targets of oxidation because of their molecular structure that
contains abundant reactive double bonds [177]. Lipid peroxidation is a series of reactions
in cell membranes that produces lipid hydroperoxides as the main product, and many
different aldehydes such as malondialdehyde (MDA), propanal, hexanal, and 4hydroxynonenal formed as secondary products. The reaction is initiated by the formation
of a carbon-centered radical within a polyunsaturated fatty acid of a complex lipid [178].
Malondialdehyde (MDA) is generated via peroxidation of polyunsaturated fatty acids
(omega-3 and omega-6 fatty acids) and is one of the most well-studied markers of lipid
peroxidation [179]. Increased MDA levels following pulmonary exposure to various NPs
have been reported in the literature [173, 180-182].
1.3.1.2.2. Inflammation: concept and biomarkers
The second major mechanism concerning NPs-induced toxicity is inflammation.
Recent research suggests that in the lung, particles (or soluble particle components)
interact with the epithelial cells and resident macrophages (primary targets of inhaled
toxicants). This result in activation of intracellular signaling cascades, triggering
transcriptional activation of pro-inflammatory genes and onset of inflammatory responses
[183]. These initial physio-pathological responses are crucial in modulating the onset and
regulation of innate and adaptive immune responses, since excess or persistence of
inflammation may induce or exacerbate respiratory, cardiovascular diseases, cancer, etc.
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[184-191]. Molecular triggering mechanisms involved in prompting inflammatory reactions
have been categorized into ROS's direct formation with subsequent oxidative stress,
interaction with the lipid layer of cellular membranes and its receptors and ion channels,
and direct interactions with intracellular molecular targets [183]. Phagocytes, specifically
alveolar macrophages (AMs) and polymorphonuclear neutrophils (PMN), and proinflammatory cytokines are known as significant components of inflammatory and
immunologic reactions and applicable tools in evaluating NPs lung defense and injury
[192, 193].
Airway macrophages are known as “the guardians of tissue repair in the lung.”
[194] as their primary role is to keep the air spaces clear by removal of all foreign
materials. AMs are long-lived cells derived from embryonic progenitors that colonize the
airways with the first breath of a newborn [195] and self-renew under homeostatic
conditions, representing the most abundant innate immune cells in the lung [196]. They
are the first to encounter incoming toxicants and pathogens and help orchestrate the
initiation and resolution of the lung's innate and adaptive immune response. To maintain
lung homeostasis, macrophage populations within the lungs identify NPs as foreign
bodies due to surface opsonization and take them up by endocytosis or phagocytosis,
leading to coordinated induction of gene expression, antigen presentation, and cytokine
production [197]. In response to lung injury, under an inflammatory state, resident AMs
are supplemented by newly recruited monocyte-derived macrophages. These are called
infiltrating AMs and are recruited from the bone marrow [198]; however, they remain
short-lived after injury or sometimes last for several months after the disease resolves.
As such, a rise in AMs in bronchoalveolar lavage fluid (BALF) has been known to occur
in response to NPs exposure [199, 200].
AMs are critical effectors in the mechanism underlying the self-clearance of the
pulmonary region. In alveoli, macrophages remove particles by phagocytosis and migrate
towards the mucociliary escalator to be eliminated; this whole process is lasting several
days. However, macrophages are less efficient in the phagocytosis of NMs than
microparticles, making NMs staying longer in the alveolar space, increasing their
probability of interacting and entering the alveolar epithelium and/or crossing the air-blood
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barrier [201]. The recruitment of PMNs in response to the damaging effect of toxicants on
macrophages plays an essential, enhanced role in this process. This neutrophil
recruitment depends on the amount of AMs breakdown products being generated. Thus,
more breakdown products will result in higher and more severe neutrophil influx,
amplifying the effects of particles on the macrophage [202, 203]. That is why neutrophil
ratio to macrophage counts in the BALF is often used as an indirect indicator to establish
different particles' toxicity [204, 205].
In response to injury, when the mucociliary clearance and the AMs are
overwhelmed, the PMNs migrate from the pulmonary vasculature to the inflammatory site
where they will produce several pro-inflammatory mediators, including chemokines that
first attract other PMNs followed by other cell types like monocytes-macrophages and
lymphocytes [206, 207]. However, in addition to their defensive role, PMNs are an
essential source of cytotoxic and proteolytic products such as IL-1α, IL-8, IL-12, TNF-α,
TGF-β, and GRO-α cytokines, which are implicated in tissue damage and inflammation
[207]. Therefore, an increase of PMNs in the respiratory tract can be associated with
significant damage and irreversible architectural changes in the lung [208-211].
Cytokines are small, non-structural proteins with low molecular weights that are
produced by various types of cells, such as neutrophils, eosinophils, basophils,
monocytes, and lymphocytes, that play a pivotal role in homeostasis by modulating and
regulating immunity and inflammation responses [212]. Cytokine functions are pleiotropic
and redundant, in that they accomplish multiple biological functions and often overlap,
acting synergistically or antagonizing each other, and exhibit both negative and positive
regulatory effects on various target cells. This is why cytokine interactions are often
referred to as a network [193].
Because the cytokines are produced very early in the immune response to a
stimulus, they are often measured to predict nanomaterials' immunomodulatory effects
and the possibility of inflammation-mediated toxicity. About 200 cytokines are recognized
and categorized based on which cell type they are produced from: either Th1 cells or Th2
cells. Lately, a third subset of Th cells (Th17) and T regulatory cells (Treg) are described,
which show different cytokine profiles from Th1 and Th2 cells [193]. Macrophages
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produce a plethora of cytokines, including TNF, IL-1, IL-6, IL-12, IL-15, IL-18, chemokines
such as IL-8, MIP1, MIP-1, MCP-1, interferons, among others. Inflammatory cytokines
are further divided into those involved in acute inflammation and those responsible for
chronic inflammation [213]. The key cytokines mediating acute inflammatory reactions
are IL-1, TNF-α, IL-6, IL-11, IL-8, and chemokines including G-CSF, and granulocytemacrophage colony-stimulating factor (GM-CSF). Of these, IL-1 (α and β), IL-6, and TNF
are extremely potent inflammatory molecules. IL-1, IL-6, and TNF-α increase vascular
permeability and, thus, cause swelling and redness associated with inflammation. IL-1
and IL-6 are responsible for fever reactions, whereas TNF-α stimulates endothelial cells
and is responsible for hypotension. IL-8 is a chemokine that plays a vital role in the
activation of neutrophils and their recruitment to the site of inflammation. Many cytokines
act together to initiate and regulate the inflammation process. For example, IFN-γ plays
a significant role in the inflammatory process. It can attract macrophages to sites where
antigens are present [214]. During chronic inflammation, cytokine interactions result in
monocyte chemotaxis to the inflammation site where IFN-γ, MCP-1, and other molecules
activate the macrophages, while GM-CSF and TNF-α retain them at the inflammatory site
[215, 216].
1.3.1.2.3. Translocation: concept and biomarkers of systemic toxicity
While the respiratory tract is considered the primary target organ for inhaled
particles, research has demonstrated that extra-pulmonary organs such as aorta, heart,
liver, spleen, and lymph nodes are also affected [217-220]. Adverse systemic effects
induced by inhalation of NPs are suggested to result via two pathways. 1) the
inflammatory or pro-thrombotic mediators can "spill-over" [221] into the interstitial space
gaining access to the blood. These then get broadcast into the entire systemic circulation,
reaching the secondary organs resulting in disorders. 2) particles' pass directly into the
systemic circulation via uptake and translocation [222]. Once NPs enter the systemic
circulation, they may accumulate in secondary organs and tissues. Uptake and
translocation are believed to occur by two pathways: 1) NP translocation across the airblood-barrier or 2) NP translocation across the gastro-intestinal-tract (GIT) walls. NPs
which were eliminated from the lungs by mucociliary clearance towards the larynx and
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swallowed can enter into the GIT and gain access to extrapulmonary organ either directly
via blood circulation or via the thoracic lymph duct. Indeed, it has been already reported
that nose-only inhalation exposure of rats to the ABS emission for 3 h induced significantly
higher mean arterial pressure concomitant with the elevated resting arteriolar tone and
impaired endothelium-dependent arteriolar dilation [223].
The exact mechanism of NP’s translocation is not clear yet. Thorley et al. [222]
proposed that the NPs uptake and translocation across the pulmonary epithelium is
controlled by alveolar type I epithelial cells but not by either the alveolar type II epithelial
cells or by paracellular transport since the NPs were unable to penetrate the tight
junctions. Riediker et al. [224] suggested the idea of the long-term, macrophage-mediated
clearance (LT-MC) mechanism. This study emphasized the role of interstitial
macrophages (IM) population in phagocytizing NPs and their long-term retention in the
septal interstitial spaces. IM facilitate gradual re-entrainment of NPs on top of the
epithelium for subsequent LT-MC towards the larynx and into the GIT. Re-entrainment
can also occur across the alveolar epithelium and/or via interstitial-lymphatic clearance
to bronchus-associated lymphoid tissue entering the epithelial surface at the airway
epithelium for clearance by surface macrophages. Next, NP’s could move through
bronchus-associated lymphoid tissue at bronchioles-alveolar duct junctions back onto the
bronchiolar epithelium.
The literature review on effects of extra-pulmonary NPs-mediated has shown that
they can mainly accumulate and retain in the liver, spleen, and lymph nodes [225-227],
which may have long-term toxicity implications, and also in the heart, brain, and even in
the soft tissue and bone [228]. Other studies have proved that NPs exposure caused proinflammatory responses in the aorta, heart, and liver [229] indirectly due to mediators
“spill-over” rather than direct NP’s translocation, and uterine microvascular sensitivity,
systemic microvascular dysfunction [220, 223, 230].
Biomarkers of potential NPs-induced systemic effects includes inflammatory
markers measured in blood and serum, while their distribution can be evaluated using
various imaging techniques.
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Complete blood cell count parameters such as neutrophil, monocytes, and platelet
indices have been shown to be highly sensitive markers of systemic inflammation [231234]. These markers have been widely used to determine the severity of inflammation
and as predictors in tissue injury [235], cardiovascular disease [236], hypertension [237],
autoinflammatory diseases, and cancer [238].
Neutrophils are polymorphonuclear phagocytic leukocytes that migrate to
inflamed/damaged tissues, where they complete their functions and ultimately are
eliminated by macrophages [239]. These cells respond quickly to trap and destroy
invading pathogens and foreign agents. Their migration process starts with adhesion to
the endothelial surface, followed by intravascular migration, extravasation, and migration
in the interstitium [240]. GM-CSF or TNF-α, two neutrophil priming agents present in the
peripheral blood, may enhance neutrophil chemotaxis, extravasation, and oxidative burst
production [241]. Therefore, neutrophils can play a dual role. Besides their antimicrobial
function, deregulation of neutrophils and their hyperactivity can lead to tissue damage
due to the accumulation of neutrophils in the vascular bed, increasing vascular
permeability and promoting organ failure [242].
Monocytes are a subgroup of circulating white blood cells that originate from
progenitor cells in the bone marrow and further differentiate into a range of tissue
macrophages and dendritic cells, which remove pathogen-associated molecular patterns,
cell debris, and foreign agents [234]. It has been reported that exposure to particles
causes a systemic inflammatory response that includes stimulation of the bone marrow
with subsequent increases in the release of monocytes [243]. At the site of
injury/inflammation, monocytes produce inflammatory cytokines and contribute to local
and systemic inflammation. In a steady-state, the patrolling anti-inflammatory monocytes
patrol the vasculature to monitor pathogen-associated molecular patterns and become
tissue-resident macrophages. During inflammation, they differentiate into antiinflammatory macrophages, which repair damaged tissues [244]. It has been shown that
MCP-1 and MCP-3 chemokines mediate monocyte recruitment [245]. However, the
mechanism of action remains unclear.
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Platelets play a critical role in tissue wounding, influencing inflammation and
immune regulation [246]. They usually initiate rapid clotting, vasoconstriction,
inflammation, and wound biology, leading to sterilization, tissue repair, and resolution
[247]. Platelets release transmigration stimulating chemokines and cytokines that can
recruit additional platelets, drive monocyte activation and differentiation, as well as
neutrophil adhesion and monocyte recruitment to the endothelium [248]. Human clinical
studies of concentrated ambient ultrafine and fine particles and in vitro and in vivo
exposure studies to diesel exhaust particles have shown that exposure to ambient UFP
activates circulating platelets [249, 250]. Platelets were linked to asthma through
increased P-selectin and eosinophil β1-integrin-mediated leukocyte recruitment [251,
252].
As already mentioned above, the cytokines and chemokines secreted in the lung
in response to NPs exposure and injury can cross into the systemic circulation [221].
Hence, measuring these markers in the serum could be used as an indicator of pulmonary
inflammation. Indeed, changes in serum levels of pro- and anti-inflammatory cytokines
have been observed in human subjects exposed to nanoparticles from photocopiers
[253], diesel emissions [254], among others. These markers will not be further discussed
here as they were already discussed in detail previously.
C-reactive protein (CRP) is the most sensitive acute-phase protein with potent proinflammatory properties, and is used extensively in clinical settings to detect incidence
and the degree of inflammation [255]. It was reported that IL-6 is the main inducer of CRP
gene expression, with IL-1 enhancing the effect [256]. In vitro and in vivo animal studies
suggest that CRP levels increase in response to particle exposure [257].
In a clinical setting, traditionally, serum biomarkers are measured to evaluate
organ damage or disease state, which could also be applied to evaluate systemic toxicity
from exposure to various environmental toxicants, including NPs. Examples of serum
biochemistry biomarkers and the most common abnormality indicated by the test are:
•

albumin (ALB): Impaired renal and hepatic function

•

alkaline phosphatase (ALKP): hepatic disease involving the biliary system
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•

alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate
dehydrogenase (LDH): hepatic parenchymal lesions

•

creatine kinase (CK): skeletal muscle lesions attributable to trauma or vigorous
exercise

•

creatinine (CREA), urea (BUN), and uric acid (URIC): renal disease

•

gamma-glutamyltransferase (GGT): hepatic neoplasia

•

ammonia (NH3): portosystemic/liver shunt (a bypass of the liver by the body's
circulatory system)

•

inorganic phosphate (PHOS): renal failure and gastroenteritis

•

total bilirubin (TBIL): intrahepatic obstruction

•

total protein (TP): Impaired renal and hepatic function, dehydration, gastrointestinal
lesions.
However, because some markers lack the specificity and sensitivity needed to

integrate these into the risk assessment process, novel improved biomarkers are needed
[258].
Field emission scanning electron microscope (FE-SEM) with energy dispersive
spectroscopy (EDS) is the simplest and most efficient method that allows analysis of
inhaled NPs deposited in the lung or translocated to secondary organs, such as the liver
and kidney [259, 260]. This method enables direct tissue examination, allowing
identification and characterization of NPs, as well as alteration of the particles by
processes active in the lung, thanks to improved image resolution, element detection, and
analytical sensitivity.
1.3.2. Volatile organic compounds
Identifying the species present in the gaseous phase released during 3-D printing
is essential in exposure assessment. It was shown that the VOCs emitted from 3-D printer
operation can pose serious risk concerns on human health and the environment as some
are known irritants, carcinogens, odorants, reprotoxins, etc. [110]. Even though the
concentrations reported in the literature were found to be low [90, 93, 98, 108, 119, 122,
126], long-term exposure to these chemicals at low concentrations may cause cancer
[261]. These are listed as hazardous air pollutants (HAPs) in the US environmental
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protection agency (EPA) database [262]. The International Agency for Research on
Cancer (IARC) classifies substances from the HAPs list in terms of groups of suspected
carcinogens [263].
Acetaldehyde, ethylbenzene, formaldehyde, methylene chloride, styrene, and
toluene were VOCs commonly detected in ABS, PLA, and nylon filaments [90, 93, 95,
107, 108, 110, 112, 119, 122, 126]. Formaldehyde is listed as a human carcinogen,
whereas methylene chloride as probable human carcinogens, and lastly, acetaldehyde,
styrene, ethylbenzene as possibly human carcinogens under the IARC [263] and
California Proposition 65 (Prop 65) [264]. Toluene is listed under Prop 65 for its
reproductive and developmental toxicity. These six VOCs are also listed under the
ACGIH® TLV® [117], Committee for the Health Assessment of Building Products’s Lowest
Concentration of Interest (AgBB LCI) [265], and California Department of Public Health
Standard Method (CDPH SM) [266]. Other common thermal degradation byproducts of
filaments listed in these health risk tables are benzenes (known human carcinogen) and
aldehydes (probable human carcinogen). Davis et al. [122] determined that 51 VOCs
(29%) for ABS, 36 VOCs (63%) for PLA, and 30 VOCs (64%) for nylon out of the total
number of individual VOCs identified for each filament material were found at least once
in the five risk tables mentioned previously.
Other hazardous chemicals released that are designated as carcinogenic to
humans

include

trichlorethylene,

acrylonitrile,

methylene

chloride,

chloroform,

tetrachloroethylene, which are defined as probably and possibly carcinogenic to humans
[122, 262]. Hexane and 1,2,4-trichlorobenzene were also detected and not listed as
carcinogens but are known to have effects on the central nervous system after inhalation.
Chlorobenzene, 1,4-dichlorobenzene, lactide, methyl methylacrylate, and hexachloro1,3-butadiene were also detected and not classified carcinogens or toxic to the central
nervous system but are hazardous pollutants that can cause narcosis, irritation, and
cardiac disease [262].
Davis et al. [122] compared predicted indoor air concentrations in personal space,
residential room, and classroom to relevant national and international IAQ criteria (Figure
1.7) based on the CDPH SM, 1/10 ACGIH TLV®, and AgBB ICL risk tables. For this study,
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they used ABS, PLA, nylon, PVA, and HIPS filaments. For ABS, PLA, and nylon,
respectively, 30 VOCs (59%), 19 VOCs (53%), 14 VOCs (47%) out of all the individual
VOCs associated with known health effects were introduced from 3-D printing at much
higher concentrations than background IAQ levels. Predicted concentrations of
caprolactam, an irritant associated with ocular and respiratory toxicity, exceeded some
personal exposure criteria and could exceed AgBB, CREL (chronic reference exposure
level), and ACGIH (1/10 TLV® TWA) criteria. The predicted concentrations of
formaldehyde, a known human carcinogen, exceeded some personal exposure and
maximum residential exposure criteria and could exceed limits set by CDPH SM.
Benzene, also a known human carcinogen, exceeded some criteria for personal exposure
and could be twice the concentration of the CDPH SM's criteria for personal exposure.
The maximum predicted residential concentration and the average personal exposure
concentration for 2-butenal, a highly reactive aldehyde that may cause inflammation and
respiratory and neurotoxic symptoms, exceeded the allowable concentration in AgBB.
The maximum concentration for personal exposure for styrene, an irritant, narcotic, and
neuropathic agent, was above the allowable concentration by AgBB. The maximum
predicted personal exposure concentrations of benzaldehyde and acetaldehyde, both
irritants and/or carcinogens, exceeded recommended AgBB and criteria in one of the
three risk tables. Other VOCs that might potentially exceed the allowable indoor
concentrations in the personal breathing zone were 1-butanol, xylenes, toluene, methyl
styrene, and ethylbenzene. While none of the chemicals of concern showed predictions
in a classroom with three operating 3-D printers that exceeded the IAQ criteria,
concentrations of both caprolactam and 2-butenal criteria could be reached if 18 3-D
printers with nylon filaments were to operate simultaneously in a classroom. The use of
this many printers in a room is common in school/university settings.
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Figure 1.7. Predicted indoor air concentrations in A: personal space, B:
residential room, C: classroom compared to relevant national and international IAQ
criteria. Error bar extends to the predicted concentration value using the maximum ER
measured. Residential background (BG) concentrations were obtained from Logue et al.
[38]and Offermann et al. [39], and classroom background concentrations from Godwin et
al. [40] and Jenkins et al. [41]. Reproduced from Davis et al. [122], Characterization of
volatile organic compound emissions from consumer level material extrusion 3D printers.
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Stefaniak et al. [119] raised concerns about potential adverse health effects
caused by VOCs' exposure during pre-printing and post-printing operations. The
researchers estimated that 50 spools of ABS filament could release about 110 and 640
μg/m3 acetaldehyde and styrene, respectively, after 4 hours of storage in a 3 m 3 closet
without ventilation. After the object was printed, it emitted 4.4–7.4 ng acetaldehyde g−1
h−1 and 5.1–5.9 ng styrene g−1 h−1. If hypothetically, 1000 combs are stored in a 12 m 3
storage room, after 4 hr, acetaldehyde and styrene concentrations would be about 5–9
and 6–7 μg/m3. It was noted that VOC’s exposure levels were low during all steps of FDM
processes, as per TLV®s and Recommended Exposure Limits (RELs). However, since
these values are not intended for home environments, the user should consider using
precautions, especially around children, the elderly, and sensitive individuals.
1.3.3. FFF 3-D printer emissions and printed parts toxicity studies: a literature
review
Concerns were expressed regarding FFF 3-D printing, as the printer-emitted
emissions/nanoparticles generated during operation have been linked to adverse health
effects [101, 223, 267, 268]. A PubMed and Google scholar literature search was
performed to include relevant publications from 2000 up to December 2020 that evaluated
the toxicity of FFF 3-D printer emissions and of FFF 3-D printed parts/raw materials.
1.3.3.1. In vitro studies
Zhang et al. [269] collected ABS and PLA emitted-particles from a consumer-level
3-D printer on membrane filters, resuspended them in deionized water, and assessed
their in vitro toxicity using rat alveolar macrophages and human tumorigenic lung
epithelial cells. It was found that both ABS and PLA were cytotoxic, decreased cell
viability, and increased oxidative stress and inflammatory responses. Furthermore, the
oxidative potential of ABS, PLA, and nylon was assess using cell-free DTT assay. This
study found that PLA had the lowest OPvDTT (particle oxidative potential normalized per
particle mass and the volume of air sampled), followed by Nylon (OPvDTT was 25 times
higher than of PLA), and ABS (OPvDTT was 60−100 higher than that of PLA).
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1.3.3.2. In vivo studies
Exposure of zebrafish embryos to 3-D printer raw materials has been found to
affect their survival and hatching rates, resulting in the inhibition of embryo development,
estrogen receptor transactivation, and oocyte maturation [270-272]. Additionally, it was
found that the stereolithography-printed parts were significantly more toxic to zebrafish
embryos than FFF-printed parts and that exposure to ultraviolet light diminished their
toxicity [271].
Stefaniak et al. [223] investigated the acute toxic effects of ABS 3-D printer
emissions on cardiovascular function after nose-only inhalation exposure in rats. It was
found that the exposure to these emissions for 3 h induced significantly higher mean
arterial pressure concomitant with elevated resting arteriolar tone and impaired
endothelium-dependent arteriolar dilation.
Zhang et al. [269] exposed mice by intra-tracheal administration of ABS or PLA
particle suspensions extracted from filters and 24 h after exposure, analysis of
inflammatory response in BALF was carried out using flow-cytometry. It was found that
all particles produced a strong inflammatory response as indicated by the increase in
neutrophils number. Furthermore, the PLA emitted particles produced stronger
inflammatory response than ABS. However, it is important to note that in this study the
filament concentrations tested were not similar.
1.3.3.3. Human studies
A case report [268] showed that a businessman with a history of childhood asthma
who operated ten 3-D printers using ABS feedstock in a small work area (approximately
85 m3) developed work-related asthma within ten days of initial exposure. He experienced
chest tightness, shortness of breath, and coughing. His symptoms slowly improved and
eventually resolved after his workplace was modified to reduce 3-D printer emissions
exposure. He replaced ABS (a high emitter filament) with PLA (a low emitter filament),
reduced the number of printers utilized, and started using an air purifier with a highefficiency particulate air filter and organic cartridge.
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In a randomized, cross-over design study [273], healthy volunteers were exposed
to ABS and PLA emissions from a desktop 3-D printer for 1 h. Before and after exposure,
pro-inflammatory cytokines (IL-1β, IL-6, TNF-α, INF-γ) and eosinophil cationic protein in
nasal secretions, exhaled nitric oxide, urinary 8-isoprostaglandin F2α (oxidative stress
biomarker), and self-reported symptoms were assessed. Although no clinically significant
acute changes in the biochemical responses of nasal secretions and urine were found,
the volunteers’ exhaled air showed slightly increased levels of nitric oxide after ABS
exposure compared to PLA, which might be due to inhaled ultrafine particle-induced
eosinophilic inflammation.
In a health survey [267], about 60% of participants using 3-D printing in commercial
prototyping businesses, educational institutions, and public libraries reported weekly
respiratory symptoms. The same study also determined that working more than 40 h per
week was significantly associated with asthma or allergic rhinitis diagnosis.

1.4.

RESEARCH GAPS AND PURPOSE OF THE STUDY

The development of low-cost FFF 3-D printers has made this technology widely
accessible for consumers and industry, and its use is likely to continue to increase.
Because of its enhanced product efficiency and reduced waste, FFF 3-D printing
is a valuable tool for more sustainable manufacturing and, possibly, the next generation
of the manufacturing process. The U.S. 3-D printing market is anticipated to grow at a
compound annual growth rate of 27% by 2024. It is expected to exceed more than a $7
billion industry in the U.S. over this time [274].
As with any emerging technology, the knowledge and research about health and
safety risks from exposure to FFF 3-D printer emissions is unclear and understudied.
Furthermore, there are no standard analytical methods to ensure all emissions are
collected uniformly for easy comparison between studies. Standardized test and analysis
methods to reduce and avoid large discrepancies are needed. The exposure variability
could lead to poor predictions of exposure concentrations and could, inevitably, mislead
the relationship between exposure levels and adverse health outcomes.
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Currently, no occupational or consumer exposure limits for 3-D printer emissions
have been established. This cannot be accomplished until the potential toxicological
effects of exposure to emissions are fully understood. It is already established and
described in detail in the previous section that FFF 3-D printing involves heating the
plastic filament to its melting point, which results in release of a mixture of volatile organic
compounds (including carcinogens and chemicals that cause nervous system disorders)
and ultrafine particles that can cause respiratory and cardiovascular diseases [90, 92, 93,
98, 101, 119, 126, 269, 275]. However, there are no sufficient published data regarding
the toxicity of aerosolized emissions from 3-D printers to address the hazards and
potential risks associated with exposure. As presented in the previous section, only five
published studies have examined the health effects of inhaled FFF 3-D printer emissions,
and three studies evaluating the potential toxicity of the printed parts or raw materials
used in FFF. Therefore, further evaluations and research to assess the exposure to 3-D
printer emissions are needed especially identifying the pulmonary adverse health effects
as inhalation is the major route of human entry and exposure for hazardous toxicants
such as particles and gases.
There is a critical need to fill knowledge gaps and assess the potential toxicological
effects of exposure to the FFF 3-D emissions in order to establish effective control
strategies and exposure limits for specific materials to prevent adverse health effects from
3-D printing emission exposure. As such, this study aims to fill the current research gap
by studying 3-D printer emissions' toxicity in order to help develop and implement
evidence-based exposure limits and control strategies. This study's objectives include 3D printer emissions hazard characterization, investigation of the in vivo respiratory and
systemic effects in rats exposed by whole-body inhalation, and in vitro evaluation of
pulmonary effects using a conventional submerged model and a human air-liquidinterface (ALI) airway tissue model.
This study's central hypotheses is that emissions generated during 3-D printing are
toxic and exposure to these emissions induces pulmonary and systemic adverse health
effects. We will test the central hypothesis and accomplish the objective of this study by
pursuing the following three specific aims:
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Aim 1: To evaluate ABS and PC filaments 3-D printer emissions-induced in vitro cell
toxicity.
Aim 2: To evaluate the inhalation respiratory and systemic toxicity of ABS emissions in
rats.
Aim 3: To evaluate the ABS emissions pulmonary effects in vitro in a physiologically
relevant air-liquid interface (ALI) model of human primary bronchial epithelial (NHBE) cell.

1.5.

Conceptual Outline of the Dissertation

Chapter 2: To assess acrylonitrile butadiene styrene (ABS) and polycarbonate (PC)
filaments three-dimensional (3-D) printer emissions-induced cell toxicity.
The main components of the 3-D printer emissions collection system used in this
study consisted of a stainless-steel chamber to house a desktop 3-D printer, a laptop
computer located outside of the chamber to control printer operation, and four
BioSamplers®. The particles and vapors in chamber air were trapped in the collection
medium as the air was drawn through biosamplers' orifices into the collection vessel. After
each print job, the contents of the four BioSamplers® were combined, aliquots were taken
for physicochemical characterization, and the remainder of the collection medium was
stored at 4 °C in a sterile glass bottle and used for in vitro toxicity assessment. To evaluate
the ABS emission-induced toxicity, small airways epithelial cells (SAEC) were seeded in
96-well plates and exposed for 24 h to six doses of ABS-emissions. To do that, the
collection medium generated from two print runs were each delivered at three dilution
levels: as undiluted (or 0% dilution), 25% dilution, and 50% dilution, resulting in six doses.
For cellular uptake and cell morphology evaluation, SAEC were seeded in 6-well plates
at a density of 0.5 x 106 cells per well and incubated overnight, followed by exposure to
undiluted 3-D printer emissions in 2 mL cell culture medium for 24 h. The background
sample was used undiluted. The control samples were treated with Small Airway
Epithelial Cell Growth Medium (SAGM™). The endpoints measured included cellular
uptake, cell viability, cell membrane damage, ROS production and apoptosis using high
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content screening, total antioxidant capacity, glutathione peroxidase levels in cell lysates,
and cytokines and chemokines released in cell supernatants.
Chapter 3: To assess pulmonary and systemic toxicity in rats following whole-body
inhalation exposure of 3-D printer emissions from acrylonitrile butadiene styrene
(ABS) filament.
To date, the only published study evaluating the effects of inhaled ABS-emissions
[223], investigated the acute toxic effects on cardiovascular function via a nose-only
inhalation in rats. It was found that exposure to 1 mg/m³ ABS-emission for 3 h induced
significantly higher mean arterial pressure concomitant with the elevated resting arteriolar
tone and impaired endothelium-dependent arteriolar dilation. These results indicated that
the 3-D printer emissions could potentially induce systemic toxic effects, similar to what
was described previously concerning the inhalation of other types of nanoparticles and
ultrafine particulate matter [276-278]. This study focused on ABS emissions-induced lung
responses, and potential involvement in transducing systemic effects after pulmonary
insult based on the Brook et al. [221] proposed “systemic spill-over” mechanism that
proinflammatory mediators travel from the lung into circulation.
The current study was designed with the objective of identifying and characterizing
potential hazards from FFF 3-D printing and provide data for quantitative inhalation risk
assessments for the development of health-based exposure limits for the use of ABS
thermoplastic filament (the most popular filament on the marker and in the industry), as
currently, no exposure limits exist.
An

inhalation

exposure

system

was

specifically

designed

and

constructed to deliver FFF 3-D printer emissions (NPs + VOCs) to a whole-body
rodent exposure chamber. Sprague-Dawley rat strain (Hla(SD)CVF) was chosen as
animal model because is a preferred animal species to characterize and evaluate the
toxicologic potential of new hazardous substances by the National Institute for
Occupational Safety and Health (NIOSH) and National Toxicology Program. Also, the
previous work in the biomedical literature validates the use of this rat strain as an animal
model for lung toxicology studies.
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The following measures of pulmonary injury and inflammation, as well as systemic
effects, were conducted on ABS-exposed and filtered-air (negative control) animals at all
time points. SEM images of lungs from animals exposed to ABS-emissions were taken to
confirm that the ABS particle reached and deposited in the alveolar region. To determine
the cellular uptake of particles and morphological changes, TEM analysis of BAL cells
was carried out. For the assessment of pulmonary damage, total lung cells as well as
differentiated cells in BAL fluid (BALF) were counted. To further examine the pulmonary
injury, the lactate dehydrogenase (LDH) activity, total protein, surfactant protein A (SP-A)
and D (SP-D) levels in BALF were measured. To evaluate inflammatory responses, a
panel of 9 pro- and anti-inflammatory cytokines were quantified. Along with inflammation,
oxidative stress is a key mechanism linking particle exposure to observable physiological
and biochemical responses. As such, protein carbonyl and malondialdehyde (MDA) levels
were measured to determine the extent of the oxidative damage of protein and lipid
oxidation after exposure to ABS emissions, respectively. To evaluate whether the
pulmonary inflammation triggered by exposure to ABS-emissions would cause systemic
toxic effects to secondary organs, blood samples were analyzed for the clinical
hematological parameters, and the biomarkers of muscles, metabolic, renal, and hepatic
function were evaluated. Furthermore, the levels of pro- and anti-inflammatory cytokines
(similar panel as assessed in BALF) in serum were measured. To confirm the particleinduced injury, sections of lung and nasal passages (T1, T2, T3, and T4) were reviewed
for lesions by a board-certified veterinary pathologist.
Chapter 4: To evaluate 3-D printer emissions pulmonary effects in a physiologically
relevant air-liquid interface (ALI) model of human primary bronchial epithelial
(NHBE) cell.
Considering the dosimetry drawbacks and lack of the physiological features of
airway mucosa when using submerged in vitro models as well as challenging data
extrapolation from animals to humans due to respiratory tract interspecies variability, in
this study normal, human-derived bronchial epithelial cells (NHBEs) cultured at the airliquid interface (ALI), were used to further test the respiratory toxicity of ABS FFF 3-D
printer emissions. Moreover, given that there are numerous types of filament on the
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market, and their toxic effects may vary as their emissions’ physicochemical
characterization varies with each type, and within each type varies with color [90, 93, 101,
119] it is very expensive and practically impossible to test all the filaments using an in
vivo model.
Primary NHBEs cultured at ALI is promising in the domain of inhalation toxicology
as it mimics the in vivo respiratory tract in its organization and stratification, and avoids
limitations posed by the submerged monolayer cultures. Moreover, we will provide new
tools for investigating the effects of FFF thermoplastic filaments, as alternatives to animal
testing. Physiologically relevant respiratory mucosa models, such as in vivo-like in vitro
models cultured at ALI, have been established and are being routinely used to study
inhaled particles or gases mediated respiratory toxicity.
In order to assess the effects of ABS emissions on NHBE 3D culture, a series of
examinations were conducted such as: H&E and periodic acid-Schiff (PAS) staining,
immunofluorescence for α-tubulin, E-cadherin, MUC5AC, and ZO-1 staining of epithelium
on fixed membranes, and trans-epithelial electrical resistance (TEER), and ciliary beat on
live epithelium. Afterward, cytotoxicity, tissue injury, and inflammatory and immune
system regulation markers were evaluated in the supernatant.
Chapter 5: General discussion.
General conclusions on the body of work will be discussed here as well as future
directions to carry the project forward.
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CHAPTER 2: ACRYLONITRILE BUTADIENE STYRENE (ABS) AND
POLYCARBONATE (PC) FILAMENTS THREE-DIMENSIONAL (3-D) PRINTER
EMISSIONS-INDUCED CELL TOXICITY

Adapted from Farcas, M.T., Stefaniak, A.B., Knepp, A.K., Bowers, L., Mandler, W.K.,
Kashon, M., Jackson, S.R., Stueckle, T.A., Sisler, J.D., Friend, S.A., Qi, C., Hammond,
D.R., Thomas, T.A., Matheson, J., Castranova, V., Qian, Y., 2019. Acrylonitrile butadiene
styrene (ABS) and polycarbonate (PC) filaments three-dimensional (3-D) printer
emissions-induced cell toxicity. Toxicology Letters 317, 1-12.
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ABSTRACT
During extrusion of some polymers, fused filament fabrication (FFF) 3-D printers emit
billions of particles per minute and numerous organic compounds. The scope of this study
was to evaluate FFF 3-D printer emission-induced toxicity in human small airway
epithelial cells (SAEC). Emissions were generated from a commercially available 3-D
printer inside a chamber, while operating for 1.5 h with acrylonitrile butadiene styrene
(ABS) or polycarbonate (PC) filaments and collected in cell culture medium.
Characterization of the culture medium revealed that repeat print runs with an identical
filament yield various amounts of particles and organic compounds. Mean particle sizes
in cell culture medium were 201 ± 18 nm and 202 ± 8 nm for PC and ABS, respectively.
At 24 h post-exposure, both PC and ABS emissions induced a dose-dependent significant
cytotoxicity, oxidative stress, apoptosis, necrosis, and production of pro-inflammatory
cytokines and chemokines in SAEC. Though the emissions may not completely represent
all possible exposure scenarios, this study indicate that the FFF could induce toxicological
effects. Further studies are needed to quantify the detected chemicals in the emissions
and their corresponding toxicological effects.

Keywords: emerging technologies, printer emitted nanoparticles, in vitro toxicity, and
inflammatory response.
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2.1. INTRODUCTION
Additive manufacturing (AM) is a family of processes used to build physical objects
from a computer-aided design model. Fused filament fabrication (FFF) is a type of
material extrusion technology used by some 3-D printers to melt and extrude a
thermoplastic filament through a heated nozzle to deposit material on a plate, layer-bylayer, to create a physical object. 3-D printing provides a novel approach for the
fabrication of intricate items that can potentially combine optical, chemical, electronic,
electromagnetic, ﬂuidic, thermal, and acoustic features [279]. Some of the uses of 3-D
printing include tissue and organ fabrication; creating prosthetics, implants, and
anatomical models; pharmaceutical research concerning drug discovery, delivery, and
dosage forms; parts for motor vehicles and rocket engines; and devices in various
industries to advance innovation, production, and efficiency. The U.S. 3-D printing market
is anticipated to grow at a compound annual growth rate of 27% by 2024, and it is
expected to exceed more than a $7 billion industry in the U.S. over this time [274].
The feedstock materials used in AM systems can be liquid or solid in the form of
plastics, metals, or ceramics. Plastics used in FFF 3-D printer filaments may also include
infill materials, such as wood fiber, carbon fiber, silica, or engineered nanomaterials (e.g.,
multi-walled carbon nanotubes). Several types of feedstock filaments are commercially
available for use in FFF 3-D printers, including, but not limited to, polycarbonate (PC) and
acrylonitrile butadiene styrene (ABS). Previous studies have shown that: 1) thermal
degradation of these filaments during 3-D printing releases fine and ultrafine particles; 2)
average particle emission rates range from ∼108 to ∼1011 particles/min with some
variances among different types and brands of filaments and within the same filaments,
but different colors; and 3) particle emission rates fluctuate over the course of printing,
with the highest emission rates occurring at the beginning of printing [86, 89-93]. In
addition to particles, FFF 3-D printers also emit numerous volatile, semi-volatile, and nonvolatile organic compounds during thermal processing, such as aldehydes, ketones,
alcohols, aromatics (benzene, toluene, ethylbenzene, xylenes, styrene), and phthalates.
Several recent studies have shown that exposure to 3-D printer-emissions can
induce potential toxic effects in humans and animals [223, 268, 270, 271]. A case report
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showed that a businessman who operated 3-D printers using ABS feedstock in a small
work area of approximately 85 m3 developed work-related asthma within 10 days of initial
exposure [268]. In a human exposure study, volunteers were exposed to emissions from
a desktop 3-D printer for 1 h, followed by assessing changes in acute inflammatory
biomarkers [273]. Although no clinically significant acute changes in the biochemical
responses of nasal secretions and urine were found, the volunteers’ exhaled air showed
increased levels of nitric oxide, which might be due to inhaled ultrafine particle-induced
eosinophilic inflammation [273]. Exposure of zebrafish embryos to 3-D printer raw
materials has been found to affect their survival and hatching rates, resulting in the
inhibition of embryo development, estrogen receptor transactivation, and oocyte
maturation [270-272]. Stefaniak et al. [223] investigated the acute toxic effects of ABS 3D printer emissions on cardiovascular function after nose-only inhalation exposure in rats.
It was found that the exposure to these emissions for 3 h induced significantly higher
mean arterial pressure concomitant with elevated resting arteriolar tone and impaired
endothelium-dependent arteriolar dilation.
Considering the fast-growing application of 3-D printing technology, the reported
emissions, and the potential adverse health effects from exposure to these emissions,
there is a need to study the toxicity of 3-D printer emissions and the mechanisms of
toxicity both in vivo and in vitro. In this study, emissions were generated in a 0.62 m³
environmental chamber using a commercially available FFF 3-D printer using PC or ABS
filaments. The emissions were collected in a serum-free cell culture medium and
characterized to determine the mean hydrodynamic particle size (nm), particle
concentration (particles/mL), zeta potential, and small organic molecule content. Human
small airway epithelial cells (SAEC) were exposed to these emissions in cell culture
medium to investigate cytotoxicity, apoptosis, and oxidative stress and inflammatory
markers at 24 h post-exposure.
2.2. MATERIALS AND METHODS
2.2.1. Emissions collection setup
The 3-D printer emissions were collected in a stainless-steel test chamber (TSE
Systems, Chesterfield, MO). The collection system consisted of 1) a 0.62 m³ stainless58

steel chamber to house a desktop 3-D printer (LulzBot Mini, Aleph Objects, Inc.,
Loveland, CO); 2) a laptop computer located outside of the chamber to control printer
operation; 3) four BioSamplers® (SKC, Inc., Eighty Four, PA) containing 20 mL of Small
Airway Epithelial Cell Basal Medium (SABM™) (Lonza Inc., Allendale, NJ) (located inside
of the chamber at a distance of 20 – 25 cm from the printer); and 4) tubing that connected
the BioSamplers® to high flow pumps (located outside the chamber) to sample chamber
air at 12.5 L/min (via sonic orifices in the BioSamplers®). The purpose of the chamber
was to collect sufficient amounts of emissions for the planned in vitro studies in a
reasonable time period. As such, the chamber volume is smaller than a typical room
where a 3-D printer may be operated; however, the distance from the BioSampler® inlet
to the printer is reasonable based on our experiences performing workplace
assessments. Each BioSampler® consists of an inlet section, a nozzle section containing
three nozzles, and a collection section containing SABM™. The three sampler
components are connected by a fritted glass fitting. When connected, the three nozzles
are positioned above SABM™ in the collection vessel and airflow through these nozzles
(flow rate controlled by sonic orifices) creates a vortex. As air is drawn through the
nozzles, particles and vapors in chamber air are trapped in the SABM™. To minimize
evaporation of the cell culture medium, two BioSamplers® were operated for the first 45
min of the print job, and two BioSamplers® were operated during the last 45 min of the
print job. Upon completion of sampling, each BioSampler® (each containing about 10 mL
of unevaporated media) was rinsed with a few milliliters of fresh media, and the contents
from all four BioSamplers® were combined in order to obtain an approximately 50 mL
sample that was representative of emissions from the entire 1.5-h print job. In preliminary
studies performed to evaluate the potential effect of temperature on emissions collection,
chamber air was sampled using BioSamplers® placed in ice baths or at room temperature;
no difference was observed in collected emissions characteristics between the two
methods. A two-piece high-efficiency particulate air filter and activated carbon filter
(Whatman, Maidstone, UK) was attached to the chamber inlet to remove particles and
organic chemicals, respectively, from the ambient air before it entered the chamber. The
chamber has sampling ports through which sampling tubing was inserted to connect to
the high flow pumps (Supplemental Figure 2.1 illustrates the sampling setup). The 3-D
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printer sat on an approximately 100 cm x 60 cm perforated stainless-steel support plate
to allow for upward airflow inside the chamber. This minimized areas of stagnant air in
the chamber and resulted in 3-D printer emissions being distributed uniformly in this
chamber; thereby, minimizing bias relative to sampling positions. The chamber leak rate
and air exchange rate were determined by dosing the chamber with sulfur hexafluoride
(SF6) and monitoring its concentration using an infrared spectrophotometer (Miran
Sapphire, Thermo Scientific, Waltham, MA). The leak rate over an eight-hour period was
found to be 0.8%, and the air-change rate was 2.42 air changes per hour [280, 281].
Black PC (Gizmo Dorks LLC, Temple City, CA) and black ABS (3DXTech, Byron
Center, MI) filaments were used to 3-D print an artifact designed by the National Institute
of Standards and Technology (NIST) [282]. Printer settings were 240 °C/110 °C (extruder
nozzle temp/printer bed temp) and 290 °C/110 °C for ABS and PC, respectively (as
recommended by manufacturers). The NIST artifact was printed three times using PC
filament (runs designated PC1, PC2, and PC3) and three times using ABS filament (runs
designated ABS1, ABS2, and ABS3) and was scaled to print within 1.5 h. A background
sample was also collected for 1.5 h by sampling chamber air, while the 3-D printer was
inside the chamber but powered off and not operating. After printing, aliquots of culture
media were taken from the samples for characterization (described below). The
remainder of the medium was stored at 4 °C in a sterile glass bottle and used for in vitro
toxicity assessment within 24 – 36 h.
2.2.2. Emissions characterization
2.2.2.1. Particle size and concentration in cell culture medium
Mean hydrodynamic particle size and particle concentration were determined
using nanoparticle tracking analysis (NTA) (NanoSight NS300, Malvern Instruments,
Worcestershire, UK). For analysis, a syringe pump was used to inject all samples through
a Low Volume Flow Cell top plate at a constant rate at room temperature. Camera and
threshold settings in the NTA instrument varied slightly with each sample to ensure
accurate particle characterization. SABM™ and background samples were also ran at
camera levels/threshold settings similar to the ABS and PC printing samples in an effort
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to determine how much the SABM™ and ambient air contributed to the NTA
measurements. Each sample was captured five times for 60 seconds, for a total capture
time of 5 minutes per sample.
Zeta potential was determined by electrophoretic light scattering (ELS) using a
Zetasizer Nano ZS90 (Malvern Instruments, Worcestershire, UK). The pH of each sample
was measured before each run using a SevenMulti calibrated electrode (Mettler-Toledo,
LLC, Columbus, OH). The parameters of all runs were as follows: refractive index of
material = 0.100, absorbance of material = 0.100, refractive index of dispersant = 1.334,
2.2.2.2. Morphology and elemental composition of particles in medium
Particles collected in cell culture medium were filtered onto a 0.2-micron
polycarbonate filter, mounted on a clean aluminum sampling stub, and coated with a thin
layer of gold/palladium. Particles collected on the filters were imaged and analyzed using
a field emission – scanning electron microscope (FE-SEM, Hitachi S-4800, Tokyo, Japan)
equipped with an energy dispersive x-ray detector (EDX, Quantax, Bruker Scientific
Instruments, Berlin, Germany) to determine elemental contents.
2.2.2.3. Analysis of organic compounds collected in the cell culture medium
Samples were stored at 4 °C until ready for analysis when they were brought to
room temperature. An unfiltered 2-mL aliquot was sampled by submerging a
polydimethylsiloxane/divinylbenzene (PDMS/DVB) (65 µm film thickness) solid-phase
microextraction (SPME) fiber in the solution for one hour. After one hour, the SPME fiber
was removed, and the sample was analyzed by gas chromatography-mass spectrometry
(GC-MS). The inlet temperature was at 250 °C in splitless mode. The GC-MS was
operated in constant flow mode at 1.2 mL/min with ultra-high purity grade helium as the
carrier gas. Separation occurred using an HP-5MS column and the following oven
program: 40 °C for 6 min, ramp to 80 °C at 20 °C/min, hold 4 min, ramp to 240 °C at 20
°C/ min, hold 2 min. Compounds were tentatively identified by comparing mass spectra
to the 2014 NIST/EPA/NIH Mass Spectral Library (NIST 14); only compounds that
matched ≥70% with the Library are reported herein.
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2.2.3. In vitro toxicity evaluation of collected 3-D printer emissions
2.2.3.1. Quantitation of endotoxin
Potential

endotoxin

contamination

was

examined

using

Pierce™

LAL

Chromogenic Endotoxin Quantitation Kit (Thermo Scientific, Waltham, MA). A standard
curve representing endotoxin unit/ mL (EU/ mL) was created using E. coli endotoxin as a
standard, according to the manufacturer’s instructions. The level of endotoxin for all
samples was similar to the endotoxin-free water sample, which was less than 0.05 EU/
mL (approx. 0.005 ng/ mL).
2.2.3.2. Cell culture
Human SAEC were obtained from Dr. Tom K. Hei’s laboratory [283] at Columbia
University (New York, NY, USA) and maintained in SABM™ supplemented with the Small
Airway Epithelial Growth Medium (SAGM™) BulletKit, at 37 °C with 5% CO 2, according
to the manufacturer's instructions (Lonza Inc., Allendale, NJ).
To assess cytotoxicity, oxidative stress response, apoptotic effects, and cytokine
production, SAEC were seeded in 96-well plates at a density of 1.5 × 10⁴ cells per well
overnight, followed by serum-starvation for 12 h. This was done to model an epithelial
monolayer response. Next, SAEC were exposed for 24 h to 100 μL/ well of medium
containing PC or ABS emissions. Each PC (prints 2 and 3) and ABS (prints 2 and 3)
emissions collected in the medium were mixed by vigorous vortexing for 5 min, and
exposed as undiluted (0%), 25% dilution, and 50% dilution in serum-free SABM™,
resulting in six doses for each filament type (Supplemental Table 2.1). For cellular
uptake and cell morphology evaluation, SAEC were seeded in 6-well plates at a density
of 0.5 x 106 cells per well overnight, followed by exposure to undiluted 3-D printer
emissions in 2 mL cell culture medium for 24 h. The background sample was used
undiluted. The control samples were treated with SABM™.
2.2.3.3. Cell viability assay
Cellular viability was determined using the AlamarBlue bioassay according to the
manufacturer’s instructions (ThermoFischer Scientific, Waltham, MA). Briefly, at 24 h
62

post-exposure, the supernatants were collected for the measurements of lactate
dehydrogenase (LDH), along with cytokine and chemokines release. The cells were
rinsed with 100 μL SABM™/ well once, followed by the addition of 200 μL of 10%
AlamarBlue solution to each well. After 4 h incubation at 37 °C, the viability was measured
by quantifying fluorescence levels (ex/em 560/590 nm) using the Synergy H1 hybrid multimode microplate reader (BioTek Instruments, Inc., Winooski, VT).
2.2.3.4. Cell membrane damage
The

release

of

LDH

into

the

cell-free

supernatants

was

assayed

spectrophotometrically by monitoring the reduction of nicotinamide adenine dinucleotide
at 340 nm in the presence of lactate using a Lactate Dehydrogenase Reagent Set (Pointe
Scientific, Inc., Lincoln Park, MI).
2.2.3.5. Transmission electron microscopy
To evaluate the cellular uptake of particles and morphological changes, exposed
SAEC were washed with HEPES Buffered Saline solution and detached using
Trypsin/EDTA Solution (Reagent Pack™ Subculture Reagents, Lonza). After cells were
released, the trypsin was neutralized with Trypsin Neutralizing Solution (Lonza) and
harvested by centrifugation at 800 × rpm for 5 min at room temperature, followed by
fixation in Karnovsky’s fixative (2.5% glutaraldehyde, 2.5% paraformaldehyde in 0.1M
Sodium Cacodylic buffer). Then, the cells were post-fixed in osmium tetroxide, mordanted
in 1% tannic acid, and stained en bloc in 0.5% uranyl acetate. The samples were
embedded in epon™ (epoxy resin in xylene), sectioned, and stained with 4% uranyl
acetate and Reynold’s lead citrate. The sections were imaged on a JEOL 1400
transmission electron microscope (JEOL, Tokyo, Japan).
2.2.3.6. Biomarkers of oxidative stress in cell lysates
Oxidative damage was evaluated using Total Antioxidant Capacity (TAC) and
Glutathione Peroxidase (GPx) assay kits (Abcam, Cambridge, CA) with minor
modifications. After the conditioned media were collected, the cells were re-suspended in
50 µL MilliQ water and 100 µL assay buffer, respectively, and stored at -80 ºC for 24 h to
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induce lysis. Upon thawing, the plates were vigorously shaken at 900 rpm for 5 min,
followed by pipetting up and down three times, and then transferred into the test tubes.
Both assays were performed according to the manufacturer’s instructions. The results
were normalized to total protein concentrations determined using Pierce™ BCA Protein
Assay (ThermoFisher Scientific, Waltham, MA).
2.2.3.7. High content screening
2.2.3.7.1. Reactive oxygen species production
For high content screening (HCS), live cells were stained with a cocktail consisting
of 5 µM CellROX™ Deep Red reagent, 5 µg/ mL of CellMask™ Green plasma membrane
stain, and 1 µM Hoechst 33342 fluorescent nuclear stain (Thermo Fisher Scientific,
Waltham, MA) in culture medium, and incubated for 30 min at 37 °C. Next, the plates
were washed two times with warm HEPES Buffered Saline Solution (Lonza) and imaged
immediately on an ImageXpress Micro XLS (IMX) system (Molecular Devices, Sunnyvale,
CA). Nine sites per well were imaged at 20X magnification with a CMOS 16-bit digital
camera using Cy5 (ex/em 628/692 nm), TRITC (ex/em 543/593 nm), and DAPI (ex/em
377/447 nm) filter cubes. Images from HCS assays were analyzed with the
MultiWavelenth Application Module in MetaXpress v5.3 software to determine mean ROS
intensity [284]. Briefly, masks were applied to cell nuclei, plasma membrane staining, and
ROS signal by user-defined parameters including minimum width, maximum width,
minimum intensity above background, and minimum area stained. Only those positively
stained masks that contained a nucleus were scored as a cell. Mean integrated intensity
of cellular ROS stain was calculated for each site by determining stain intensity under the
area of each mask divided by the number of cells in each image. Mean intensities were
then averaged within and across replicates.
2.2.3.7.2. Apoptosis and necrosis
The apoptotic and necrotic cells were determined using Cell Meter™ Apoptotic and
Necrotic Multiplexing Detection kit (AAT Bioquest, Inc., Sunnyvale, CA) according to the
manufacturer’s instructions. Briefly, at 24 h post-exposure, a cocktail consisting of 2 μL
of Apopxin™ Red apoptosis stain, 1 µL of 200X Nuclear Green™ DCS1 necrotic stain,
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and 1 µL of CytoCalcein™ Violet 450 cytoplasmic stain was added to each well in culture
medium and incubated for 30 min at 37 °C. Next, the plates were washed twice with warm
HEPES Buffered Saline Solution and imaged immediately on the IMX system. Apopxin™
Deep Red staining on the plasma membrane indicated dye binding to phosphatidylserine,
an indicator of the apoptosis. Nine sites per well were imaged at 10X magnification using
Cy5, FITC (ex/em 470/525 nm), and DAPI filter cubes. To analyze the images, masks
were applied using minimum/maximum diameters and minimum intensities for each
channel as described above. Apoptotic cells appeared red and green + red, the necrotic
cells were green, and viable cells appeared blue only. Cell counts and percentages for
each phenotype at each site were calculated and averaged within and across replicates.
2.2.3.8. Cytokines, chemokines, and growth factors
The levels of IL-1β, IL-6, IL-8, TNF-α, IL-12/IL-23p40, IL-16, IL-1α, and IL-13 in the
cell-free supernatants were determined using V-PLEX Cytokine and Chemokines Human
Kits from Meso Scale Discovery (MSD, Meso Scale Discovery). Plates were read using
MSD QuickPlex SQ 120 (Meso Scale Discovery) for electrochemiluminescence. Sample
concentrations were derived from a standard curve plotted using a four-parameter logistic
fit using MSD Workbench software. Data were normalized to total cell number per well
determined using HCS.
2.2.4. Statistics
Studies were performed in three independent experiments with 3 - 6 replicates
each. The data are represented as percent of control. All statistical analyses were
performed in either SAS v9.4, or JMP v13. Mixed model regression analyses were
performed on the measured variables using particle number*10 -4 as the independent
variable, and printer batch as a random factor. These analyses included background
levels of particles as data points, as well as zero particle controls. Regression coefficients
which are significantly different from 0, indicate dose-responsiveness of the dependent
variables. Analyses were performed for the two filaments separately. All analyses are
considered significant at p < 0.05.
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2.3. RESULTS
2.3.1. Physicochemical characterization of FFF 3-D printer emissions in cell
culture medium
3-D printer emissions were collected in SABM™ and characterized to determine
particle concentration, mean hydrodynamic diameter size, zeta potential, particle
morphology, and organic compounds content. Supplemental Table 2.2 presents
characteristics of the SABM™ medium for the PC and ABS print runs. The printing of both
filaments resulted in higher numbers of particles in cell culture medium compared to the
background air control. Note that the “background” sample was collected by pulling
chamber air through the BioSamplers® with SABM media while the 3-D printer was off.
The background particle counts in media may be from 1) particles in the chamber or in
chamber air that passed through the HEPA-filtered make-up air (usually <500
particles/cm3); 2) solids in the culture media; and/or, 3) air bubbles formed during
sampling from agitation and swirling of the media in the BioSampler®. During extrusion of
ABS and PC, peak particle number concentrations are 104 to 105 particles/cm3 [92, 285],
meaning that the contribution of ambient particles to printer emitted particles is at most
5%. NTA of media (no air pulled through it) confirmed that the media contained virtually
no particles indicating that there were no solids in the media that were incorrectly counted
as particles. Hence, the background “particle” concentration in the SABM media
presented in Supplemental Table 2.2 consists of a small fraction of ambient dust
particles, but the majority of “particle” counts were likely an artifact from the instrument
sensing air bubbles formed by agitation and swirling of media while drawing air through
the BioSamplers®. PC filament led to a higher number of particles compared with ABS.
The mean diameters of particles of PC and ABS in the medium were 201±18 nm and
202±8 nm, respectively. The zeta potentials of particles in both suspensions were
negative, about −18 mV. The number-based size distribution of the particles showed that
the PC run had mainly one large distinct mode between 140-170 nm, while ABS run had
two modes, the first at about 140-150 nm and the second at around 250-300 nm,
suggesting that particles from ABS had a broader distribution than those from PC (Figure
2.1).
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Representative images of 3-D printer emissions particles collected in cell culture
medium indicating surface morphology (FE-SEM) and elemental composition (EDX) are
shown in Figure 2.2. Occasionally particles composed of silicon were observed on the
background filter that may be from the low level of particles in the filtered make-up air or
a contaminant on the filter. The morphology of the background particle was more angular
than the printer emitted particles, and its elemental composition was consistent with
ambient dust and dissimilar from the printer emitted particles. EDX analysis showed that
the main elements of PC and ABS particles were C, O, Ca, Na, Si, Ni, Cr, Fe, S, Al, and
Cl (Figure 2.2).
SPME/GC-MS was used to identify the organic compounds in the collected
emission medium. The results were compared with the NIST/EPA/NIH Mass Spectral
Library, and the compounds that matched ≥ 70% with the library are shown in
Supplemental Figure 2.2. Supplemental Table 2.3 shows for information only the
qualitative results of the detected individual compounds from all print runs.
Representative chromatograms in Supplemental Figure 2.2 show the retention times for
each compound identified during the PC and ABS print runs (no organic compounds were
detected in the background sample). During the PC print run, the compounds observed
in the sample collection medium were tentatively identified as bisphenol A (BPA), pisopropenylphenol, and phenol; whereas, styrene, 3-cyclohexen-1-ylbenzene, α,αdimethylbenzenemethanol, and acetophenone were detected when the ABS filament was
used.
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Figure 2.1. Number-based size distribution of 3-D printer-emitted particles
collected in the cell culture medium. 3-D printer emissions using PC (A) and ABS (B)
were collected in cell culture medium, followed by analysis using NTA.
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Figure 2.2. Representative images of 3-D printer-emitted particles collected
in the cell culture medium indicating surface morphology and elemental
composition. 3-D printer emissions were collected in cell culture medium, passed
through a track-etched polycarbonate filter, and analyzed using FE-SEM (A-C) and EDX
(D-F). (A) Background, (B) PC, (C) ABS. D-F are representative elemental analysis
spectra for A-C. Magnification at 70k× for all images, scale bar at 400 nm.
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2.3.2. Toxicological evaluation of 3-D printer emissions collected in media
2.3.2.1. Uptake of 3-D printer-emitted particles by SAEC
The uptake of particles in the medium by SAEC was investigated. The cells were
cultured to confluence in 6-well plates and then were exposed to PC or ABS emissions in
suspension, followed by TEM analysis. Figures 2.3 presents TEM images indicating the
internalization of PC and ABS 3-D printer-emitted particles that were enclosed in a lipid
membrane, similar to an endosome.
2.3.2.2. Cytotoxicity
Both cell viability assays and LDH measurements were performed to determine
cellular toxicity from exposure to emissions collected in media. The AlamarBlue-based
cell viability assay revealed changes in cell proliferation, while the LDH measurements in
the supernatants showed the release of a soluble cytosolic enzyme upon cell death due
to cell membrane damage. 3-D printer emitted particles collected in media induced a
significant (p < 0.0001) dose-dependent decrease in cell proliferation (Figure 2.4, Table
2.1). Results revealed that for each 104 PC and ABS particle exposure, the cell viability
decreased by 0.048% (Table 2.1). The decrease of cell viability correlated with the dosedependent increase in LDH activity (p < 0.0001) in the supernatants. Specifically, each
104 PC and ABS particle exposure resulted in a significant dose-dependent increase by
0.051% and 0.110% LDH levels in SAEC, respectively (Figure 2.4, Table 2.1). Taken
together, these results demonstrate that exposure to both PC and ABS emissions
collected in cell culture medium showed dose-dependent toxicity in SAEC.
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A

B

2 µm

C

2 µm

D

400 nm
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E

F

2 µm

400 nm

Figure 2.3. Uptake by SAEC of 3-D printer-emitted particles collected in the
cell culture medium. SAEC were treated with medium containing 3-D printer emissions
for 24 h, followed by TEM image analysis. (A) Control, (B) Background, (C) 100% PC,
(D) C inset, (E) 100% ABS, and (F) E inset. A, B, and C images are at 2,000x
magnification, and image E at 2,500x magnification. D and F images are at 15,000x
magnification. A, B, C, and E scale bar at 2 μm; D, F scale bar at 400 nm.
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Figure 2.4. Cytotoxicity of the 3-D printer-emitted particles collected in the
cell culture medium: cell viability and LDH activity following exposure to PC (A)
and ABS (B) emissions. Experiments were performed in three independent experiments
with n = 6 replicates each. The regressions lines illustrate a significantly (p < 0.0001)
decreased dose-response relationship between cell proliferation and the numbers of the
PC and ABS 3-D printer-emitted particles, which correlated with a significant (p < 0.0001)
dose-dependent increase in the LDH activity in the supernatants. The shaded area
represents the 95% confidence interval around the regression line.
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PC

Variable

ABS

Slope

StdErr

Slope

StdErr

Viability, % of Control

-0.04790*

0.00319

-0.04794*

0.00733

LDH, % of Control

0.05077*

0.00636

0.11021*

0.00852

ROS, % of Control

0.07479*

0.00960

0.14836*

0.01950

TAC, % of Control

-0.00657*

0.00233

-0.03915*

0.00847

GPx, % of Control

-0.01604*

0.00133

-0.03511*

0.00690

Apoptosis, % of Control

0.28506*

0.05598

0.37508*

0.05277

Necrosis, % of Control

0.23467*

0.03618

0.14447*

0.03246

IL-12p70, pg/total cells

0.00650*

0.00111

0.00760*

0.00112

IL-13, pg/total cells

0.00020*

0.00004

0.00022*

0.00003

IL-16, pg/total cells

0.12797*

0.02741

0.09414*

0.00960

IL-1β, pg/total cells

0.09851*

0.03645

0.00125*

0.00017

IL-1α, pg/total cells

0.01725*

0.00543

0.00268*

0.00081

IL-6, pg/total cells

0.00001*

0.00000

0.00002*

0.00000

IL-8, pg/total cells

0.00095*

0.00018

0.00005

0.00015

TNF-α, pg/total cells

0.00619*

0.00119

0.00064

0.00038

Table 2.1. Linear regression slopes (with standard errors) of the all variable
investigated following exposure to PC and ABS 3-D printer-emitted particles
collected in the cell culture medium. All statistical analyses were performed in either
SAS v9.4, or JMP v13.

Mixed model regression analyses were performed on the

measured variables using particle number*10-4 as the independent variable, and printer
batch as a random factor. Regressions coefficients which are significantly different from
0, indicate dose-responsiveness of the dependent variables. Analyses were performed
for the two filaments separately. All analyses are considered significant at p < 0.05 (*).
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2.3.2.3. ROS production and oxidative stress
It has been well-established that exposure to particulate matter induces the
production of ROS, which causes cell injury or oxidative stress, leading to the
development of various diseases [142, 286]. SAEC were exposed to PC or ABS 3-D
printer emissions collected in cell culture medium for 24 h, followed by high content
imaging to determine the production of ROS. Both PC and ABS particles induced a
significant (p < 0.0001) dose-dependent increase in the production of ROS (Figure 2.5,
Table 2.1). The mixed model regression analyses revealed that for each 10 4 particle
exposure, ROS production increased by 0.075% and 0.148% for PC and ABS in SAEC,
respectively (Table 2.1).
One of the main properties of ROS is to cause cellular injury, and cellular systems
are protected from ROS-induced injury by an array of anti-oxidant defenses.
Measurements of TAC and GPx activity can indirectly reflect ROS-induced oxidative
stress in cells. As shown in Figure 2.6, PC and ABS emitted-particles collected in cell
culture medium triggered a significant dose-dependent decrease (p < 0.0001) in TAC
levels, with concomitant decline in GPx activity (Table 2.1). Specifically, for each 104
particle exposure, the TAC levels decreased by 0.007% and 0.039% for PC and ABS in
SAEC, respectively, whereas the GPx activities decreased by 0.016% and 0.035% for PC
and ABS in SAEC, respectively (Table 2.1).
2.3.2.4. Apoptosis and necrosis
To confirm apoptosis from exposure to PC and ABS emissions collected in media,
the measurement of externalization of phosphatidylserine, a hallmark of apoptosis, was
applied. Results illustrated that for each 10⁴ PC and ABS exposure, the number of
apoptotic cells increases by 0.235% and 0.144% in SAEC, respectively (Table 2.1). To
further identify other mechanism-involved cell death, 7-amino actinomycin D (7-AAD), a
membrane impermeant dye which is bound to double-stranded DNA of non-viable cells
and excluded from viable cells, was used to determine necrosis upon exposure to
emissions collected in media. Results reveal a significantly increased dose-response
relationship (p < 0.0001) between apoptotic or necrotic events and the numbers of the
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PC and ABS 3-D printer-emitted particles collected in the cell culture medium (Figure 2.7,
Table 2.1). Results showed that for each 10⁴ PC and ABS particles, the number of
necrotic cells increases by 0.285% and 0.375% in SAEC, respectively (Table 2.1).
2.3.2.5. Cytokine and chemokine responses
A panel of 8 pro-inflammatory cytokines and chemokines in the supernatants was
evaluated to determine the inflammatory responses upon exposure to 3-D printer-emitted
particles collected in medium and exposed to SAEC. With the exception of IL-8 and TNFα in the collected ABS emissions-exposed cells, model regressions analysis (Table 2.1)
reveals a significant (p<0.0001) positive correlation between the levels of IL-12p70, IL13, IL-16, IL-1β, IL-1α, IL-6, IL-8, and TNF-α levels and the quantity of particles in the
ABS and PC emissions sample medium. Details of cytokines/chemokines changes are
given in Supplemental Table 2.4.
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Figure 2.5.

ROS production following exposure to 3-D printer-emitted

particles collected in the cell culture medium. SAEC were stained with a cocktail
consisting of 5 µM CellROX™ Deep Red reagent, 5 µg/mL of CellMask™ Orange plasma
membrane stain, and 1 µM Hoechst 33342 fluorescent nuclear stain. (A) Representative
confocal images of untreated cells, and cells exposed to background, PC, and ABS
collected emissions for 24 h. Quantitative ROS levels of PC (B) and ABS (C) using high
content screening. Magnification at 20× and scale bars are at 50 µm for all images.
Experiments were performed in three independent experiments with n = 6 replicates each.
The regressions lines illustrate a significantly (p < 0.0001) increased dose-response
relationship between ROS production and the numbers of the PC and ABS 3-D printeremitted particles. The shaded area represents the 95% confidence interval around the
regression line.
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Figure 2.6. Oxidative stress response following 3-D printer-emitted particles
collected in the cell culture medium: total antioxidant capacity and glutathione
peroxidase activity following exposure to PC (A) and ABS (B) emissions.
Experiments were performed in three independent experiments with n = 3 replicates each.
The regressions lines illustrate a significantly (p < 0.0001) decreased dose-response
relationship between total antioxidant capacity and glutathione peroxidase activity and
the numbers of the PC and ABS 3-D printer-emitted particles. The shaded area
represents the 95% confidence interval around the regression line.
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Figure 2.7. 3-D printer-emitted particles collected in the cell culture medium
increase apoptosis and necrosis. SAEC were stained with a cocktail consisting of 2 μL
of Apopxin™ Red apoptosis stain, 1 µL of 200× Nuclear Green™ DCS1 necrotic stain,
and 1 µL of CytoCalcein™ Violet 450 cytoplasmic stain. (A) Representative confocal
images of untreated cells, and cells exposed to background, PC, and ABS collected
emissions for 24 h. Quantitative apoptosis and necrosis analysis of PC (B) and ABS (C)
using high content screening image analysis. Magnification at 10× and scale bars are at
50 µm for all images. Experiments were performed in three independent experiments with
n = 6 replicates each. The regressions lines illustrate a significantly (p < 0.0001) increased
dose-response relationship between apoptotic or necrotic events and the numbers of the
PC and ABS 3-D printer-emitted particles. The shaded area represents the 95%
confidence interval around the regression line.
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2.4. DISCUSSION
The toxicity evaluation of emissions generated during 3-D printing is essential. The
widespread use of this emerging technology in industries, along with the lack data on
health effects available to consumers in homes and schools, highlights a knowledge gap,
which must be filled.
This study sought to evaluate the cellular toxicity of emissions generated from a
commercially available 3-D printer, while operating with PC or ABS filaments. Total
emissions were collected during printing a 1.5 h print job, which is equivalent to production
of a small object. It is probable that not all particles emitted during extrusion of ABS or PC
filament were present in the media exposed to cells because of losses in the chamber
and the BioSamplers® as well as agglomeration in the media. Chamber wall losses occur,
but in our experience with this chamber, the fraction of particles lost is on the order of 104

[92]. Particle losses in the BioSampler® include internal losses (the fraction of particles

collected in media that is aerosolized from the collection liquid, adheres to the samplers
walls, and remains on the walls), which can be 30% [287] and sampling inefficiency, which
may exceed 90% in the 20 to 300 nm size range because small particles have insufficient
inertia to be collected in media by the centrifugal collection motion in the sampler [288].
Accounting for chamber and BioSampler® losses, we estimate that less than 25% of
emitted particles were collected in the SABM™ media. However, this value is likely
underestimated because the number of airborne particles that formed agglomerates in
the media after being trapped in media but prior to determination of colloidal concentration
is unknown.
This study revealed that the 3-D printer emissions collected in cell culture medium
from PC and ABS filaments could be cytotoxic. This observation may be an effect of
particle size. It has been well established that smaller particles cause more severe
inflammation and oxidative stress than the larger particles at the same administered mass
dose due to increased reactive surface area per particle [289, 290]. Note that the size
and morphology of particles in culture media that was delivered to cells likely differs from
the characteristics of particles emitted into air during 3-D printing. In a prior study,
extruding these ABS and PC filaments on the same printer released diffuse clusters of
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nanoscale polymer particles with geometric mobility mean sizes of 22.7 nm and 47.5 nm,
respectively [285]. In culture media, the measured particle hydrodynamic diameters were
about 170 to 200 nm (Supplemental Table 2.2). It is important to clarify that the airborne
particle size is the mobility diameter, whereas the particle size in media is the
hydrodynamic size. Hence, differences in the basic measurement principle of each
technique explain at least some of the observed deviation in particle size. Other factors
contributing to the difference in particle size between the aerosol phase and the media
include agglomeration in SABM™ if the particle surfaces are hydrophobic. Emitted
particles from extrusion of ABS and PC are diffuse clusters with morphology similar to
welding fume [126], whereas the particles in the culture medium were denser clusters
(Figure S2). Though changes in size and morphology were observed between the
aerosol phase and particle in culture media, in humans, inhaled emissions would interact
with lung airway-lining fluid and presumably be subject to interactions that alter particle
size and morphology as well.
Metals may be present in filaments as constituents of plasticizers. Additionally, to
enhance the printed object’s aesthetic, structural, or functional properties, many types of
additives and pigments, which may contain transition metals such as Cr, Fe, and Co, are
added to the base polymer used to produce 3-D printer filaments. In this study, EDX
analysis showed that the main metals of health significance in the ABS and PC particles
were Ni, Cr, and Fe. Aside from this study to our knowledge, there is no information on
the elemental composition of particles released during 3-D printing with PC filament. The
presence of Ni, Cr, and Fe in particles emitted during 3-D printing with ABS were noted
in this study as well as in other published studies [90, 115], and might undergo redoxcycling (Fenton or Haber-Weiss reactions) and promote the production of ROS.
The induction of ROS and oxidative stress is one of the central proposed
mechanisms of nanoparticle-induced toxicity. ROS are a collective term for the
intermediates formed during oxidative metabolism, including both oxygen radicals and
non-radical reactive oxygen derivatives. Cells normally maintain a low physiological level
of ROS with antioxidant defense systems. Cellular systems are protected from ROSinduced cell injury by an array of defenses composed of various antioxidants with different
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functions. When levels of ROS overwhelm defense systems, either due to an increase in
ROS production or a decrease antioxidant defense systems, oxidative stress can induce
cellular macromolecule damage, including DNA, proteins, and lipids [291]. In this study,
we detected elevated production of ROS after exposure to medium containing emissions
from printing with PC and ABS filaments. Similar findings were noted by Watson-Wright
et al. [292], who reported increased ROS production in SAEC exposed to the particulate
matter released from the thermal decomposition of PC thermoplastic.
Oxidative stress is a biological process of an imbalance between the amount of ROS
produced and the protective response of antioxidant defense systems. The measurement
of antioxidant status can be used indirectly to assess oxidant stress [293]. Most
antioxidant enzymes are naturally induced upon ROS production in vivo, and the
induction of antioxidant activities decreases or delays ROS-induced oxidative damage.
Therefore, the measurement of antioxidant status not only indicates the status of the ROS
production but also reflects the propensity of individuals to oxidative damage. In this
study, collected PC and ABS emissions decreased TAC in exposed SAEC, indicating
oxidative stress.
GPx is an antioxidant enzyme that catalyzes the reduction of hydrogen peroxide
(H2O2) to water and lipid peroxides to lipid alcohols via the oxidation of reduced
glutathione (GSH) into its disulfide form (GSSH). In the absence of adequate GPx activity
or glutathione levels, H2O2 and lipid peroxides are not detoxified and may be converted
to OH-radicals and lipid peroxyl radicals, respectively, which may result in oxidative
stress-induced pathologies. We found that exposure of SAEC to medium containing PC
or ABS emissions decreased total antioxidant capacity and GPx activity. Similarly,
Watson-Wright et al. [292] reported that released particulate matter from the thermal
decomposition of PC thermoplastic caused a reduction in GSH levels in SAEC.
Additionally, exposure to the products of oxidative thermal degradation of ABS caused a
decrease of GSH and impairment of membrane integrity in isolated rat hepatocytes [294].
The production of ROS and oxidative stress has been implicated in triggering and
modulating apoptosis [295]. In this study, increased apoptosis in SAEC was detected after
exposure to PC or ABS emitted-particles collected in cell culture medium, which could be
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caused by the impairment of cellular redox homeostasis [296, 297]. Similarly, WatsonWright et al. [292] demonstrated that the released particulate matter from the thermal
decomposition of PC thermoplastic caused a reduction in mitochondrial membrane
potential in SAEC, which could suggest a link between the disruption of intracellular redox
homeostasis and the stimulation of mitochondrial apoptotic pathway. Additionally, we
found that PC and ABS emissions collected in cell culture medium induced necrosis in
SAEC. Recent studies found that some components of the apoptotic signaling pathway,
such as the BH3-only protein (Bmf), are also crucial in necrotic pathogenesis [298].
Several studies showed that apoptosis and necrosis are closely linked to each other [299,
300]. The apoptotic process may proceed to an autolytic necrotic outcome called
secondary necrosis [301].
In an experimental exposure study in healthy human volunteers that investigated
acute health effects of 3-D printing using high ultrafine particle-emitting ABS vs. lowemitting polylactic acid (PLA) filaments, after 1 h post inhalation exposure, Gumperlein et
al. [273] found no acute effect on inflammatory markers in nasal secretions and urine. In
our in vitro study, cellular exposure to medium containing emissions from 3-D printing
with PC increased the production of pro-inflammatory cytokines, such as IL-1β, IL-1α, IL6, IL-12(p70), IL-8, IL-13, IL-16, and TNF-α in SAEC. In contrast, medium containing ABS
emissions increased the production of IL-13, IL-8, IL-8, and IL-16. Further, these findings
were correlated with increased ROS production and higher occurrence of apoptosis and
necrosis in PC emissions-exposed cells. Cytokines and chemokines are known to
orchestrate the intricate network of interactions associated with the inflammatory process
[302], and play an essential role in the pathogenesis of lung fibrosis, asthma, and chronic
obstructive pulmonary disease [303-306]. IL-1 is a central mediator of innate immunity
and inflammation and is released from lung epithelial cells to induce inflammatory
responses [307]. It was found that IL-1β and TNF-α mediate apoptosis by disrupting
normal mitochondrial function in human chondrocytes [308]. Also, IL-1α can be released
from cells during apoptosis or necrosis [309-311], alerting the immune system to general
tissue damage and initiating a cascade of inflammatory cytokines and chemokines [312,
313]. IL-13 secretion plays a key role in many aspects of airway remodeling [314-316].
Overproduction of IL-13 could be a response to inadequate epithelial repair due to injury.
84

Previous studies established overexpression of IL-13 by epithelial cells in response to
exposure to diesel exhaust using an in vivo model [317]. Whether inhalation of 3-D printer
emissions triggers inflammatory signaling in humans is still unclear, and further studies
using longer exposure times representative of workers are needed.
There are many types of thermoplastic filaments and 3-D printers on the market; it
would be a hard task to evaluate all of them in this research study. Therefore, we focused
on one printer and two widely used filaments, PC and ABS using a chamber emissions
collection system. First, we would like to emphasize that it is not possible to generalize
our results from a single printer and two types of filaments to cover all 3-D printing.
Second, in this study, major organic compounds present in cell culture medium after 3-D
printing were qualitatively identified using SPME/GC-MS. However, it is well known that
organic compound emission rates can be on the order of tens to hundreds of micrograms
per gram of extruded polymer [93, 95]. Hence, it is possible that not all emitted organic
compounds were collected in the cell culture medium during 3-D printing. Third, any
reactive chemical species generated may be lost or form new species that may not exist
in the printer emissions due to interaction with components of the culture medium.
However, the inhaled emissions would interact with lung airway-lining fluid and
presumably be subject to interactions as well. It is also possible that if the particles
collected in the medium exhibit aqueous solubility, those with greater solubility would be
more likely to go into solution or leach adsorbed constituents into the media. Fourth, when
inhaled, organic compounds and particles with surface adsorbed organics might not
solubilize at the same relative levels as direct exposure to the cells; again, there would
be an interaction of deposited contaminants with airway-lining fluid. Fifth, the operation of
3-D printers with polymer feedstock simultaneously releases both particulate and organic
compounds, making it difficult to disentangle their relative effects on the observed
endpoints. Sixth, the proximity of the BioSamplers® to the printer is only representative of
some workplace scenarios where the employee is near a printer, so the amount of
emissions collected are likely higher than in a room with ventilation or where an employee
only routinely checks the progress of a print job. Finally, even performing repeat print runs
of the same filament using the same 3-D printer does not yield exactly the same results
each time in terms of number of particles or types and amounts of organic compounds.
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Hence, within and between study comparisons of toxicity endpoints will be challenging
because of inherent printer variability.
In this study, we observed that the FFF 3-D printer emissions collected in culture
medium induced increased production of ROS and expression of pro-inflammatory
cytokines and chemokines, as well as apoptosis and necrosis. Based on our results, we
believe that the toxicological profiles of PC and ABS emissions are different. However,
due to the complexity of these two emissions and different ranges of the particle numbers
generated, it is hard to give a conclusion of toxicity between PC and ABS emissions in
SAEC at this time. We will address this issue in the future.
2.5. CONCLUSIONS
This study demonstrated that 1) FFF 3-D printing with PC filaments resulted in
more particles in cell culture medium than ABS over a similar printing time; 2) exposure
to 3-D printer emissions collected in media induced dose-dependent toxicity in SAEC;
and 3) emissions collected in media induced ROS production and oxidative stress,
increased apoptosis and necrosis, and stimulated secretion of inflammatory chemokines
and cytokines. The potential relationship with the observed in vitro effects as well as with
hazard and risk of the workplace activity will need further studies with an exhaustive
quantitative assessment of the detected chemicals, in vitro testing with defined mixtures
of the relevant chemicals.
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2.8. APPENDIX
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Supplemental Figure 2.1. 3-D emissions collections setup. The FFF 3-D
printer emissions were collected in a stainless-steel test chamber.
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Sample type

Dilution,
%

Average particles
concentration
(particles/ml)

Average

Average

particles/well

particles/cm²

Background 0

2.67 × 106

2.67 × 105

8.34 × 105

0

3.47 × 107

3.47 × 106

1.08 × 107

25

2.60 × 107

2.60 × 106

8.13 × 106

50

1.74 × 107

1.74 × 106

5.42 × 106

0

6.24 × 107

6.24 × 106

1.95 × 107

25

4.68 × 107

4.68 × 106

1.46 × 107

50

3.12 × 107

3.12 × 106

9.75 × 106

0

9.08 × 106

9.08 × 105

2.84 × 106

25

6.81 × 106

6.81 × 105

2.13 × 106

50

4.54 × 106

4.54 × 105

1.42 × 106

0

1.51 × 107

1.51 × 106

4.72 × 106

25

1.13 × 107

1.13 × 106

3.54 × 106

50

7.55 × 106

7.55 × 105

2.36 × 106

PC2

PC3

ABS2

ABS3

Supplemental Table 2.1. Average particle concentrations per cm² of the
background sample, PC and ABS collected emissions. The particle concentrations
were determined using nanoparticle tracking analysis (NTA) (NanoSight NS300, Malvern
Instruments, Worcestershire, UK). SAEC were seeded in 96-well plates (surface area =
0.32 cm²) and exposed to 100 μL of PC or ABS particles/well collected in cell culture
medium.
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Calculation of estimated particles deposition fraction in the human alveoli based
on the International Commission for Radiation Protection (ICRP) reference worker
model for particles emitted during FFF 3-D printing with PC and ABS filament
For a print run using ABS that emits particles having a geometric mean diameter of 22.7
nm (GSD = 1.3), modeling using MPPD2 [318] indicates that 35.8% of particles would
deposit in the alveoli.
For PC, the geometric mean diameter of airborne particles released during printing is 47.5
nm (GSD = 1.3), and modeling indicates that 23.8% would deposit in the alveoli. Both
particle sizes are means from n = 5 runs per filament from a prior study [285].
Using default values for the International Commission for Radiation Protection
(ICRP) reference worker model (20 breaths per minute, 1000 mL tidal volume, 3300 mL
FRC volume) as a nose-mouth breather (ICRP. International Commission on Radiological
Protection. Publication 66: Human respiratory tract model for radiological protection vol.
24. Pergamon: Oxford, UK, 1994):
ABS
8 hours work day = 480 min,
20 breaths /min,
1000 ml tidal volume,
•

480 × 20 × 1,000 = 9.6 × 106 total mL breath per work day

Assuming that the average particles concentration in the chamber = 5 × 104 particles/ cm3
(reasonable based on our previous work [92], the total # of inhaled particles would be
•

5 x 104 × 9.6 × 106 = 4.8 × 1011 particles inhaled

Next, to get the # particles/ cm2 of alveoli
•

(total # inhaled particles) × (fraction deposited in alveoli region) / (total surface

area of the lung) = (4.8 × 1011) × 0.358 / (102 × 104) = 1.7 × 105 particles/ cm2
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PC
Same as above but using 0.238 as alveolar deposition fraction = 1.1 x10 5 particles/ cm2
These calculated values are in good agreement with the in vitro dose values given in
Table S2.2.
Concentration

Sample

(particles/mL)

a

Background

PC1

PC2

PC3

ABS1

ABS2

ABS3
a

0.267 × 107 ±
4.06 × 105
3.43 × 107 ±
1.17 × 106
3.47 × 107 ±
3.47 × 106
6.24 × 107 ±
3.66 × 106
2.53 × 107 ±
1.22 × 106
0.908 × 107 ±
1.39 × 106
1.51 × 107 ±
1.47 × 106

Mean

Mode

Diameter

Diameter

(nm)

(nm)

D50
(nm)

209.8 ± 13.1 183.9 ± 28.1 172.4 ± 12.6

232.6 ± 12.9 163.3 ± 13.0 201.6 ± 13.9

201.0 ± 8.0

151.5 ± 8.7

166.8 ± 7.3

169.5 ± 8.0

139.5 ± 4.2

147.2 ± 3.1

217.3 ± 1.1

171.1 ± 15.9 196.0 ± 6.5

192.5 ± 9.1

176.3 ± 34.7 173.6 ± 14.3

197.5 ± 9.6

157.8 ± 27.3 170.0 ± 20.1

Zeta
Potential
(mV)
-19.7 ± 0.7
(pH = 8.0)
-15.7 ± 2.5
(pH = 7.9)
-19.1 ± 0.8
(pH = 7.9)
-19.4 ± 0.3
(pH = 7.9)
-21.3 ± 1.8
(pH = 7.8)
-17.6 ± 0.6
(pH = 8.0)
-18.0 ± 0.7
(pH = 8.0)

“Background” refers to chamber air while the printer was powered off and not operating.

Supplemental Table 2.2. Characterization of particles generated during a
total of seven print runs (one background, three of PC, and three of ABS):
concentration of undiluted collected samples and mean hydrodynamic diameter, mode
diameter, and size of the particles in the 50th percentile were measured using NTA, and
zeta potential was determined using ELS.
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Supplemental Table 2.3. Volatile organic compounds (VOCs) emitted during
a total of seven print runs (one background, three of PC, and three of ABS)
identified by GC-MS.
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Supplemental Figure 2.2. Representative chromatograms of the organic
compounds emitted during a total of seven print runs (one background, three of
PC, and three of ABS). 3-D printer emissions were collected in cell culture medium and
organic compounds were analyzed by SPME/GC-MS, followed by tentative identification
by comparing mass spectra to the 2014 NIST/EPA/NIH Mass Spectral Library (NIST 14).
As we did not quantify the levels of the chemicals, these data should be considered for
information only.
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Supplemental Figure 2.3. Cytotoxicity of the FFF 3-D printer emissions: cell
viability and LDH activity of SAEC exposed to PC (A) and ABS (B) emissions. The
PC (prints 2 and 3) and ABS (prints 2 and 3) collected emissions were subjected to
vigorous vortex mixing for 5 min, and exposed as 50% dilution, and 25% dilution in serumfree SABM™, and undiluted (0%), resulting in six doses for each filament type
(Supplemental Table S1). The background sample was used undiluted. The control
samples were treated with SABM™. Following one-way analyses of variance, where the
assumptions of the model were examined, Dunnett’s Test was used to determine
significance of each treatment compared to either control non-treated cells or background
(p<0.05). The symbol (¤) indicate statistically significant differences compared to serumfree cell culture medium treated control (p < 0.05). The number (#) signs indicate
statistically significant differences compared to the background (ambient air) treated
groups (p < 0.05).
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Agent

Dilution,
%

Control

NA

0

BKGD.

0

0.834E+06

50

5.42E+06

25

8.13E+06

0

10.8E+06

50

9.75E+06

25

14.6E+06

0

19.5E+06

50

1.42E+06

25

2.13E+06

0

2.84E+06

50

2.36E+06

25

3.54E+06

0

4.72E+06

PC2

PC3

ABS2

ABS3

Analyte, pg/total cells (x 10-4) ± SEM

Average
particles/cm2
IL-12p70

IL-1α

IL-13

IL-1β

IL-6

IL-8

IL-16

TNF-α

1.427 ±
0.48
1.935 ±
0.21
2.704 ±
0.07
3.980 ±
0.59¤#
13.171 ±
0.98¤#
1.445 ±
0.47
2.550 ±
0.44
3.039 ±
0.22¤#
1.263 ±
0.24
1.377 ±
0.16
1.135 ±
0.07
1.886 ±
0.34
1.642 ±
0.35
3.228 ±
0.68

1.287 ±
0.01
1.902 ±
0.24
4.310 ±
0.47
8.117 ±
0.30¤#
62.670 ±
3.15¤#
1.260 ±
0.07
2.098 ±
0.36
3.261 ±
0.12
0.848 ±
0.01
1.004 ±
0.06
1.126 ±
0.09
1.483 ±
0.24
1.275 ±
0.01
2.490 ±
0.32

696.209 ±
24.68
887.601 ±
88.93
1431.56 ±
72.08¤#
2418.064 ±
244.37¤#
6278.268 ±
249.32¤#
786.841 ±
113.71
1281.809 ±
47.44¤#
1736.912 ±
94.12¤#
778.315 ±
58.09¤#
610.418 ±
48.05
674.216 ±
27.35
603.601 ±
26.87
672.43 ±
34.94
1133.304 ±
260.87¤#

0.791 ±
0.04
0.954 ±
0.07
1.572 ±
0.06
2.761 ±
0.15
370.918
± 48.43¤#
1.105 ±
0.03
1.424 ±
0.26
2.352 ±
0.08
0.985 ±
0.03
0.763 ±
0.07
0.751 ±
0.02
0.928 ±
0.04
1.329 ±
0.10
1.386 ±
0.01

145.978 ±
2.77
129.15 ±
34.98
927.116 ±
37¤#
784.944 ±
23.43¤#
976.032 ±
17.63¤#
255.645 ±
15.79¤#
367.843 ±
6.19¤#
259.588 ±
3.81¤#
186.598 ±
7.16
193.677 ±
1.59
234.538 ±
8.10¤#
131.905 ±
6.15
135.475 ±
1.18
208.989 ±
5.67¤#

4265.423 ±
132.75
5318.803 ±
159.51
11082.741 ±
184.21¤#
20559.863 ±
272.47¤#
32377.009 ±
842.63¤#
3388.327 ±
515.7
8654.719 ±
224.36¤#
9050.036 ±
40.02¤#
6529.206 ±
56.22¤#
4720.557 ±
104.95
5424.276 ±
73.44
3925.374 ±
63.63
2468.865 ±
40.22
5039.533 ±
99.95¤#

21.603 ±
4.69
32.795 ±
3.62
65.197 ±
8.11
110.102 ±
11.65¤#
371.096 ±
47.47¤#
27.951 ±
13.79
48.326 ±
6.42
106.033 ±
12.12¤#
40.247 ±
5.58
31.410 ±
1.03
30.753 ±
2.41
29.871 ±
0.22
38.818 ±
0.02
67.015 ±
2.54¤#

2.281 ±
0.12
2.087 ±
0.07
4.112 ±
0.04
5.912 ±
0.37¤#
17.907 ±
1.56¤#
1.967 ±
0.23
3.875 ±
0.23
6.154 ±
0.18¤#
2.288 ±
0.29
1.793 ±
0.11
1.868 ±
0.03
1.989 ±
0.11
1.842 ±
0.18
2.414 ±
0.31
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Supplemental Table 2.4. Cytokine and chemokine production in SAECs exposed to FFF 3-D printer
emissions. SAEC were exposed the PC and ABS emissions in culture medium for 24 h. The PC (print 2 and 3) and
ABS (print 2 and 3) collected emissions were subjected to vigorous vortex mixing for 5 min, and exposed as 50% dilution,
and 25% dilution in serum-free SABM™, and undiluted (0%), resulting in six doses for each filament type (Supplemental
Table S1). The background sample was used undiluted. The control samples were treated with SABM™. Experiments were
performed in three independent experiments with n = 3 replicates each. Following one-way analyses of variance, where the
assumptions of the model were examined, Dunnett’s Test was used to determine significance of each treatment compared
to either control or background (p<0.05). The symbol (¤) indicates statistically significant differences compared to serumfree cell culture medium treated control (p < 0.05). The number (#) signs indicate statistically significant differences
compared to the background (ambient air) treated groups (p < 0.05).
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ABSTRACT
Fused filament fabrication 3-D printing with acrylonitrile butadiene styrene (ABS) filament
emits ultrafine particulates (UFPs) and volatile organic compounds (VOCs). However, the
toxicological implications of the emissions generated during 3-D printing have not been
fully elucidated. The goal of this study was to investigate the in vivo toxicity of ABSemissions from a commercial desktop 3-D printer. Male Sprague Dawley rats were
exposed to a single concentration of ABS-emissions or air for 4 hours/day, 4 days/week
for five exposure durations (1, 4, 8, 15, and 30 days). At 24 hours after the last exposure,
rats were assessed for pulmonary injury, inflammation, and oxidative stress, as well as
systemic toxicity. 3-D printing generated particulate with an average particle mass
concentration of 240 ± 90 µg/m³, with an average geometric mean particle mobility
diameter of 85 nm (geometric standard deviation = 1.6). The number of macrophages
increased significantly at day 15th. In bronchoalveolar lavage, IFN-γ and IL-10 were
significantly higher at days 1 and 4, with IL-10 levels reaching a peak at day 15th in ABSexposed rats. Neither pulmonary oxidative stress responses nor histopathological
changes of the lungs and nasal passages were found among the treatments. There was
an increase in platelets and monocytes in the circulation at day 15 th. Several serum
biomarkers of hepatic and kidney functions were significantly higher at day 1. At the
current experimental conditions applied, it was concluded that the emissions from ABS
filament caused minimal transient pulmonary and systemic toxicity.

Keywords: thermoplastics, emerging technologies, thermal decomposition, printer
emissions, printer emitted nanoparticles, volatile organic compounds, inhalation
toxicology, pulmonary toxicity, systemic markers.
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3.1. INTRODUCTION
Fused filament fabrication (FFF), a three-dimensional (3-D) printing process, is an
emerging technology that has recently gained wide popularity among both consumers
and manufacturers due to their increased product efficiency, reduced waste, and greater
design flexibility. This makes 3-D printing a valuable tool for more sustainable
manufacturing and may represent the next generation of manufacturing processes. The
projected global market for 3-D printing and related services is expected to grow to almost
50 billion U.S. dollars by 2025 [319], with 6.7 million unit shipments of 3-D printers by
2020. There are many types of 3-D printers used in consumer settings, including those
that use solid (filaments) or liquid matrices. The chemical composition and resulting
emissions of these types of printers needs further investigation.
FFF 3-D printing involves heating a plastic filament to its melting point and
extruding it layer-by-layer to build an object. It has been found that during the thermal
decomposition of the filaments, numerous incidental ultrafine particles (UFP) and
gaseous or volatile organic compounds (VOCs) with potential adverse respiratory health
effects are released into the air [86, 93, 94, 103]. Currently, there are a very limited
number of toxicity studies of FFF 3-D printer emissions. In our previous study, we
evaluated the toxicity of 3-D printing emissions with ABS filaments (referred to as ABSemissions thereafter) in an in vitro model using human small airway epithelial cells
(SAEC). We found that the mean particle size of the 3-D emissions in cell culture medium
was 202 ± 8 nm, and styrene was the predominant VOC. At 24 hours (h) post-exposure,
ABS-emissions caused significant dose-dependent cytotoxicity, oxidative stress,
apoptosis, necrosis, and production of pro-inflammatory cytokines and chemokines in
SAEC cells. Similar findings were reported by another group, which showed that particles
in ABS-emissions from a consumer-level 3-D printer caused decreased cell viability and
increased oxidative stress and inflammatory responses. Stefaniak et al.

[223]

investigated the acute toxic effects of ABS-emissions on cardiovascular function via noseonly inhalation study in rats. Exposure to 1 mg/m 3 ABS-emission for 3 h induced
significantly higher mean arterial pressure concomitant with elevated resting arteriolar
tone and impaired endothelium-dependent arteriolar dilation. Their results indicated that
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the 3-D printer emissions could potentially induce systemic toxic effects, similar to what
was described previously in relation to inhalation of nanoparticles and ultrafine particulate
(UFPs) matter [277, 278]. In a health survey, about 60% of participants using 3-D printing
in commercial prototyping businesses, educational institutions, and public libraries
reported weekly respiratory symptoms [267]. The same study also determined that
working more than 40 h per week was significantly associated with asthma or allergic
rhinitis diagnosis. In a randomized, cross-over design study, healthy human volunteers
were exposed to ABS 3-D printer emissions for 1 h [273]. No acute effects on
inflammatory markers in nasal secretions or urine were found. However, a slight increase
in exhaled nitric oxide was noted, which could be induced by eosinophilic inflammation
from inhaled UFPs. In a case report study [268], a self-employed businessman with a
history of childhood asthma operated ten 3-D printers with ABS filaments in a small work
area, and, after 10 days working with ABS printing, he experienced chest tightness,
shortness of breath, and coughing.
Given that the use of this technology has expanded from workplaces/industry or
small businesses to schools and homes and the lack of data addressing the toxicity of
emissions, there is a critical need to fill knowledge gaps and assess the potential
toxicological effects of exposure to the FFF 3-D emissions, which would help to establish
effective control strategies and exposure limits for specific materials to prevent adverse
health effects from 3-D printing emission exposure. This study sought to evaluate the in
vivo respiratory and systemic toxicity of emissions from FFF 3-D printing with ABS
filaments. A real-time 3-D printer generation system was designed to allow for
simultaneous printing of three commercially available desktop 3-D printers and delivery
of an aerosol comprised of a mixture of particles and VOCs to the animal exposure
chamber. A time-course exposure study was conducted via whole-body inhalation
exposure. Male Sprague-Dawley rats were exposed to a single concentration (240 µg/m³
ABS average particle mass concentration) for 4 h/day throughout five exposure durations:
1, 4, 8, 15, and 30 days (4 days/week). At 24 h after the last exposure, histopathological
changes in the nasal cavity tissue and pulmonary injury, inflammation, and fibrotic
responses, as well as systemic toxicity blood markers, were assessed.
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3.2. MATERIALS AND METHODS
3.2.1. Three-dimensional printer emissions inhalation exposure system
An inhalation exposure system was specifically designed and constructed to
deliver FFF 3-D printer emissions to a whole-body rodent exposure chamber (Figure 3.1).
The airtight 55 cm × 55 cm × 50 cm (L × W × H) exposure chamber was constructed out
of 16-gauge stainless steel with a clear polycarbonate door. The system automatically
controlled chamber pressure, airflow, temperature, particle concentration, and exposure
time using custom software. During exposures, rats were housed in a stainless-steel cage
rack, which could hold up to 12 rats in individual cage partitions. The cage rack rested on
top of cage support beams, which were 1 cm outside diameter stainless steel tubes with
small holes (0.33-cm diameter) drilled into the undersides. Each hole was placed at the
center of each cage partition such that aerosols would be drawn to each animal's
breathing space.
The exposure chamber discharged exhaust air into a carbon/HEPA filter bank. The
flow rate of the exhaust was controlled by a mass flow controller (MCRW-50-DS; Alicat
Scientific, Tucson AZ) that had its downstream port connected to a vacuum. During
exposures, this flow was held constant at 30 l/min. The air entered the top of the exposure
chamber either from being pulled through an airtight chamber (50 cm × 64 cm × 122 cm
L × W × H) that housed 3 consumer-grade desktop FFF 3-D printers (Manufacturer A) or
from a mass flow controller (MCR-50, Alicat Scientific) that provided filtered dilution air.
The exposure chamber pressure was monitored using a differential pressure
transducer (Model 264; Setra Systems, Inc. Boxborough MA). Under typical exposure
conditions, filtered air was set to zero flow, and the pressure inside the exposure chamber
was -6.35 cm H2O to ambient. This slight negative pressure pulled air from the 3-D printer
housing chamber into the exposure chamber via conductive silicone tubing (0.80 cm ID).
Room air entering the 3-D printer housing chamber first passed through a HEPA filter and
carbon bed.
The temperature and relative humidity inside the exposure chamber were
continuously monitored using an electronic probe (HMP60; Vaisala Corporation, Helsinki
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Finland). The 3-D printers produced significant heat during operation. Therefore, the
inhalation exposure chamber was fitted with a cooling device to maintain air temperatures
between 22 and 24 °C. This was necessary for animal welfare and was more
representative of the real-world exposure condition where room air helps cool down the
heat emission in larger spaces. A thermoelectric module (CP-110; TE Technology, Inc.,
Traverse City, MI) was fitted to the outside back wall of the exposure chamber using four
mounting holes. Inside the exposure chamber, custom cooling fins were mounted through
the same four mounting holes directly onto the other side of the thermoelectric module.
These cooling fins were made of 6061 aluminum and had two circulating fans. The
exposure system's custom software monitored the exposure chamber's air temperature
and activated the cooler as needed. The two circulating fans always remained active
during operation.
3.2.2. Three-dimensional printer settings for ABS filament
The three FFF 3-D printers were each programmed to print simultaneously an
object shown in Supplemental Figure 3.1. from a commercially available ABS filament.
The objects printed were 12.7 cm wide by 12.7 cm long, with a height of about 2.54 cm.
The width and length were chosen because it occupied most of the build plate. Preliminary
testing showed that this type of object produces more particles than a part with a smaller
footprint. The object used 240 g of filament to fully print. The 3-D printers all used a nozzle
size of 0.4 mm. When not in use, the filament was stored at room temperature in an
airtight dry box. Supplemental Table 3.1. details the 3-D printer settings. These settings
produced 3-D printed parts without layer separation, warping, and a smooth outer surface.
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Figure 3.1. Diagram of the custom-built computer automated inhalation
exposure system for testing the ABS 3-D printing emissions. The exposure chamber
air was exhausted into a carbon/high-efficiency particulate air (HEPA) filter bank. The flow
rate of this air was controlled by a mass flow controller that had its downstream port
connected to a hose vacuum. During exposures, this flow was held constant at 30 l/min
(LPM). The airflow was controlled using multiple mass flow controllers (MFC) operated at
continuous flow rates. Animals were exposed to fumes (particles and gasses) generated
from three commercially available 3-D printers placed inside an airtight chamber (300 l
volume).
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3.2.3. ABS emissions collection and characterization
3.2.3.1.

Particle collection and characterization

The aerosol mass concentration inside the exposure chamber was continuously
monitored with a Data RAM (DR-40000; Thermo Electron Co., Waltham, MA), and
gravimetric determinations (37 mm cassettes with 0.45 µm pore-size Teflon filters, 2 l/min
sample flow) were used to calibrate and verify the Data RAM readings during each
exposure run. For this study, a 4-h average concentration of 250 µg/m 3 was delivered.
Particle counts were also recorded by the custom software connected to a condensation
particle counter (CPC) (Model 3787; TSI Inc. Shoreview, MN).
A fast mobility particle sizer (FMPS, Model 3091, TSI Inc.) was used to collect
particle size data in 5-second intervals during several 4-h test exposures. The test
exposures were conducted in the same manner as a typical exposure run, but without
animals present in the exposure chamber. In addition, during these test runs, a field
emission – scanning electron microscope (FE-SEM; Hitachi S-4800, Tokyo, Japan) was
used to analyze particle physical morphology by drawing aerosol samples, for 20 min at
a flow rate of 1 l/min, from the exposure chamber onto 25 mm 0.1 µm pore sized
polycarbonate filters.
3.2.3.2.

VOCs collection and characterization

VOCs in the ABS-emissions were sampled and analyzed according to the NIOSH
Manual of Analytical Method (NMAM) 3900 (NIOSH 2018). The emissions were sampled
using fused-silica lined, evacuated canisters (450 ml; Entech Instruments Inc., Simi
Valley, CA) with a 3-h capillary flow controller and analyzed for a suite of VOCs using an
Entech 7200/7650 preconcentration system coupled with an Agilent 7890/5975 gas
chromatrograph/mass spectrometer (GC/MS) (Santa Clara, CA). These samples were
taken from the exposure chamber during the first 4-h of test runs without animals present.
The VOC collection was repeated on five different days, and the average and standard
deviation were calculated for each VOC identified.
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3.2.4. Animals
Male Sprague-Dawley [Hla: (SD) CVF] (SD) rats (6-7 weeks old, 200–225 g) were
purchased from Hilltop Lab Animals (Scottdale, PA), housed in ventilated polycarbonate
cages, and acclimated for at least seven days before the study began. The animals were
provided HEPA-filtered air, irradiated Teklad 2918 diet (Harlan, Madison WI), a
combination of ALPHA-dri® and Teklad sani-chips as bedding and tap water ad libitum.
Rats were housed four per cage with a 12-h light-dark cycle, and the facility was
maintained at 22 ± 2 ˚C and 40–60% humidity. The study protocol was reviewed and
approved by the CDC-Morgantown Institutional Animal Care and Use Committee. The
CDC-Morgantown Institutional Animal Care and Use Committee is accreditated by
AAALAC International.
3.2.5. Experimental design
After acclimatization, the animals were randomly divided into two groups (n = 8 per group)
and exposed by whole-body inhalation to HEPA- and carbon-filtered air or an average
concentration of 240 µg/m3 ABS-emissions, 4 h/day, 4 days/week for 1, 4, 8, 15, and 30
day exposure durations. (Additional information regarding the animal exposure paradigm
can be found in the Supplemental material). At 24 h after the last exposure, the rats
were euthanized following an intraperitoneal injection of 100-200 mg sodium
pentobarbital/kg body weight (Fort Dodge Animal Health; Fort Dodge, IA). Whole blood
was collected from the abdominal aorta and transferred to two collection tubes: a
vacutainer containing EDTA (used for whole blood hematological analysis), and a
vacutainer containing clot activator and a polymer gel (used for serum chemistry analysis)
(Becton-Dickinson; Franklin Lakes, NJ). After clamping the left lung lobe and tying off the
right cardiac lobe, bronchoalveolar lavage fluid (BALF) was collected from the remaining
right lobes (BALF collection further described below). After lavage, the tied-off right lung
lobe and the lavaged right lobes were collected and stored at -80 °C. The left lung lobe
and

the

head/nasal

tissues

were

preserved

for

histopathological

evaluation

(Representation of experimental design is displayed in Supplemental Figure 3.2).
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3.2.6. Particle deposition estimates in the nasal passages, tracheobronchial, and
alveolar regions
The ABS-emissions particle deposition mass for the head/nose region,
tracheobronchial region, alveolar region, and the sum of the tracheobronchial and
alveolar regions were estimated using the MPPD model [320] based on two different
scenarios: without clearance and with clearance, respectively. Furthermore, the in vivo
alveolar deposition estimates were compared to our previous in vitro SAEC study results
(Supplemental material).
3.2.6.1.

Particle deposition mass without clearance

Particle mass deposition in nasal passages and lung regions was calculated. The
size distribution data (particle count based) provided by the FMPS of the ABS-emissions
inside the exposure chamber was converted to mass distribution. For this conversion, all
particles were assumed spherical with a density of 1.04 g/cm 3 (density of the ABS
filament). The FMPS instrument software was used for the calculations. This estimated
mass distribution was used as input into the MPPD model [320] with the following
parameters: animal breathing rate of 120 breaths/min, tidal volume of 1.7 ml, 4-h of total
exposure time, and 240 µg/m3 as the 4-h average concentration.
3.2.6.2.

Particle deposition mass with clearance

Exposures were conducted for four consecutive days, followed by three rest days.
In order to account for clearance, deposition in the nose, tracheobronchial and alveolar
regions calculated in the model without clearance were used in a discrete-time model that
accounted for clearance from each region between the daily exposures. The particle
mass deposited for a day of exposure was taken from the one-day exposure particle mass
depositions listed in the model without the clearance described above. The deposition for
each region was assumed to be the same each subsequent day of exposure. On each
day, the amount of material remaining in each region was taken as the sum of the amount
present in that region from the previous day, plus the one-day exposure particle mass
deposition, minus one-day clearance for each region. The one-day clearance
percentages were 100% for the nose, 90% for the tracheobronchial region, and 4% for
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the alveolar region. This was repeated for the first four-day exposure. For the next three
rest days (Friday, Saturday, and Sunday), only clearance from the various compartments
was assumed. The process of 4 day exposures and 3 rest days with daily clearance
patterns was repeated for the remaining exposure duration groups (8, 15, and 30 days).
3.2.7. Bronchoalveolar lavage analysis
3.2.7.1.

Bronchoalveolar lavage fluid collection and cytology

After exsanguination, the trachea was cannulated, the chest cavity opened, and
BALF collected from the right lung (except the cardiac lobe) via the tracheal cannula. The
first BAL fraction was obtained by gently filling the right lung with 6 ml cold PBS,
massaging for 30 sec, withdrawing, and repeating the process for another 30 sec. The
second BAL fraction consisted of subsequent aliquots of 5 ml PBS (instilled and
withdrawn) that were combined until a 15 ml volume was obtained. Both BAL fractions
were centrifuged (800 × g for 10 min at 4 °C). The supernatant from the first fraction was
set aside to measure total protein, lactate dehydrogenase activity, as well as surfactant
and cytokine levels. After discarding the supernatant from the second BAL fraction, the
cell pellets from both BAL fractions were combined, resuspended in 1 ml of PBS (Lonza,
Pearland, Texas), and aliquots were used to determine the total cell number and cell
differential. Briefly, total cell counts were quantified using a Beckman Coulter Multisizer 4
particle counter (Coulter Electronics; Hialeah, FL), and morphology identified using
cytospin preparations stained with HEMA solutions (Fisher Scientific; Kalamazoo, MI),
counting at least 500 cells per slide. The numbers of alveolar macrophages (AMs),
polymorphonuclear leukocytes (PMNs), lymphocytes, and eosinophils were normalized
to the total number of cells.
3.2.7.2.

Transmission electron microscopy (TEM) staining of BAL cells

BAL cells were fixated in 1 ml Karnovsky's fixative (2.5% glutaraldehyde, 2.5%
paraformaldehyde in 0.1 M sodium cacodylic buffer) and stored at 4 °C until processing.
The cells were post-fixed in 2% osmium tetroxide for 1 h, mordanted in 1% tannic acid,
and stained en bloc in 0.5% uranyl acetate. After a graded series of ethanols for
dehydration, the samples were infiltrated in propylene oxide. The samples were
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embedded in EPON™ (epoxy resin). The blocks were sectioned at 70 nm, and the
resulting grids were stained with 4% uranyl acetate and Reynold's lead citrate. The
sections were imaged on a JEOL 1400 transmission electron microscope (JEOL, Tokyo,
Japan).
3.2.7.3.

Scanning electron microscopy (SEM) images of lungs

A 5-micron non-lavaged lung paraffin section was mounted on a carbon planchet
and deparaffinized with propylene oxide for 30 min. The sample was sputter-coated with
gold-palladium for 30 sec and imaged using a Hitachi S4800 field emission scanning
electron microscope (Tokyo, Japan) at 5 kV.
3.2.7.4.

Total protein and LDH activity

Total protein levels and lactate dehydrogenase (LDH) activity were evaluated from
the acellular first BAL fraction by using the Pierce™ BCA Protein Assay Kit (Fisher
Scientific) and Lactate Dehydrogenase Reagent Set (Pointe Scientific; Lincoln Park, MI),
respectively. Data were acquired using Synergy H1 Microplate Reader (BioTek;
Winooski, VT).
3.2.7.5.

Surfactant proteins A and D

Surfactant protein A and D, known to contribute to surfactant homeostasis and
pulmonary immunity, were quantified from the 3-fold diluted first BAL fractions using
surfactant associated protein A (SP-A) and surfactant associated protein D (SP-D) kits
(Biomatik USA; Wilmington, DE), according to the manufacturer guidelines. Data were
acquired using Synergy H1 Microplate Reader (BioTek, Winooski, VT).
3.2.7.6.

BALF cytokines levels

The levels of pro- and anti-inflammatory cytokines were measured from undiluted
first BAL fraction, i.e., interleukin (IL)-1β, IL-4, IL-5, IL-6, IL-10, IL-13, interferon (IFN)gamma, neutrophil-activating protein 3 (KC/GRO), and tumor necrosis factor (TNF)-alpha
were measured from undiluted first BAL fractions using a V-PLEX Pro-inflammatory Panel
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2 Rat Kit (MSD; Meso Scale Discovery, Rockville, MD), according to the manufacturer
protocol. Data were acquired using a QuickPlex SQ 120 plate reader (MSD).
3.2.8. Oxidative stress markers
The right lung (except the cardiac lobe) was homogenized with a Bead Mill 24
Homogenizer (Fisher Scientific International, Inc.; Hampton, NH) for 2 min at 4 °C in 1 ml
cold PBS (pH 7.4) containing protease inhibitor cocktails and EDTA (Halt™ Protease
Inhibitor Cocktails, Thermo Scientific™, Waltham, MA). The protein carbonyl and the
malondialdehyde (MDA) levels were quantified from 100-fold diluted lung homogenate
suspensions using Protein Carbonyl content and Lipid Peroxidation assay kits (Cell
Biolabs, Inc.; San Diego, CA), respectively, according to the manufacturer's protocol.
Data were acquired using a Synergy H1 Microplate Reader (BioTek, Winooski, VT). The
concentrations were normalized to the total protein content determined using the Pierce™
BCA Protein Assay Kit (Fisher Scientific International, Inc., Hampton, NH).
3.2.9. Blood processing and analysis
Whole blood collected from each rat was equally divided between a vacutainer
tube containing EDTA as an anticoagulant (hematological analysis) and a tube containing
spray-coated silica, to help in clotting, and a polymer gel (serum separation and analysis).
3.2.9.1.

Characterization of blood cells and hematological parameters

Complete blood count (CBC) tests were performed 30-45 minutes post-exposure
to evaluate hematological parameters, which included peripheral erythrocyte and
leukocyte counts, leukocyte differentials (percent lymphocytes, neutrophils, monocytes,
basophils, and eosinophils), platelet counts, mean platelet volume (MPV), hemoglobin
levels, hematocrit, mean corpuscular hemoglobin (MCH) and hemoglobin concentration
(MCHC), red blood cell distribution width (RDV), reticulocyte counts, mean platelet
volume (MCV), and platelet distribution width (PDW), using a ProCyte Dx Hematology
Analyzer (IDEXX Laboratories, Inc., Westbrook, ME).
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3.2.9.2.

Serum chemistry profile

For serum chemistry analysis, the whole blood was allowed to clot at room
temperature and centrifuged at 2,500 rpm for 10 min. Using a Catalyst One Chemistry
Analyzer (IDEXX Laboratories, Inc., Westbrook, ME), the following serum biochemical
parameters were evaluated: albumin (ALB), globulin (GLOB), alkaline phosphatase
(ALKP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea
nitrogen (BUN), calcium (Ca), cholesterol (CHOL), creatine kinase (CK), creatinine
(CREA), C-reactive protein (CRP), lactate dehydrogenase (LDH), ammonia (NH3),
inorganic phosphate (PHOS), total bilirubin (TBIL), total protein (TP), triglycerides (TRI),
and uric acid (URIC).
3.2.9.3.

Serum cytokine levels

The levels of pro- and anti-inflammatory cytokines IL-1β, IL-4, IL-5, IL-6, IL-10, IL13, IFN-gamma, KC/GRO, and TNF-α, were determined from samples diluted 4-fold using
the V-PLEX Pro-inflammatory Panel 2 Rat Kit (MSD), according to the manufacturer
protocol. Data were acquired using a QuickPlex SQ 120 plate reader (MSD).
3.2.9.4.

Serum immunoglobulin E

The quantity of immunoglobulin E (IgE) was measured from 2-fold diluted samples
using a Rat IgE ELISA Kit (Abcam; Cambridge, MA), according to the manufacturer's
protocol. Data were acquired using a Synergy H1 Microplate Reader (BioTek).
3.2.10. Lung and nasal passages histopathological evaluation
The left lung (non-lavaged) was inflated with 10% neutral buffered formalin (NBF),
embedded in paraffin, cut at 5 microns on Schott slides, and stained with Hematoxylin
and Eosin (H&E) for histopathological evaluation. Lesions were reviewed by a boardcertified veterinary pathologist and classified as following: within normal limits (WNL); 1,
minimal (change barely exceeds that which is considered normal); 2, mild/slight (the
lesion is easily identified but is of limited severity); 3, moderate (the lesion is prominent,
but there is significant potential for increased severity); 4, severe (the change is as
complete as possible, occupies the majority of the organ).
110

After the lungs were processed, the nasopharynx was lightly flushed with 10%
NBF, and the nasal passages were collected. Nasal tissues were fixed in formalin for
approximately one week, then decalcified in 13% formic acid. Standard nasal sections
(T1, T2, T3, and T4) were taken [321]. The sections were embedded in paraffin, cut at 5microns, and stained with H&E.
3.2.11. Statistical analysis
All statistical analyses were performed using SAS/STAT for Windows v9.4. Twoway analyses of variance (treatment by duration) were performed on the measured
variables. Post-hoc comparisons between relevant groups were performed using Fishers
LSD. All analyses are considered significant at p < 0.05.

3.3.

RESULTS

3.3.1. ABS printing emissions characterization
3.3.1.1.

Particle mass and count concentrations

Chamber particle concentration readings during four representative exposure runs
are shown in Figure 3.2. All runs shown had the same 4-h mass average of 240 µg/m3.
In order to ensure that the same 4-h average particle mass was delivered daily at a
constant and repeatable exposure dose, the exposure system software calculated every
two sec what the 4-h average mass concentration would be if particles were immediately
not delivered to the exposure chamber. If the mass concentration exceeded 240 µg/m 3,
the system automatically set the mass flow controller for the dilution flow to 30 l/min, thus
providing the exposure chamber with filtered air rather than air from the 3-D printer
housing chamber. This method of average particle concentration control was used
because significant inconsistencies were observed, day-to-day, in particle generation
from the 3-D printers even though they were all ABS printers from a single manufacturer.
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Figure 3.2. Chamber particle characterization. A) Particle mass concentrations (red lines), and particle counts
(blue lines) over time; B) Particle size distribution plot count-based; C) Particle size distribution from count based converted
to mass by assuming all particles were spherical and had a density of 1 g/cm³; D) Particle geometric mean electric mobility
diameter during two 4-h print jobs.
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The average mass concentration, determined with gravimetric filters, was 240
µg/m3 with a standard deviation of 90 µg/m3, and the daily average count concentration
measured by the CPC was 88,400 particles/cm3 with a standard deviation of 23,000
particles/cm3. Typical particle count concentrations peaked during the first 10 min of
printing at about a million particles per cm 3, and from 20 min to 120 min, the count
concentration slowly declined. From 120 min to the end of the print job, the particle count
gradually increased. Particle mass readings peaked between 40 and 60 min into the print
job, then slowly decreased either through the remaining print job or had a second peak
mid-print (120 min).
3.3.1.2.

Particle size

A typical size distribution plot (particle count based) of the ABS-emissions inside
the exposure chamber during a test run is shown in Figure 3.2B. This type of data was
collected every 5 secs using the FMPS. Figure 3.2C shows the data from Figure 2B
converted to mass by assuming all particles were spherical and had a density of 1 g/cm³.
The geometric mean diameter (electric-mobility-based) for every 5-second sample during
two separate 4-h test runs is shown in Figure 3.2D. The geometric mean diameter during
the start of the print jobs was 40 nm, and it increased to approximately 85 nm after 20
min and remained between 79 nm to 95 nm for the remainder of the 4-h print. The
geometric standard deviation was 1.6.
The particles were also sampled onto filters and imaged with a scanning electron
microscope (SEM). Several representative particles are shown in Figure 3.3. The circular
dark holes are the pores in the polycarbonate filter. The typical physical diameters of the
particles ranged from 40 nm to 500 nm. Some of the particles were elongated and not
perfectly spherical with rounded edges.
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Figure 3.3. Representative images of ABS 3-D printer-emitted particles
indicating surface morphology. 3-D printer emissions were analyzed using FE-SEM.
Scale bar at 500 nm for all images.
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3.3.1.3.

Analysis of volatile organic compounds by GC/MS

Table 3.1 lists the most commonly detected volatile compounds (VOCs) in the
emissions from five ABS print runs. The emissions were analyzed by GC/MS over a 4-h
collection time. Included in Table 3.1 are the OSHA and NIOSH permissible exposure
limits (PEL) and recommended exposure limits (REL) for these VOCs, respectively, for
an 8-h work shift. The levels of benzene and acetaldehyde were the highest among the
detected compounds, though much lower than the PEL and REL.
3.3.2. Particle deposition estimates in the nasal passages, tracheobronchial, and
alveolar regions
3.3.2.1.

Particle deposition mass without clearance

The particle deposition estimates for the nasal passages, the tracheobronchial,
and the alveolar regions are provided in Table 3.2.
3.3.2.2.

Particle deposition mass with clearance

The estimated particle mass burden remaining in each region after the specified
number of days of exposure is given in Table 3.3.
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Compound

Average
(ppm)

Standard
deviation

OSHA PEL
(ppm)

NIOSH REL
(ppm)

2,3-Hexanedione

0.0011

0.0022

None

None

Acetaldehyde

0.1105

0.0331

200

None

Acetone

0.0112

0.0109

1000

250

Acetonitrile

0.0045

0.0037

40

20

Benzene

0.0036

0.0014

1

0.1

D-Limonene

0.003

0.0015

None

None

Ethanol

0.019

0.0106

1000

1000

Isopropyl Alcohol

0.0034

0.0067

400

400

Methyl Methacrylate

0.0037

0.003

100

100

Styrene

0.0024

0.003

100

50

Toluene

0.0084

0.0168

200

100

m,p-Xylene

0.0024

0.0005

100

100

Table 3.1. VOCs in the ABS-emissions were sampled and analyzed according
to the NIOSH Manual of Analytical Methods (NMAM) 3900 (NIOSH 2018).
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Days of
exposure

Particle mass deposited (µg)
Nose

Tracheobronchial Alveolar

Total Lung

1

0.54

0.23

0.85

1.08

4

2.16

0.91

3.41

4.32

8

4.32

1.82

6.81

8.63

15

8.09

3.42

12.77

16.19

30

16.19

6.83

25.54

32.38

Table 3.2. Modeled total lung burden without clearance.

Days of
exposure

Particle mass remaining at the end of exposure (µg)
Nose

Tracheobronchial Alveolar

Total Lung

1

0.5

0.2

0.8

1.0

4

0.5

0.3

3.2

3.5

8

0.5

0.3

5.9

6.2

15

0.5

0.3

9.2

9.5

30

0.5

0.3

12.1

12.4

Table 3.3. Modeled lung burden estimates with clearance.
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3.3.3. Pulmonary Injury and Inflammation
Figure 3.4 represents SEM images of lungs from animals exposed to ABSemissions, confirming that the ABS particle reached and deposited in the alveolar region
as early as after one day of exposure.
A TEM analysis of BAL cells was carried out to determine the cellular uptake of
particles and morphological changes. Figure 3.5 revealed the pulmonary ABS particle
uptake by alveolar macrophages in BAL cells after one and 30 days of exposure (similar
outcomes were observed at all durations of exposure). The images showed particle
uptake in membrane-lined vacuoles or particle localization in the cytoplasm (arrows).
Gross analysis of the morphological appearance of BAL cells indicated no significant
differences in cellular morphology.
For the assessment of pulmonary damage, total lung cells, and differentiated cells
were counted in the BALF (Figure 3.6). The number of macrophages was significantly
higher (33%) only at day 15 of exposure. Exposure to ABS emissions caused slightly
increased total cell numbers in BALF from day 1 to day 15 of exposure. However, this
increase was not significant when compared to air-control rats, and by the 30th day of
exposure, total cell numbers returned to control levels. Similarly, there were no significant
differences in BALF neutrophil, lymphocyte, and eosinophil counts at any exposure
duration, although the numbers of neutrophils and lymphocytes were slightly increased in
ABS-exposed rats throughout the entire study.
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Figure 3.4. Representative images of ABS particles deposited in the alveolar region at days 1 and 30 of
exposure using FE-SEM: (A) air-control, (B, C, D, E) day 1 of exposure, (F, G, H, I) day 30 of exposure. Scale bar at
10 µm for images B, D, and F, 5 µm for image H, 1 µm for images C, E, and G, and 500 nm for image I.
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Figure 3.5. Cellular uptake of ABS particles in BAL cells at days 1 and 30 of exposure by TEM: (A) air-control,
(B, C) day 1 of exposure, (D, E) day 30 of exposure. Scale bar at 1 µm for images A, B, and D, and 500 nm for images
C and E.
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Figure 3.6. BAL cell differential. Total cells (A), AMs (B), PMNs (C), lymphocytes (D), and eosinophils (E). The
rats were exposed for 1, 4, 8, 15, and 30 days to air or ABS emissions (240 µg/m 3) and euthanized at 24 h post last
exposure. Values represents means ± SEMs; N = 8/group/time point. *Significantly different from corresponding air control,
p < 0.05.
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To further examine the pulmonary injury, LDH activity, total protein, SP-A, and SPD levels in BALF were measured. We found that the LDH activity and total protein levels
were not significantly different between the ABS-exposed animals and the air-control
group at any time point (Figure 3.7). There were also no significant differences in SP-A
and SP-D in the BALF (Figure 3.8). However, the levels of these two proteins, known for
their protective role in lung disease, were slightly decreased in ABS-exposed rats, which
suggests that the emissions might have the potential to alter the host's lung immune
responses. Specifically, SP-A levels decreased beginning at the 8th day of exposure and
persisted until day 30; SP-D levels decreased starting with the 4th day of exposure and
lasted until the 15th day of exposure.
To evaluate ABS emission-induced inflammatory responses in airways, a panel of
9 pro- and anti-inflammatory cytokines were measured in BALF. Significant changes were
observed in BALF IFN-γ and IL-10 levels, with no significant differences in levels of IL1β, IL-4, IL-5, IL-6, KC, and TNF-α when compared to air-control rats (Table 3.4). IFN-γ
levels increased early (73% at day 1) and returned to control levels after day 4. Similarly,
IL-10 levels significantly increased early, but remained elevated, peaking at day 15 day,
a 39% increase compared to air-control animals.
Along with inflammation, oxidative stress is a key mechanism linking particle
exposure to observable physiological and biochemical responses. As such, protein
carbonyl and MDA levels were measured to determine the extent of protein and lipid
oxidation after exposure to ABS emissions (Figure 3.9). There were no significant
differences in protein carbonyl and MDA levels between exposed and air-control rats at
any exposure time point. However, similar to surfactant protein levels, protein carbonyl
concentrations were slightly increased in ABS-exposed rats from day 1 through day 15,
returning to control values by day 30.
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Figure 3.7. Pulmonary injury markers: LDH activity (A) and total protein (B)
in BALF. The rats were exposed for 1, 4, 8, 15, and 30 days to air or ABS emissions (240
µg/m3) and euthanized at 24 h post last exposure. Values represents means ± SEMs; N
= 8/group/time point.

Figure 3.8. Markers of injury to the alveolar epithelium: surfactant proteins
SP-A (A) and SP-D (B). The rats were exposed for 1, 4, 8, 15, and 30-days to air or ABS
emissions (240 µg/m3) and euthanized at 24 h post last exposure. Values represents
means ± SEMs; N = 8/group/time point.
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Figure 3.9. Lung oxidative stress markers: protein carbonyls (A) and
malondialdehyde (B). The rats were exposed for 1, 4, 8, 15, and 30 days to air or ABS
emissions (240 µg/m3) and euthanized at 24 h post last exposure. Values represents
means ± SEMs; N = 8/group/time point.
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3.3.4. Systemic effects
To assess for exposure-induced systemic toxic effects after pulmonary exposure
to ABS emissions, blood samples were analyzed for clinical and hematological
parameters, in addition to biomarkers of muscle, metabolic, renal, and hepatic function.
Significant increases in platelet (2-fold) and monocyte (73%) levels were measured at
day 15 of exposure (Table 3.5), accompanied by a nonsignificant increase in platelet and
monocyte populations on day 30 (62% and 39%, respectively) when compared to aircontrol. There were no significant differences in the other hematological measurements
at any time point, although elevations were observed for neutrophils and eosinophils (35%
and 53%, respectively), peaking on day 15. Serum chemistry analysis indicates that
creatinine kinase and aspartate aminotransferase, markers of hepatic and kidney
function, were significantly higher after one day of exposure, returning to control levels by
day 4 (Table 3.6). In addition, although the levels of inorganic phosphate and lactate
dehydrogenase, markers of hepatic function were within normal intervals, they were
significantly higher in ABS-exposed animals when compared to air-controls. Similarly,
after 15 days of exposure, blood urea nitrogen, inorganic phosphate, and uric acid were
significantly higher, with concentrations falling within standard ranges. No significant
changes in any of the serum chemistry markers were observed after 30 days of exposure.
The systemic inflammation was further assessed by measuring the response of
pro- and anti-inflammatory cytokines (similar panel as assessed in BALF) in serum.
Furthermore, there were no significant differences in serum levels of pro- or antiinflammatory cytokines, at any time point (Supplemental Table 3.2). Slightly higher
serum levels of IFN-γ, IL-6, IL-10, and KC were observed at day 15. IFN-γ, IL-6, and IL10 remained slightly increased at exposure day 30, as well as serum levels of IL-1β.
No significant difference in serum IgE levels, an immune-mediated marker of
allergic response, was observed (Supplemental Figure 3.4).
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Air

Exposure duration (days)
1
4
1.79 ± 0.34
1.69 ± 0.15

8
1.62 ± 0.20

15
1.78 ± 0.15

30
1.59 ± 0.11

ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS

3.11 ± 0.62*
1.79 ± 0.25
2.37 ± 0.13*
4.69 ± 0.30
4.78 ± 0.42
0.43 ± 0.06
0.37 ± 0.03
5.98 ± 0.68
6.01 ± 0.32
80.67 ± 8.91
91.11 ± 4.73
89.23 ± 15.6
64.82 ± 6.05
1.57 ± 0.17
2.02 ± 0.21

2.18 ± 0.20
2.24 ± 0.16
2.57 ± 0.12
6.40 ± 1.14
6.60 ± 0.88
0.46 ± 0.03
0.44 ± 0.04
6.62 ± 0.72
7.03 ± 0.27
93.59 ± 7.08
99.90 ± 3.18
107.37 ± 15.34
134.49 ± 24.14
1.95 ± 0.34
1.80 ± 0.32

2.35 ± 0.09
2.14 ± 0.12
2.99 ± 0.10*
5.95 ± 0.57
6.29 ± 0.35
0.43 ± 0.05
0.53 ± 0.02
6.46 ± 0.71
7.72 ± 0.44
111.58 ± 8.93
104.62 ± 5.38
140.42 ± 24.97
127.99 ± 8.57
1.94 ± 0.29
1.63 ± 0.21

2.13 ± 0.19
2.25 ± 0.11
2.54 ± 0.15
5.28 ± 0.39
5.76 ± 0.38
0.51 ± 0.04
0.48 ± 0.05
6.49 ± 0.45
7.65 ± 0.58
104.58 ± 8.64
105.68 ± 8.56
141.61 ± 28.79
113.25 ± 7.84
1.54 ± 0.17
1.40 ± 0.13

Marker

Treatment

IFN-γ
(pg/ml)
IL-10
(pg/ml)
IL-1β
(pg/ml)
IL-4
(pg/ml)
IL-5
(pg/ml)
IL-6
(pg/ml)
KC
(pg/ml)
TNF-α
(pg/ml)

2.61 ± 0.48*
2.05 ± 0.18
2.53 ± 0.21*
6.04 ± 1.09
5.58 ± 0.65
0.47 ± 0.05
0.43 ± 0.06
6.64 ± 0.93
6.73 ± 0.57
102.00 ± 7.17
104.56 ± 11
114.62 ± 25
80.75 ± 4.53
1.74 ± 0.48
1.40 ± 0.10

Table 3.4. Level of cytokines in bronchoalveolar lavage fluid. Values represents means ± SEMs; n = 8/group/time
point. *p<0.05 versus air-control group.
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Parameter

Treatment

Erythrocytes
(M/μL)

Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS

Hemoglobin
(g/dL)
Hematocrit
(%)
MCV
(fL)
MCH
(pg)
MCHC
(g/dL)
RDW-CV
(%)
Reticulocytes
(K/uL)
Reticulocytes
(%)
Platelets
(K/μL)
PDW
(fL)
MPV
(fL)

Exposure duration (days)
1
4.86 ± 0.58
5.15 ± 0.42
10.05 ± 1.20
10.54 ± 0.80
32.23 ± 2.27
30.43 ± 2.63
59.64 ± 0.85
59.00 ± 0.77
20.71 ± 0.24
20.47 ± 0.16
34.76 ± 0.38
34.70 ± 0.39
14.71 ± 0.17
14.42 ± 0.31
323.79 ± 19
311.38 ± 33
6.06 ± 0.19
5.74 ± 0.23
566.67 ± 56
415.67 ± 102
8.30 ± 0.27
8.00 ± 0.60
7.00 ± 0.17
6.75 ± 0.65

4
6.64 ± 0.23
6.76 ± 0.15
13.06 ± 0.39
13.18 ± 0.18
38.57 ± 1.22
39.11 ± 0.43
58.19 ± 0.66
57.96 ± 0.85
19.70 ± 0.18
19.54 ± 0.29
33.87 ± 0.21
33.70 ± 0.29
14.99 ± 0.31
15.55 ± 0.56
304.61 ± 14
324.55 ± 13
4.60 ± 0.19
4.82 ± 0.25
765.80 ± 53
700.20 ± 98
8.28 ± 0.06
8.43 ± 0.22
7.30 ± 0.05
7.28 ± 0.08
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8
7.27 ± 0.17
6.90 ± 0.30
13.79 ± 0.18
12.91 ± 0.56
40.40 ± 0.94
37.84 ± 1.88
55.64 ± 0.53
54.79 ± 0.54
19.01 ± 0.25
18.71 ± 0.16
34.20 ± 0.43
34.24 ± 0.29
16.14 ± 0.47
15.93 ± 0.38
222.24 ± 15
215.20 ± 11
3.08 ± 0.24
3.21 ± 0.32
643.43 ± 158
592.17 ± 137
8.36 ± 0.25
8.78 ± 0.34
7.16 ± 0.17
7.42 ± 0.20

15
7.25 ± 0.50
7.43 ± 0.32
13.15 ± 0.86
13.58 ± 0.54
37.61 ± 2.74
39.33 ± 1.87
51.75 ± 0.37
53.00 ± 0.47
18.18 ± 0.11
18.30 ± 0.12
35.16 ± 0.38
34.54 ± 0.39
16.78 ± 0.74
17.71 ± 0.60
197.94 ± 14
221.35 ± 10
2.73 ± 0.05
2.96 ± 0.04
438.20 ± 167
838.67 ± 83*
8.44 ± 0.45
7.95 ± 0.16
7.22 ± 0.25
6.83 ± 0.11

30
7.07 ± 0.42
7.01 ± 0.97
12.09 ± 0.68
12.05 ± 1.68
34.93 ± 2.27
34.95 ± 4.86
49.31 ± 0.39
49.13 ± 0.92
17.14 ± 0.12
16.68 ± 0.55
34.75 ± 0.34
33.94 ± 0.57
19.49 ± 0.88
20.10 ± 0.78
201.98 ± 12
243.14 ± 10
2.86 ± 0.08
3.05 ± 0.14
415.50 ± 109
675.80 ± 89
8.47 ± 0.12
8.39 ± 0.14
7.07 ± 0.07
7.05 ± 0.16

Leukocytes
(K/μL)
% Neutrophils
%
Lymphocytes
% Monocytes
% Eosinophils
% Basophils

Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS

4.26 ± 0.72
2.44 ± 0.65
6.08 ± 1.12
4.77 ± 0.87
89.34 ± 1.59
92.58 ± 1.32
2.42 ± 0.22
1.65 ± 0.19
1.24 ± 0.27
1.16 ± 0.37
0.30 ± 0.03
0.18 ± 0.02

5.01 ± 0.64
5.71 ± 0.76
8.79 ± 1.72
8.59 ± 0.82
87.17 ± 2.47
86.45 ± 1.32
2.37 ± 0.65
2.21 ± 0.25
1.56 ± 0.54
1.60 ± 0.28
0.27 ± 0.07
0.27 ± 0.04

4.41 ± 0.66
4.59 ± 0.48
9.82 ± 0.90
9.78 ± 1.72
84.86 ± 1.56
85.15 ± 2.51
2.50 ± 0.57
1.85 ± 0.40
3.05 ± 0.90
3.04 ± 0.97
0.28 ± 0.06
0.25 ± 0.03

4.31 ± 0.57
4.46 ± 0.47
8.80 ± 0.73
11.85 ± 1.18
87.13 ± 0.88
80.56 ± 2.51
2.20 ± 0.28
3.80 ± 0.51*
1.71 ± 0.19
2.60 ± 0.76
0.16 ± 0.07
0.23 ± 0.02

3.75 ± 0.64
3.93 ± 0.64
13.11 ± 1.31
15.84 ± 1.86
80.24 ± 2.98
77.38 ± 2.23
1.56 ± 0.16
2.18 ± 0.38
5.66 ± 1.92
4.35 ± 0.87
0.38 ± 0.07
0.35 ± 0.06

Table 3.5. Hematological parameters. Values represents means ± SEMs; n = 8/group/time point. *p<0.05 versus
air-control group.
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Exposure duration (days)
Marker
CREA
(mg/dL)
BUN
(mg/dL)
PHOS
(mg/dL)
TP
(g/dL)
ALB
(g/dL)
GLOB
(g/dL)
ALT
(U/L)
ALKP
(U/L)
TBIL
(mg/dL)
CHOL
(mg/dL)
CK
(U/L)

Treatment 1

4

8

15

30

Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS

0.18 ± 0.02
0.16 ± 0.02
15.88 ± 0.81
13.88 ± 0.93
8.68 ± 0.13
9.26 ± 0.23
5.25 ± 0.05
5.28 ± 0.07
2.71 ± 0.04
2.74 ± 0.05
2.54 ± 0.04
2.54 ± 0.05
55.50 ± 5.05
50.25 ± 3.50
227.25 ± 9
244.38 ± 18
0.14 ± 0.03
0.15 ± 0.04
47.250± 1.26
49.57 ± 1.66
92.00 ± 7
120.80 ± 16

0.20 ± 0.03
0.19 ± 0.02
16.63 ± 0.50
18.63 ± 1.09
8.41 ± 0.41
9.05 ± 0.26
5.23 ± 0.10
5.24 ± 0.12
2.73 ± 0.08
2.68 ± 0.08
2.50 ± 0.05
2.56 ± 0.50
59.38 ± 6.07
61.88 ± 10.95
186.88 ± 12
212.38 ± 17
0.13 ± 0.03
0.15 ± 0.05
39.38 ± 3.54
36.25 ± 4.86
102.50 ± 21
118.53 ± 14

0.21 ± 0.01
0.19 ± 0.01
14.75 ± 0.96
17.88 ± 0.93*
7.98 ± 0.21
9.51 ± 0.51*
5.38 ± 0.06
5.48 ± 0.14
2.74 ± 0.05
2.86 ± 0.09
2.64 ± 0.05
2.61 ±0.07
51.63 ± 3.35
47.70 ± 7.23
184.13 ± 11
215.17 ± 18
0.15 ± 0.04
0.20 ± 0.08
43.00 ± 3.99
46.88 ± 2.17
105.70 ± 12
108.53 ± 19

0.24 ± 0.02
0.21 ± 0.02
18.75 ± 0.65
19.00 ± 0.60
7.01 ± 0.20
7.03 ± 0.13
5.51 ± 0.110
5.66 ± 0.10
2.66 ± 0.05
2.78 ± 0.05
2.85 ±0.06
2.89 ±0.06
54.13 ± 4.23
52.50 ± 2.32
161.25 ± 6
161.25 ± 8
0.13 ± 0.02
0.17 ± 0.05
42.50 ± 4.42
34.75 ± 2.63
87.45 ± 7
99.40 ± 14

0.13 ± 0.02
0.10 ± 0.01
15.57 ± 0.65
15.50 ± 1.29
9.89 ± 0.31
10.93 ± 0.49*
5.24 ± 0.16
5.37 ± 0.10
2.80 ± 0.15
2.85 ± 0.07
2.44 ± 0.02
2.52 ± 0.03
63.57 ± 11.12
64.33 ± 5.41
215.86 ± 15
215.17 ± 18
0.31 ± 0.14
0.52 ± 0.11
50.29 ± 3.00
50.00 ± 3.00
200.80 ± 65
457.37 ± 64*
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Standard
ranges
0.1 - 0.7
9 -21
5.8 - 11.2
5.3 - 6.9
3.8 - 4.8
1.5 - 2.8
20 - 61
16 - 302
0.1 - 0.7
20 - 92
48 - 340

LDH
(U/L)
URIC
(mg/dL)
AST
(U/L)
NH3
(µmol/L)
CRP
(mg/dL)

Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS

326.55 ± 45
649.80 ± 97*
1.64 ± 0.67
1.62 ± 0.43
128.00 ± 29
206.00 ± 47*
57.71 ± 16.95
66.33 ± 14.01
0.17 ± 0.02
0.18 ± 0.03

388.04 ± 56
448.03 ± 76
0.68 ± 0.07
0.93 ± 0.23
100.25 ± 9
97.50 ± 8
31.00 ± 7.04
46.13 ± 10.19
0.16 ± 0.02
0.16 ± 0.03

322.51 ± 90
383.01 ± 65
1.33 ± 0.87
0.80 ± 0.16
106.00 ± 14
118.75 ± 19
27.75 ± 4.02
34.63 ± 5.23
0.19 ± 0.02
0.18 ± 0.03

558.25 ± 66
694.00 ± 25
0.50 ± 0.08
1.60 ± 0.59*
108.25 ± 9
113.71 ± 13
25.88 ± 3.76
30.43 ± 5.71
0.20 ± 0.05
0.16 ± 0.03

335.49 ± 42
382.39 ± 34
0.45 ± 0.05
0.69 ± 0.08
87.38 ± 2
93.25 ± 7
19.00 ± 3.13
24.50 ± 3.07
0.19 ± 0.03
0.16 ± 0.04

167 - 1428
0.8 - 4.4
39 - 111
na
na

Table 3.6. Serum chemistry profiles. Values represents means ± SEMs; n = 8/group/time point. *p<0.05 versus
air-control group.
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3.3.5. Histopathology of lung and nasal passages
H&E-stained sections of the left lung lobe and four levels of nasal passages (T1, T2,
T3, and T4) were examined for routine histopathology using light microscopy (Olympus
BX53). Tissue sections from air-exposed control animals were also examined for
determining background pathology. Exposure-related changes were not observed in any
lung or nasal passage sections examined for any treatment group.

3.4. DISCUSSION
From industrial, educational to medical and healthcare applications, 3-D printing
proves to be an exciting and promising technology [103]. However, as with any emerging
technology, little is known about the toxicity of the emissions generated during printing
and how emissions may differ from various types of raw material.
In our study, the ABS-emissions generated during real-time printing with a
consumer-grade level 3-D printer included incidental UFPs and VOCs. The temporal
pattern and size distributions (including peak, average number, and mass concentrations)
of particle emissions were characterized during animal exposures to compare to realworld exposure settings. Particle number concentration in the exposure chamber followed
a temporal pattern that consisted of a rapid rise during the first few min of printing,
followed by a slower decline throughout the remainder of the print time. A similar pattern
was reported for indoor environments and industrial workplaces where FFF 3-D sprinters
extrude ABS filament. During animal exposures, peak particle concentrations were about
106 particles/cm3, which is a factor of 15 to 25 higher than levels observed in industrial
workplaces where FFF 3-D printers extrude ABS filament. The daily average particle
number concentration during animal exposures was 88,000 ± 23,000 particles/cm 3. This
daily average value is similar to that reported for a poorly ventilated college dormitory
[275] and a Finnish workplace [113], but a factor of three to five higher than reported for
other industrial workplaces [322]. Geometric mean particle diameter was about 40 nm at
the start of printing and increased to 80 nm as printing progressed. Although data on
aerosol size distribution in occupational environments are sparse, our observed size is
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similar to that reported for a non-industrial indoor environment. Given their small size,
UFPs from FFF 3-D printers have a low mass. Vaisanen et al. [113] measured, via a realtime monitor, a particle mass concentration of 10 µg/m3 in a workplace. McDonnell et al.
[275], also using a real-time monitor, calculated particle mass concentrations ranging
from 120 to 620 µg/m3 for a dormitory room and small office on a college campus.
Our previous in vitro study delivered an average particle concentration of 1 x 10 7
ABS particles per ml, which would result in an equivalent alveolar lung burden of ABS
particles of 758 µg in the rat. In our current study, the day 30 alveolar deposition estimates
were 25.54 µg and 12.10 µg, representing the model without and with clearance,
respectively, which is about 30 to 60 times lower than the in vitro study. As such, we
attribute the minimal respiratory and systemic changes observed in this study to lower
particle deposition than that delivered in the in vitro study.
In terms of VOCs concentrations, we found that all detected VOCs emitted over 4h print jobs were at average levels that were much lower than workplace exposure limits
(REL or PEL), whose values are appropriate for comparison to exposure measurements
collected in occupational settings and would not be protective of sensitive individuals or
children in non-occupational settings. We identified styrene, benzene, and acetaldehyde
vapor, which may irritate the mucous membranes of the respiratory tract [323, 324]. An
important finding from previous studies is that filament factors such as the formulation,
the temperature to which it is heated, and the brand influences its breakdown and
resultant released gas profile. Wojtyła et al. [102] identified more than 70 different VOCs
in ABS filament emissions, with styrene, ethylbenzene, benzaldehyde, formaldehyde,
acetophenone, and vinyl cyclohexene as the most abundant. Another study [107] found
that printing with ABS filaments released ethylbenzene at levels 16.4 times higher than
outdoor air concentrations, isovaleraldehyde 11.9 times higher, and acetaldehyde 3.2
times higher. More recently, Davis et al. [122] detected 177 individual VOCs during FFF
3-D printing with ABS. These studies substantiate the potential for human exposure and
subsequent health effects from VOCs emitted during printing. Technologies to reduce and
prevent VOC emissions from FFF 3-D printing are emerging. When testing the efficiency
of commercially available filter covers and air-purifiers, varying capabilities of these
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control measures in removing VOCs were observed. It was found that conditioning the
new filters and pre-operating the control devices for a few days helped reduce VOCs
emissions. However, these control measures were unable to eliminate VOCs completely
and even produced new types of VOCs, demonstrating that the development of effective
control strategies for reducing VOC emissions could be more problematic. Recently, an
advanced filtration system such as photocatalytic filtration has been created. It was based
on doped graphitic carbon nitride materials and was able to successfully decompose and
therefore reduce the emission of hazardous VOCs [325].
As noted in our study and previously reported by others [93, 113], most incidental
particles emitted from FFF 3-D printing are smaller than 100 nm. Therefore, they have
the potential to penetrate deeper into the lungs than larger particles and trigger local
inflammatory and oxidative stress effects by activating resident macrophages and
epithelial cells [326]. To evaluate the pulmonary effects of FFF ABS-emissions, we
measured inflammatory and injury markers in BALF (cell differential, total protein, LDH
activity, surfactant proteins A and D, and pro- and anti-inflammatory cytokines and
chemokines) and in lung homogenates (the lipid peroxidation-derived malondialdehyde
and protein carbonyl). Furthermore, sections of the left lung lobe and four levels of nasal
passages were examined for histopathological changes. We found that after one day of
exposure to ABS-emissions, the levels of IFN-γ, one of the most potent macrophage
activators, spiked significantly in BALF and decreased thereafter. At day one of exposure,
we also noted a slight increase in TNF-α, a cell-signaling cytokine produced by activated
macrophages and involved in acute systemic inflammation, and IL-6, a cytokine with both
pro-inflammatory and anti-inflammatory functions. However, the number of alveolar
macrophages in BALF didn't increase significantly until the 15th day of exposure, when
we also found that a decrease in IFN-γ levels correlated with increased secretion of the
anti-inflammatory cytokine IL-10. We speculate that at earlier time points, the
macrophages were activated by the pro-inflammatory mediators IFN-γ and TNF-α
released in response to subtle injuries, resulting in the macrophages adhere to the
alveolar lung wall, as previously reported [327, 328]. To counteract the tissue-damaging
potential of the pro-inflammatory state of "classically activated" [329] macrophages (M1
phenotype), a switch to an anti-inflammatory or reparative state, "alternatively activated"
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or M2 phenotype [330], occurred stimulated by the production of anti-inflammatory
markers, such as IL-10.
This injury-repair response may explain the "delayed" influx of alveolar
macrophages at the damaged site and its peak occurrence in BALF at the 15th day of
exposure, which corresponded with increased blood monocytes and platelets. These
results tie to previous studies [331, 332] that demonstrate that inflammatory signals (e.g.,
cytokines) produced by alveolar macrophages after phagocytosis of particles can
stimulate the release of monocytes from the bone marrow into the circulation. Monocytes
that are attracted to the injured site by growth factors released by platelets enter the lung
through blood vessel walls and mature into macrophages [333]. Increased platelet count
is a notable finding as it is also associated with cardiovascular effects [334-336],
suggesting a possible link between FFF 3-D printer emissions and cardiovascular events.
A previously published study observed that exposure to 3-D printer emissions stimulates
acute hypertension and microvascular dysfunction.
Surfactant proteins SP-A and SP-D play a critical role in lung host defense by
inhibiting inflammation, enhancing the elimination of pathogens and foreign particles, and
influencing overall surfactant homeostasis and disease progression [337]. Recent
advances in lung pathogenesis and understanding the roles of these two pulmonary
collectins suggest that SP-A and SP-D may potentially serve as biomarkers of disease or
injury [338, 339]. In our study, we found slightly decreased SP-A (day 8) and SP-D (day
4) levels in BALF. Decreased concentrations of surfactant proteins in BALF were reported
as a result of long-term smoking [340, 341] or as an age-related effect [341-343], perhaps
indicating pulmonary damage due to loss of alveolar epithelium integrity.
Lung endothelial and epithelial cells form a functional air-blood barrier that is
important for rapid and effective gas exchange between alveoli and microvasculature,
and for preventing translocation of micron-size inhaled particles into the circulatory
system. However, the nanometer size of particles emitted during additive manufacturing
may facilitate penetration of the air-blood barrier, and result in adverse health effects, as
shown for polystyrene nanoparticles. To further explore the potential systemic toxicity of
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ABS-emitted particles, we evaluated serum chemistry biomarkers involved in
inflammatory and injury processes, as well as biomarkers of muscle, metabolic, liver, and
kidney function. Among the 16 markers analyzed, the only significant changes above
normal ranges in ABS-treated rats occurred on day 1 of exposure with an increase in
creatinine kinase and aspartate aminotransferase, markers of kidney and hepatic
function, respectively. A significant increase in other markers of hepatic (day 1) and renal
(day 15) damage was noted. However, these changes fell within normal ranges, and
returned to air-control levels by day 30 of exposure, indicating a transient systemic toxic
effect. Pulmonary findings are consistent with the blood analysis, suggesting that the
changes caused by exposure to ABS-emissions, at the durations and dose studied, are
minimal and transitory. A similar pattern was observed in a previous study, which
evaluated

the

effects

of

thermo-oxidative

degradation

products

of

heated

poly(acrylonitrile-butadiene-styrene) at 300 – 330 ºC. Male Wistar rats were exposed to
a single concentration of degradation products for 1, 3, and 10 days (6 h/night, 5
nights/week), and 3 h post-exposure animals were assessed for adverse effects on lung,
liver, kidney, and brain. The degradation products included styrene (11 – 24 ppm), carbon
monoxide (4-5 ppm), formaldehyde (0.20 - 0.31 ppm), hydrogen cyanide (0.08 – 0.67
ppm), acrolein (1.4 -1.9 ppm), acrylonitrile (2 - 4 ppm), and aerosol fraction (8 - 26 mg/m³).
The authors observed that exposure caused a significant reduction of 7-ethoxycoumarin
O-deethylation activity (a marker for assessing substrate specificities of cytochrome
P450) in the lung and kidney, but not in the liver, after one day of exposure. At the same
exposure endpoint, a decrease in reduced glutathione concentration (GSH) in the liver
and kidney, but not in the lung, was noted, suggesting decreased antioxidant defense.
After 3 days of exposure, lung GSH levels remained decreased and returned to control
levels by day 10.
At this time, it is unclear if particle number, mass, or surface area is the most
relevant metric of toxicity for FFF 3-D printer emissions. Gumperlein et al. [273] exposed
human volunteers to ABS emissions at 1.6 × 106 particles/cm3 and reported minimal
evidence of inflammatory responses based on biomonitoring. Specifically, the volunteers'
exhaled air showed increased levels of nitric oxide, which might be due to inhaled ultrafine
particle-induced eosinophilic inflammation. However, no clinically significant acute
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changes in the biochemical responses of nasal secretions and urine were found. In an in
vivo toxicology study, Stefaniak et al. [223] exposed rats once to ABS emissions at 0.9 ±
0.1 mg/m3 (Dp ~ 70 nm) and observed acute hypertension. Hence, caution is needed
when interpreting the results of the current inhalation study because the lack of significant
responses for several toxicological outcomes may not prove the absence of ABS toxicity,
but rather be an effect from 1) the choice of exposure metric and/or 2) the relatively low
particle number and mass exposures compared to those employed in other toxicology
studies. While the temporal pattern of particulate emissions in the exposure chamber was
in the range or higher than observed in real-world settings [113, 275], a significant
challenge for this and future inhalation toxicology studies of FFF 3-D printer emissions is
the generation of consistent daily aerosol exposure with number and mass concentration
characteristics that are higher than observed in the real-world workplace to establish a
minimal effect and no effect level. Furthermore, careful selection of the most appropriate
and relevant animal species is essential considering the differences in the anatomy of the
airways, the characteristics of particle deposition and clearance, which would ultimately
have implications in the observed health effects. In addition, a dose-dependence
relationship would be relevant to establish some criteria to base the relative safety of FFF
3-D printer emissions.

3.5. CONCLUSIONS
Repeated whole-body inhalation exposures to FFF 3-D printing emissions
(particles at 240 ± 90 µg/m³ concentration, and the listed VOC types at the concentrations
reported) released from ABS filament in commercially available desktop 3-D printers for
4 h/day for 1, 4, 8, 15, and 30 days of exposure (4 days/week) caused minimal and
transient pulmonary and systemic effects to rats. Our findings suggest that ABS
emissions elicited an adaptive response in this exposure paradigm. This adaptive
phenomenon refers to when a low stimulating dose of stress is administered that initiates
compensatory biological processes [344]. However, considering the significant variability
observed in the emission characteristics for one ABS filament and one printer model
combination, to multiple printers, filament and operation condition combinations, we
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cannot exclude the potential of further acute and chronic inflammatory responses,
particularly when human case studies report the development of respiratory symptoms
and new diagnoses of asthma and allergic rhinitis from workplace 3-D printer exposures
[267, 268].
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3.6.

APPENDIX
Supplemental Figures, Methods, and Results

Supplemental Figure 3.1. Object printed for each exposure and sample run:
A) completed 3-D printed object, and B) 3-D printed object stopped before printing the top
layers to show infill pattern. The objects printed were 12.7 cm wide by 12.7 cm long, with
a height of about 2.54 cm.
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Supplemental Figure 3.2. Experimental design. The 4 hours per day exposure
duration was selected due to time issues. This was the maximum amount of time that
could be allocated to our study by the NIOSH Inhalation Facility staff without impacting
other inhalation exposure projects conducted at the same time. Prior to each exposure,
the staff had to clean the chambers, remove old, printed parts, clean build plates, replace
clogged print heads, load / unload animals into the two different exposure chambers
(HEPA-filtered air and printer emissions-exposure chamber, respectively), load the
filaments into the three printers, ensure proper printing, etc. The 4 days per week
exposure schedule was selected to accommodate the schedule of our collaborators who
were involved in FFF 3-D printer emission-induced neurotoxicity, hepatotoxicity,
microvascular, cardiovascular, and reproductive toxicities studies.
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Two identical exposure chambers were used to simultaneously conduct the
exposures to HEPA-filtered air and ABS emissions, respectively. The exposures were
performed during the daylight portion of the rats' circadian cycle (from about 9:00 am until
1:00 pm), when they would be mostly inactive/sleeping. Also, during this time, the animals
did not have access to food/water or bedding.
Uniformity of exposure from one animal to another was achieved by rotating the
rat's locations daily, throughout the exposure sessions within the animal cage.
Furthermore, based on previous tests conducted on the same exposure chambers, we
observed less than a 12% concentration variation across animal cage locations, indicating
a spatial uniformity of airborne distribution of printer emissions.
The aerosol mass concentration inside the exposure chamber was continuously
monitored with a Data RAM (DR-40000; Thermo Electron Co., Waltham, MA), which was
connected to a 1/4 inches (0.64 cm) stainless steel sample tube to sample air from a
location near the animals' breathing space. The 240 µg/m³ exposure concentration was
the maximum concentration that we could reliably achieve for the repeated exposure
runs. Based on our previous experience and other researcher's reports [93], the inherent
variability in the ultrafine particulate (UFP) between the repeated print runs using the
same filament is recognized and unavoidable at the moment.
We have not evaluated the particle size or transformations/agglomerations pretube (inside printer generation chamber) versus post-tube (inside animal exposure
chamber). However, the tubing length was about 6 inches (15 cm) long. Therefore, the
particle agglomeration could be affected more by the time spent in the 3-D printer
enclosure or time in the exposure chamber. Moreover, the particle size range generated
with our system is similar to what has been reported in the literature, suggesting that our
system does not affect the particle size and is relevant to indoor environments and
occupational settings.
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Supplemental

Figure

3.3.

Body

weight

of

animals

at

euthanasia

demonstrating that the rats were gaining weight over time, and that there is no
significant difference between the air-control and ABS-treated group.
Estimating equivalent alveolar lung burden in a rat based on previous cell
exposures
For comparison of results in the current study, calculations were made to estimate
the equivalent lung burden required for rat lungs to achieve the same dose as that given
to the cell culture.
The following calculations were made using a custom MATLAB script (MathWorks
Inc., Natick, MA). In the cell exposure study, the median particle size in the cell culture
medium was found to be 201 nm and ranged in size from about 100 nm to 400 nm. A lognormal distribution curve was generated with a median of 200 nm and to have 95% of its
total area between 100 and 400 nm. This distribution had a bin (data point) every 10 nm
ranging from 50 to 600 nm. The total sum of all the bins was set to 1 x 10 7. This was
meant to represent one ml of a solution containing 10 7 particles. In our previous study,
the ABS average particle concentration per ml ranged from 0.45 × 10 7 to 1.51 × 107. The
107 value was used because it corresponded to one of the doses previously measured
and tested in the cell culture media and for easier back-calculation. Assuming all particles
are spherical and have a density of 1.04 g/cm 3 (density of ABS filament), the mass
distribution can be calculated. Each data point in the count distribution was converted to
mass using the following equation:
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Mass = D x (4/3) × π × r3
Where: D = density, and r = radius of the particle. The sum of mass from every bin in the
distribution was then calculated, resulting in 0.626 µg/ml of solution. Each well was given
0.100 ml of solution. Thus, the estimated particle mass per cell well was 0.0626 µg. Each
cell well had a surface area of 0.33 cm2. By dividing mass per cell well by area of well,
the result was 0.190 µg/cm2. A typical rat lung has an alveolar surface area of
approximately 4,000 cm2. To achieve the same mass per surface area in a rat lung as
what was calculated to be on the wells, a rat would have a lung burden of (0.190 µg/cm 2)
× (4,000 cm2) = 759 µg.

Summary of MATLAB calculations
mass per ml per 1 × 107 particles in solution = 0.626 µg
each cell well was given 0.100 ml of solution.
mass per well = 0.062606 µg
each cell well area = 0.33 cm2
mass per area on cells = 0.189716 µg/cm2
area of a typical rat lung = 4,000 cm2
equivalent lung burden in a rat for 107 particles = 758.8 µg
Based on MATLAB calculations, the equivalent alveolar lung burden in a rat for 10 7 ABS
particles per ml would be equal to approximately 758 µg in this study.
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Supplemental Figure 3.4. Figure adapted from our previous study displaying the
regression analyses performed on the cell viability and LDH activity of small airway
epithelial cells using particle number*10-4 as the independent variable. The dotted black
line indicates 3.5 × 10⁶ particle/cm², which is approximately equal to 1 × 107 ABS particles
per ml, which caused a 10% decrease in viability and 20% increase of LDH over control.
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Supplemental Figure 3.5. IgE serum levels. The rats were exposed for 1, 4, 8,
15, and 30 days to air or ABS emissions (240 µg/m³) and euthanized at 24 h post last
exposure. Values represents means ± SEMs; N = 8/group/time point.
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Setting Name

Value

Print nozzle temperature

260 ºC

Print bed temperature

100 ºC

Layer Height

0.25 mm

Line Width

0.5 mm

Wall thickness

3 lines (1.5 mm)

Number of solid bottom layers

4 (1.0 mm)

Number of solid top layers

4 (1.0 mm)

Infill density

25%

Print speed (1st layer)

45 mm/sec

Print speed after 1st layer

120 mm/sec

Print bed adhesion

PEI sheet, no glue.

Supplemental Table 3.1. Three-dimensional printer settings.
Acrylonitrile butadiene styrene (ABS) is one of the most popular filaments used in FFF 3D printers. It is a petrochemical material derived from the copolymerization of 1,3butadiene and styrene. The butadiene units offer good impact strength, the styrene units
give the copolymer its rigidity, and the acrylonitrile units allow heat resistance, making it
widely used in industry [345].
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Marker
(pg/ml ± Agent
SEM)
IFN-γ
IL-10
IL-13
IL-1β
IL-4
IL-5
IL-6
KC/GRO
TNF-α

Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS
Air
ABS

Exposure duration (days)
1

4

8

15

30

14.87 ± 1.50
13.92 ± 1.28
61.55 ± 3.77
61.53 ± 3.273
4.28 ± 0.40
3.66 ± 0.47
5.10 ± 1.20
3.87 ± 0.01
8.48 ± 0.53
8.98 ± 0.67
46.43 ± 7.13
44.58 ± 4.30
79.59 ± 9.69
70.72 ± 11.83
267.57 ± 28.59
258.51 ± 16.41
5.74 ± 0.65
5.81 ± 0.55

15.59 ± 1.50
16.04 ± 1.16
71.49 ± 4.77
70.68 ± 3.79
4.41 ± 0.63
3.99 ± 0.70
6.75 ± 2.37
8.24 ± 3.56
9.75 ± 0.86
9.41 ± 0.45
51.97 ± 5.87
42.76 ± 7.25
79.69 ± 10.60
82.34 ± 14.25
181.10 ± 10.08
235.71 ± 18.34
5.40 ± 0.49
3.78 ± 0.78

18.79 ± 1.41
15.13 ± 2.03
73.26 ± 2.42
74.74 ± 4.90
4.71 ± 0.40
4.45 ± 0.38
12.43 ± 4.15
4.48 ± 0.67
9.48 ± 0.50
9.72 ± 0.47
51.98 ± 6.46
42.74 ± 5.19
86.73 ± 7.58
86.90 ± 27.25
205.37 ± 12.92
234.60 ± 26.05
5.30 ± 0.31
5.79 ± 1.33

16.57 ± 2.71
18.30 ± 2.88
77.68 ± 6.82
80.24 ± 6.57
4.47 ± 0.40
4.64 ± 0.59
12.61 ± 4.28
11.12 ± 3.60
10.29 ± 0.85
10.25 ± 1.14
36.74 ± 5.55
37.29 ± 5.42
94.47 ± 11.03
106.39 ± 17.45
199.08 ± 14.89
237.26 ± 12.76
4.27 ± 0.35
4.76 ± 0.47

19.41 ± 3.28
24.20 ± 3.05
80.89 ± 5.55
88.32 ± 3.91
3.67 ± 0.40
4.38 ± 0.79
16.45 ± 4.06
20.57 ± 3.50
11.14 ± 1.08
11.04 ± 0.94
43.17 ± 10.22
40.27 ± 6.77
78.18 ± 13.06
92.70 ± 25.44
232.98 ± 19.94
186.87 ± 17.37
4.60 ± 0.29
4.88 ± 0.31

Supplemental Table 3.2. Serum cytokines in rats following exposure to ABS emissions at any time point
when compared to air-control rats. The rats were exposed for 1, 4, 8, 15, and 30 days to air or ABS emissions (240
µg/m³) and euthanized at 24 h post last exposure. Values represents means ± SEMs; N = 8/group/time point.

146

CHAPTER 4: EVALUATION OF PULMONARY EFFECTS OF ACRYLONITRILE
BUTADIENE STYRENE (ABS) 3-D PRINTER EMISSIONS USING AN AIR-LIQUID
INTERFACE (ALI) MODEL OF HUMAN PRIMARY BRONCHIAL EPITHELIAL (NHBE)
CELLS
ABSTRACT
To date, the potential toxicity of aerosolized emissions from FFF 3-D printers has been
tested in vitro in conventional submerged single-cell culture and in rodents. Considering
the dosimetry drawbacks and lack of the physiological features of airway mucosa when
using submerged in vitro models as well as challenging data extrapolation from animals
to humans due to respiratory tract interspecies variability, efforts focused on developing
human-relevant models, with particular emphasis on in vitro models. This study aimed to
investigate the use of primary normal, human-derived bronchial epithelial cells (NHBEs)
as in vitro inhalation toxicity model of lung epithelium to mimic and study the behavior of
respiratory epithelium upon exposure to emissions from FFF 3-D printing with acrylonitrile
butadiene styrene (ABS) filament. NHBEs epithelium integrity and differentiation
changes, cytotoxicity, tissue injury, and inflammatory and immune system regulation
markers were evaluated following 4 hrs. exposure to ABS filament emissions. The mean
diameter and the mode diameter of ABS particle in the medium was 170 ± 21 nm, and
144 ± 15 nm, respectively. The average ABS particle deposition per surface area of the
epithelium was 1.7 x 107 ± 1.6 x 107 particle/cm2. Overall, at the conditions applied,
exposure of NHBEs to ABS emissions did not affect epithelium integrity, ciliation, mucus
production, or induce cytotoxicity. At 24 hrs. after the exposure, significant increases in
IL-12p70, IFN-γ, TNF-α, IL-17A, VEGF, and MIP-1α were noted in the basal cell culture
medium of ABS-exposed cells compared to non-exposed chamber control cells. To
identify potential threshold values and mechanistic studies, exposure to higher
concentrations of AB emissions should be performed.
Keywords: 3-D printers, printer emitted nanoparticles, filament, air-liquid interface, in
vitro, normal human bronchial epithelial cells.
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4.1. INTRODUCTION
We are witnessing an accelerating expansion and evolution of additive
manufacturing (AM). AM has a tremendous social, economic, and environmental impact
providing numerous advantages in many areas [3, 6, 8, 23, 45, 50, 51, 60, 64, 77, 346,
347]. This revolutionary process is predicted to become a mainstream technology for
serial production and automation [8]. However, considerable evidence [73, 85-96, 98-103]
shows that the FFF 3-D printing process releases a significant number of nanoparticles
(NPs), that can deposit deep in the lower respiratory tract and may cause adverse
respiratory effects. The release of various volatile organic comounds (VOCs) might also
pose serious risk concerns to human health as they are known irritants, carcinogens,
odorants, and reprotoxins [110]. VOCs exposure can occur to gas phase substances as
well as particle adhered VOCs.
The potential toxicity of aerosolized emissions from 3-D printers has been tested
in conventional submerged single-cell culture [269, 348] and animal models [223, 269,
349]. However, the relevance of using submerged single cell in vitro models for
performing cytotoxicity assessment of the respiratory system manifest drawbacks. First,
these models do not mimic in vivo conditions such as physiological features of airway
mucosa characterized by the presence of ciliated columnar cells, mucous-producing
goblet cells, and basal cells [350]. Second, the addition of test agents in liquid form directly
into the cell culture medium may alter its physicochemical properties, such as size,
surface charge, solubility, transformation, or agglomeration state, leading to unreliable
outcome or dose-response [351]. Third, there is an inability to recapitulate physiological
inhalation conditions and aerosol deposition patterns comparative to in vivo human
conditions [351]. Animal models, such as mice and rats, have been routinely used in
experimental toxicology and risk/hazard assessments. However, data extrapolation from
animals to humans is challenging because of respiratory tract interspecies variability. For
example, such differences are based on 1) respiratory tract architectural features (e.g.,
nasal gross anatomy, airway structure, and branching pattern, the number of cartilaginous
airways, cell types, and composition within the regions of the respiratory tract),
2) respiratory physiology (e.g., breathing mode and ventilatory patterns, metabolic rates),
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and 3) biochemistry (e.g., composition and biotransformation capacity of P450
monooxygenases, epoxide hydrolase and glutathione S-transferase) [352-356].
Moreover, studies of translational toxicology from rats to humans in setting occupational
exposure limits for hazard classification found that the extrapolation and standardization
to rat lung mass or to rat body weight is varying and inconsistent [357], and the genomic
responses in mouse models poorly mimic human inflammatory diseases [358]. Therefore,
these variations influence the local toxic effects due to differences in the airflow pattern
in the respective respiratory tract architecture, which affects the deposition of the given
inhaled test agent as its retention and clearance from the lungs [359]. These limitations
explain research efforts focused on developing human-relevant models, with particular
emphasis on in vitro models [351, 360, 361].
Physiologically relevant respiratory epithelium models, such as in vivo-like in vitro
models cultured at the air-liquid interface (ALI), have been established and routinely used
to study inhaled particles or gases mediated respiratory toxicity [362]. These methods are
promising in the domain of inhalation toxicology as they mimic the in vivo respiratory
epithelium in its organization and stratification, avoiding limitations posed by the
submerged monolayer cultures. This three-dimensional (3D) in vitro tissue model consists
of normal, human-derived bronchial epithelial cells (NHBEs) cultured at the ALI on porous
membrane inserts, and results in a polarized mucociliary differentiated airway epithelial
cell layer. This in vitro epithelium is predominantly composed of three cell types, including
mucus-producing goblet cells (secretory cells), ciliated respiratory epithelial cells, and
basal cells (progenitor cells). This architecture mimics the biology of the in vivo respiratory
tract by modeling epithelial barrier function (e.g., development of high trans-epithelial
electrical resistance, expression and functionality of tight junctions, paracellular
permeability), mucous production, and cilia function. Furthermore, the suitability of ALI
cultures as benchmark for a human-relevant model has been further confirmed through
transcriptome analyses [363], with several experiments demonstrating physiological
responses to toxicants or pathogens [364-368]. Furthermore, due to intense ethical,
societal, and legal support for the implementation of the "3R principle" (reduce, refine,
and replace the number of animal use), the ALI approaches have been used successfully
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as alternative methods for the replacement of animal-based inhalation toxicity studies
[369].
Given that there are numerous types of filament on the market, and that the FFF
3-D printing emissions physicochemical characteristics vary with each filament type and
within each type varies with color [119, 122], this might suggest that their toxic effects
may vary as well in these conditions. Thus, ALI culture models provide a unique in vitro
platform to assess the exposure to 3-D printer emissions avoiding the drawbacks of using
submerged single cell in vitro models and animal models and would likely reduce the time
and expenses of toxicity testing and screening of multiple filaments at once.
This study aimed to investigate the use of primary NHBEs as an in vitro inhalation
toxicity model of lung epithelium to mimic the respiratory behavior upon exposure to FFF
3-D printer emissions. As such, we evaluated cytotoxicity, tissue injury, and inflammatory
and immune system regulation markers following exposure to ABS filament, the most
common filament on the market.

4.2. MATERIALS AND METHODS
4.2.1. Cell culture model
Primary NHBEs, isolated from the surface epithelium of human bronchi, were
purchased from PromoCell (cat. C-12640, PromoCell GmbH, Germany). Cryopreserved
cells (healthy donor number 446Z036.9 and 432Z016.5; viability ≥ 94%; 500,000 cells per
vial) were cultured and differentiated according to the manufacturer’s instructions. Briefly,
cells (passage P+1) were expanded in 1 x T75 Corning™ Cell Culture Treated Flasks,
using the Pneumacult-Ex Plus expansion medium (cat. 05040, Stemcell Technologies,
Vancouver, Canada), supplemented with 0.1% (v/v) hydrocortisone (cat. 07925, Stemcell
Technologies, Vancouver, Canada). NHBE were cultured at 37 °C and under 5% CO2
conditions, with a medium change every other day. After reaching 70% confluency, the
cells were passaged into 4 × T75 Corning™ Cell Culture Treated Flasks (cell density at
0.5 x 104 cells/cm2) using an Animal Component-Free Cell Dissociation Kit (Stemcell
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Technologies, Vancouver, Canada) for 7 -10 min at 37 °C. The detached cells (passage
P+2) were centrifuged at 350 g for 5 min and re-suspended in the expansion medium.
Cells were cultured for additional 4-5 days in the expansion medium, with medium change
every other day, and subsequently used for the ALI procedure. To proceed with the ALI,
0.12 x 106 cells in 0.5 mL PneumaCult™-Ex Plus Medium were seeded on the apical side
of inserts (0.4 μm pore membrane, Polyester, Costar® 12 mm Transwell®, Stemcell
Technologies, Vancouver, Canada) in a 12-well plate with 1 mL expansion medium added
into the basolateral side. The ALI condition was initiated 5 days post-seeding by the
complete aspiration of the expansion medium in the apical compartment, thereby
exposing the epithelial cells to the atmosphere (day 0 post-ALI) and replacing the medium
from the basal compartment with the PneumaCult™-ALI Maintenance Medium (ALI
medium). The ALI medium consisted of PneumaCult™-ALI Basal Medium containing
10% (v/v) PneumaCult™-ALI 10X Supplement, 1% (v/v) PneumaCult™-ALI Maintenance
Supplement, 0.2% (v/v) heparin solution, 0.5% (v/v) hydrocortisone and 1% (v/v)
Penicillin/Streptomycin. The cells were fed exclusively from the basal compartment with
fresh ALI medium and maintained for 23 days before exposure to 3-D printer emissions.
4.2.2. Air-liquid interface cell exposure
4.2.2.1. Exposure system
The differentiated NHBEs cells were exposed to ABS 3-D printer emissions at the
air-liquid interface using the exposure system utilized previously to expose Sprague
Dawley rats to emissions generated during real-time printing via a whole-body inhalation
exposure system. The 3-D printer emissions generation chamber and exposure chamber
are described in detail in Chapter 3, 3.2.1 paragraph, pages 112-113..
4.2.2.2. Cell exposure treatment
Before cell exposure treatment, cell morphology was inspected using phasecontrast microscopy (Figure 4.1) followed by transepithelial electrical resistance (TEER)
measurements, as described in the next paragraph.
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Figure 4.1. Representative phase contrast microscopy image of NHBEs grown
23 days post-ALI.
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Four different sets of treatments were employed, as follows: 1) cell inserts were
placed in the middle of the chamber and exposed for 4 hrs. to the ABS FFF 3-D printer
emissions (marked as ABS-exposed cells), 2) another set of cells on inserts were kept
inside the emissions chamber covered, with the lid on (marked as “exposure chamber”
samples), 3) the third set of cells were maintained in the incubator at normal growing
conditions (marked as “incubator” samples), and 4) the last set of cells was treated on the
apical surface of epithelial tissue with 0.1 ml 2% TX-100 (1 hr. prior to when the exposure
ended) and used as a positive control for cytotoxicity and disruption of barrier integrity.
After the 4 hrs. exposure treatment (time 0 hrs.) and 24 hrs. after exposure, various
endpoints were evaluated, such as changes in phenotypic characteristics, functional
changes, cytotoxicity, and inflammatory and immune system regulation markers
(cytokines, chemokines, and growth factors). To check if the exposure might be a source
of contamination, a plate containing cell culture medium without antibiotics was kept open
in the exposure chamber during the 4 hrs. exposure. Next, the plate was maintained in
the incubator for two weeks, inspected for contamination visually, and by trypan blue
stain. After two weeks, the media was clear, no growth was observed, and no cells were
present in the trypan blue-stained cell suspension.
4.2.2.3. Deposition characterization
During the 4 hrs. exposure to ABS-emissions, a 12-well Costar® Transwell® plate
containing 0.5 ml PneumaCult™-Ex Plus Medium added on the apical side of 12 empty
inserts (no cells) was kept inside the exposure chamber. After exposure, the cell culture
medium was collected, stored in a sterile glass container, and used to characterize the
ABS-emitted particles (mean hydrodynamic particle size and particle concentration) that
would reach and deposit on the surface of the epithelial layer using nanoparticle tracking
analysis (NTA) (NanoSight NS300, Malvern Instruments, Worcestershire, UK), as
described in detail in Chapter 2, 2.2.2.1 paragraph, pages 71-72. The deposition of ABSemitted particles was estimated by normalizing the number of ABS particles per mL
measured in the collection medium using NTA to the surface area of the Transwell®
inserts (1.12 cm2).
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4.2.3. Evaluation of epithelial barrier integrity
As an important indicator of barrier integrity, TEER was measured using an Evom2
Epithelial Volt/Ohm meter equipped with 4 mm chopstick electrodes (World Precision
Instruments Inc., Sarasota, FL). TEER was measured prior to treatment and at the end
of the time point (0 and 24 hrs. after the exposure). To measure TEER, 0.5 mL of the
corresponding fresh medium was added to the apical side of a 6-well insert, equilibrated
for an additional 30 min at 37 °C, 5% CO2, and then the chopstick electrodes were placed
on either side of the primary airway epithelium. All TEER values were measured in
duplicate for each well and corrected for cell-free insert (≈40 Ω) resistance and the surface
area of a 12-well insert (1.12 cm2).
4.2.3. Video microscopy of cilia beating
The ciliary beating of live ALI tissue was visualized via phase-contrast microscopy
before and after treatment using Revolve microscope (Echo Laboratories, San Diego,
CA) at 40X magnification. The cilia movement was visualized prior to treatment and at
the end of the time point.
4.2.4. Histology
Cultures were fixed in 4% (w/v) paraformaldehyde at room temperature until ready
for processing. After fixation, the membrane inserts were rinsed twice with PBS. The
samples were dehydrated using a series of increasing ethanol concentrations, cleared
with xylene, infiltrated with paraffin wax, and embedded in wax blocks. Sections of 5 µm
thickness were cut using a Thermo Scientific™ HM 325 Rotary Microtome (Thermo Fisher
Scientific, Waltham, MA). The sections were stained with H&E or PAS using standard
histological techniques and imaged using Olympus BX63 light microscope.
4.2.5. TEM analysis
For TEM analysis, the cells on the Transwell® membrane were fixed with 2%
paraformaldehyde/ 2.5% glutaraldehyde solution (Karnovsky’s fixative) in sodium
cacodylate buffer for at least 24 h, subsequently washed three times with 8% sucrose
and 0.9% sodium chloride and post-fixed with 1% osmium tetroxide (2 hrs.), washed with
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sucrose buffer, and stained en bloc with 1% tannic acid (1 hr). followed by 0.5% filtered
uranyl acetate (1 hr). Afterwards, the cells were dehydrated in ascending ethanol series
and embedded in epon. From the embedded cells, ultrathin sections were cut parallel to
the vertical axis of the inserts, mounted on copper grids and stained with 4% uranyl
acetate. The sections were imaged on a JEOL JEM 1010 Transmission Electron
Microscope (JEOL, Tokyo, Japan) operating at 80kv with a side-mount digital AMT Orca
camera system and software.
4.2.6. Immunofluorescence microscopy
Cultures were fixed in 4% (w/v) paraformaldehyde for 15 min at room temperature.
The samples were incubated in 0.5 ml permeabilization buffer (0.5% [v/v] Triton X-100 in
Dulbecco’s phosphate-buffered saline (D-PBS) for 15 min, washed once with 0.5 ml DPBS and blocked for 1 h in 1% (w/v) bovine serum albumin (BSA) in D-PBS. Next, the
cultures were incubated with primary antibodies diluted in blocking buffer for 1 h at room
temperature. The primary antibodies included rabbit anti-ZO-1 antibody (cat. 40-2200,
Thermo Fisher Scientific Inc., Waltham, MA) used at a 1:100 dilution to identify tight
junction formation, mouse anti-MUC5AC (45M1) antibody (cat. MA5-12178, Thermo
Fisher Scientific Inc., Waltham, MA) used at a 1:200 dilution to identify the mucous cells,
mouse anti-alpha tubulin antibody (B-5-1-2) (cat. 32-2500, Thermo Fisher Scientific Inc.,
Waltham, MA) used at a 1:200 dilution to identify cilia, and rabbit anti-e-cadherin (5HCLC)
(cat. 710161, Thermo Fisher Scientific Inc., Waltham, MA) used at a 1:200 dilution to
identify adherent junction. The samples were subsequently washed three times with 0.5
ml D-PBS and incubated with secondary antibodies and 1 µM Hoechst 33342 (cat. 62249,
Thermo Fisher Scientific Inc., Waltham, MA) for 1 h at room temperature in the dark. The
secondary antibodies included goat anti-mouse-Alexa Fluor 647 (cat. A-21236, Thermo
Fisher Scientific Inc., Waltham, MA) used at a 1:500 dilution and goat anti-rabbit Alexa
Fluor 488 (cat. A-11008, Thermo Fisher Scientific Inc., Waltham, MA) used at a 1:400
dilution. The samples were washed three times with 0.5 ml D-PBS, hold in 0.5 ml D-PBS
until were visualized and imaged with Revolve microscope (Echo Laboratories, San
Diego, CA).
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4.2.7. Cytotoxicity
The possible cytotoxic effects of ABS emissions were assessed by measuring the
cell viability and release of the cytosolic enzyme lactate dehydrogenase (LDH) into the
medium.
4.2.7.1. Cell viability assay
AlamarBlue™ Cell Viability Reagent (cat. DAL1025, Thermo Fisher Scientific,
Waltham, MA), a non-toxic, cell-permeable compound, was used to assess cell viability.
The assay was performed on the apical side as follows. After harvesting culture
supernatants from the basolateral chamber for further analysis (LDH and cytokines
analysis), 200 μL of 10% AlamarBlue solution was added to each insert, and fresh
medium was supplemented in the basolateral chamber. After 4 h incubation at 37 °C, the
viability was measured by quantifying fluorescence levels (ex/em 560/590 nm) using the
Synergy H1 hybrid multi-mode microplate reader (BioTek Instruments, Inc., Winooski,
VT).
4.2.7.2. LDH release assay
The supernatant from the basal chamber was collected, and the release of the
cytosolic enzyme LDH into the medium, indicative of cell membrane damage, was
assayed spectrophotometrically by monitoring the reduction of nicotinamide adenine
dinucleotide at 340 nm in the presence of lactate using a Lactate Dehydrogenase
Reagent Set (Pointe Scientific, Inc., Lincoln Park, MI).
4.2.8. Measurement of cytokine release
Media collected from the bottom (basolateral) wells were stored at – 80 °C until
analysis. The concentrations of IL-17A, IL-21, IL-22, IL-23, IL-27, IL-31, MIP-3α, IL-17A/F,
IL-17B, IL-17D, IL-3, IL-9, GM-CSF, IL-23p40, IL-15, IL-16, IL-17A, IL-1α, IL-5, IL-7, TNFβ, VEGF, IFN-γ, IL-10, IL-12p70, IL-13, IL-1β, IL-2, IL-4, IL-6, IL-8, TNF-α, Eotaxin,
Eotaxin-3, IL-8(HA), IP-10, MCP-1, MCP-4, MDC, MIP-1α, MIP-1β, and TARC (pg/ml)
were measured using V-PLEX Human Biomarker Kits from Meso Scale Discovery (MSD,
Meso Scale Discovery). Plates were read using MSD QuickPlex SQ 120 (Meso Scale
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Discovery) for electrochemiluminescence. Sample concentrations were derived from a
standard curve plotted using a four-parameter logistic fit using MSD Workbench software.
4.2.9. Statistics
Studies were performed in one independent experiments with N = 1 - 3
inserts/treatment, n = 2 - 3 replicates each. The TEER, viability, and LDH data are
represented as mean ± standard deviation. All statistical analyses were performed in JMP
v13. Significant differences were determined by an ANOVA followed by the Tukey-Kramer
multiple comparison procedure. All analyses are considered significant at p < 0.05.
The analysis of cytokines dataset began with checking the assumptions for twoway analysis of variance (ANOVA). The Normal Quantile Plot was used to assess the
assumption of normality, while a Residual Plot was used to assess the equality of
variances. The Levene’s test was also used to confirm the equality of variances. A
logarithmic transformation of the response was used in the analysis if a residual plot
exhibited a funnel shape and if the residual plot improved with the transformation. If the
residuals of the response confirmed both assumptions, two-way ANOVA was performed.
Any significant results in the two-way ANOVA table were further assessed with pooled ttests to identify the specific main treatment effect and interaction effect. If a response did
not pass the ANOVA assumptions, a Kruskal Wallis Test was performed on both main
effects. Outliers in the data were identified using boxplots in R. To assess the significance
of the outliers, a subset of the data was created without the identified outliers and analysis
redone. If the outliers did not create a significant difference in the overall results, the
outliers were included in the official analysis. If the outliers created a significant effect, the
subset of the original data was used in the official analysis.

4.3. RESULTS
4.3.1. Particle characterization and deposition
Figure 4.2 presents the number-based size distribution of cell culture medium
(background) and ABS 3-D printer-emitted particles (ABS1 - ABS4) collected in the cell
culture medium analyzed using NTA.
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Figure 4.3. Representative TEM image of ABS agglomerated printer-emitted
particles on the surface of NHBEs cells 24 hrs. after the exposure.
The mean diameter and the mode diameter of ABS particle in the medium varied
from 150 to 198 nm (170 ± 21 nm), and from 131 to 165 nm (144 ± 15 nm), respectively
(Supplemental Table 4.1).
After background subtraction (plain cell culture medium, 3.6 × 10⁷ particles/insert),
the average ABS particle concentration in medium ranged from 2.5 × 105 to 4.4 × 107
particles per insert (0.5 ml culture medium/1.12 cm2), which is equivalent to 2.2 × 105 to
3.9 × 107 (average 1.7 × 107 ± 1.6 × 107) ABS particles per unit surface area of the
epithelium (Supplemental Table 4.2).
4.3.2. Evaluation of NHBEs epithelial tight junction barrier integrity
Before proceeding with the exposure (23 days post-ALI), the barrier integrity of the
primary NHBEs was assessed and confirmed based on TEER measurements (data not
shown). Following 4 hrs. exposure to ABS emissions, no significant changes in TEER
were observed between ABS-exposed cells and chamber-control cells or cells maintained
in the incubator at the end time points, 0 hrs. or 24h post-treatment (Figure 4.4).
The integrity of the fully differentiated primary NHBEs was further confirmed by
visualizing cilia movement (Video 4.1). There were no noticeable differences between
the treatments.
In addition, the junctional integrity of the fully differentiated primary NHBEs was
assessed using TEM (Figure 4.5). In addition to tight junctions (tj), adherens junctions
(aj) and desmosomes (d) were identified, further confirming the presence of junctional
complexes and barrier integrity within the NHBEs cultures. Tight-junction and adherens
junction formation was also confirmed using immunofluorescence staining of the ZO-1
and E-cadherin proteins (Figure 4.6 and Figure 4.7). There were no noticeable
differences between the treatments.
Overall, exposure of NHBEs to ABS emissions did not affect epithelium integrity at
the conditions applied.
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Figure 4.2. Number-based size distribution of cell culture medium (BKGD) and
ABS 3-D printer-emitted particles (ABS1 - ABS4) collected in the cell culture medium and
analyzed using NTA.
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Figure 4.3. Representative TEM image of ABS agglomerated printer-emitted
particles on the surface of NHBEs cells 24 hrs. after the exposure.

160

Figure 4.4. Barrier function of fully differentiated NHBEs measured by
transepithelial resistance (TEER). Values are means ± standard deviation. N = 2 inserts,
n = 2 replicates.
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Figure 4.5. Representative TEM images of fully differentiated NHBEs showing
junctional complex formation: tight-junctions (TJ), adherens junctions (AJ) and
desmosomes (DS).
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Figure 4.6. Representative labelled immunofluorescence images of fully
differentiated NHBEs showing epithelial features, including MUC5AC-producing goblet
cells (turquoise) and ZO-1 for tight junctions (green). Nucleus was stained with Hoechst
33342 (blue).
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Figure 4.7. Representative labelled immunofluorescence images of fully
differentiated NHBEs showing epithelial features, including α-tubulin (red) for ciliated cells
and e-cadherin for adherens junctions (green). Nucleus was stained with Hoechst 33342
(blue).
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4.3.3. Evaluation of NHBEs epithelium differentiation
The bronchial epithelium was composed of fully differentiated airway epithelial
cells (Figure 4.8), as noted from H&E and PAS staining. All of the major epithelial cell
types, including ciliated respiratory epithelial cells (c), mucous-secreting (goblet cells),
and basal cells (b), were identified within the NHBEs layer. This was further confirmed by
TEM imaging (Figure 4.9). Ciliated cells and mucous cells were present at the apical side
of the epithelium. Histological analysis revealed that overall ciliation did not appear
different between ABS-exposed cells and chamber-control cells or cells maintained in the
incubator at the end time points, 0 hrs. or 24h post-treatment. Basement membrane and
basal cells were present in NHBEs cultures stained with PAS and was seen as a distinct
single thin layer at the interface between the epithelium and insert membrane.
The ultrastructure of the NHBEs’ cilia configuration reveals both the cilial basal
bodies and the 9 + 2 axoneme arrangements (Figure 4.10).
Immunofluorescence microscopy of the apical surface revealed the presence of
mucous (goblet) and ciliated cells detected using the specific markers MUC5AC and αtubulin, respectively (Figure 4.6 and Figure 4.7).
Overall, exposure of NHBEs to ABS emissions did not affect ciliation or mucus
production at the conditions applied.
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Figure 4.8. Presentative photomicrographs of ALI epithelium stained with hematoxylin and eosin (H&E) and
Periodic acid–Schiff (PAS) stains showing normal architecture typical of the airway respiratory epithelium (40x
magnification). Black arrows point to ciliated respiratory epithelial cells. The yellow box surrounds cells within the basal
layer of the epithelium. Asterisks (*) highlight mucus containing goblet cells. Yellow arrows point to the basement membrane
separating the epithelium from the underlying filter.
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Figure 4.9. Representative TEM images showing the distribution of ciliated (C) and goblet (G) cells at the epithelial
surface of fully differentiated NHBEs, and basal (B) cells at the basal region of the epithelium.
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Figure 4.10. Representative TEM images of fully differentiated NHBEs showing ultra-structural cilia formation in
differentiated NHBEs: (A) longitudinal sections of cilia and basal bodies (arrowheads) and (B) transverse sections of cilia
showing 9 + 2 axoneme arrangement (arrowheads).
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4.3.4. Evaluation of cytotoxic and inflammatory response in differentiated NHBEs
The viability of cells exposed to ABS emissions was slightly decreased, but it was
not significantly different compared with incubator or exposure chamber controls (Figure
4.11A). Cytotoxicity was also evaluated by cell membrane integrity as indicated by LDH
leaking from exposed cells. Figure 4.11B showed that exposure to ABS emissions did
not induced significant LDH release from exposed cells compared to incubator or
chamber controls.
To investigate the inflammatory response from NHBEs cells associated with ABS
emissions exposure, screening was performed for a panel of 43 cytokines and
chemokines secreted in the basolateral compartment (Table 4.1). At the end of the
exposure period (0 hrs.), statistically significant increased levels of IL-7 (1.65-fold) were
seen in the cells exposed to ABS emissions compared to the cells maintained in the
chamber control environment. At 24 hrs. after the exposure, significant increase in IL-17A
(2.35-fold), VEGF (1.59-fold), IFN-γ (2.18-fold), IL-12p70 (1.78-fold), TNF-α (2.10-fold),
and MIP-1α (2.70-fold) were also noted in ABS-exposed cells compared to chamber
control cells.
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Figure 4.11. Cytotoxicity of fully differentiated NHBEs: cell viability (A) and LDH
activity (B). Values are means ± standard deviation. N = 3 inserts, n = 4 replicates.
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Marker
(pg/ml ±
SD)
IL-17A
IL-21
IL-22
IL-23
IL-27
IL-31
MIP-3α
IL-17A/F
IL-17B
IL-17D
IL-3
IL-9

0 hrs.

24 hrs.

Incubator

Chamber

ABS

5.20 ±
1.61
0.83 ±
0.18
0.49 ±
0.22
2.85 ±
0.88
69.88 ±
26.26
0.23 ±
0.08
1785.57 ±
1292.56
0.15 ±
0.18
0.19 ±
0.19
0.10 ±
0.19
5.69 ±
3.53
84.42 ±
87.82

3.07 ±
0.25
0.56 ±
0.15
0.20 ±
0.06
1.24 ±
0.16
50.73 ±
1.65
0.13 ±
0.03
79.94 ±
14.98
0.73 ±
0.58
0.02 ±
0.02

3.86 ±
0.70
0.67 ±
0.11
0.24 ±
0.06
1.67 ±
0.51
56.82 ±
10.62
0.16 ±
0.04
176.78 ±
93.80
0.81 ±
0.60
0.06 ±
0.07
0.24 ±
0.25
4.14 ±
0.97
55.22 ±
18.16

0
3.53 ± 1.6
69.91 ±
5.81

Tx-100ᵃ Incubator
4.48
0.69
0.27
1.81
54.08
0.18
75.95
10.84
3.91
9.34
41.5
885.11

3.04 ±
1.23
0.66 ±
0.16
0.25 ±
0.15
1.73 ±
0.74
43.36 ±
11.80
0.13 ±
0.06
217.61 ±
316.42
0.40 ±
0.47
0.96 ±
0.39
0.06 ±
0.06
14.92 ±
3.13
49.30 ±
18.54
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Chamber

ABS

Tx-100ᵃ

2.19 ±
0.43
0.36 ±
0.11
0.17 ±
0.05
1.17 ±
0.32
35.28 ±
4.11
0.10 ±
0.01
48.74 ±
31.78
0.40 ±
0.54
1.17 ±
0.49
0.17 ±
0.14
10.28 ±
2.30
46.25 ±
31.92

5.14 ±
2.52*

4.44

0.69 ± 0.37

0.81

0.37 ± 0.33

0.28

2.67 ± 1.90

1.3

72.14 ±
36.31

59.53

0.24 ± 0.15

0.33

1186.03 ±
1595.40

90.23

0.92 ± 1.02

11.33

1.16 ± 0.40

4.64

0.34 ± 0.42

11.13

9.7 ± 1.29

35.59

79.67 ±
41.99

963.9

GM-CSF
IL-23p40
IL-15
IL-16
IL-1α
IL-5
IL-7
TNF-β
VEGF
IFN-γ
IL-10
IL-12p70
IL-13
IL-1β

21.49 ±
38.09
0.40 ±
0.27
0.34 ±
0.24
1.14 ±
0.73
6.55 ±
10.31
0.24 ±
0.09
2.24 ±
1.41
0.12 ±
0.04
807.91 ±
689.44

4.21 ±
1.34
0.17 ±
0.03
0.42 ±
0.06
0.72 ±
0.01
6.28 ±
2.43
0.15 ±
0.10
1.91 ±
0.16
0.04 ±
0.04
517.89 ±
137.60

4.61 ±
3.52
0.23 ±
0.10
0.51 ±
0.13
1.08 ±
0.68
1.94 ±
0.59
0.23 ±
0.09
3.15 ±
0.64*
0.07 ±
0.05
712.90 ±
295.69

5.31 ±
1.49
3.01 ±
2.05
2.35 ±
1.31
17.17 ±
9.68
3.68 ±
2.36

4.85 ±
0.78
3.22 ±
0.34
2.26 ±
0.27
22.87 ±
1.24
3.27 ±
0.52

7.06 ±
2.84
3.29 ±
1.31
3.62 ±
1.32
21.38 ±
7.82
3.42 ±
1.40

8.34
0.42
1.33
1.67
30.08
0.28
6.22
0.08
286.16
4.02
2.07
2.93
22.67
2.49

15.23 ±
14.38
0.46 ±
0.25
0.95 ±
0.19
1.58 ±
0.52
1.77 ±
1.18
0.31 ±
0.15
10.38 ±
3.32
0.13 ±
0.11
1492.57 ±
283.41

7.38 ±
0.88
0.33 ±
0.12
0.87 ±
0.02
1.04 ±
0.70
1.27 ±
0.46
0.22 ±
0.04
10.89 ±
0.87
0.05 ±
0.03
1517.69 ±
68.22

5.33 ±
3.66
2.74 ±
1.09
2.56 ±
1.61
13.68 ±
2.87
2.89 ±
1.07

4.01 ±
1.48
2.69 ±
0.64
2.71 ±
0.98
19.77 ±
3.40
2.88 ±
0.59
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16.45 ±
9.77

20.51

0.52 ± 0.23

0.68

1.24 ± 0.37

3.67

1.69 ± 1.02

6.93

5.96 ± 8.96

90.04

0.27 ± 0.15

0.36

12.19 ±
0.83

14.04

0.17 ± 0.13

0.03

2407.87 ±
718.94*
8.74 ±
2.23*
3.88 ± 1.12
4.83 ±
0.91*
29.71 ±
6.72
4.11 ± 1.06

415.48
7.73
2.76
4.39
19.98
3.38

IL-2
IL-4
IL-6
IL-8
TNF-α
Eotaxin
Eotaxin3
IL-8(HA)
IP-10
MCP-1
MCP-4
MDC
MIP-1α

2.75 ±
1.75
0.86 ±
0.39
129.11 ±
165.88
1361.29 ±
872.24
7.68 ±
5.80
2.75 ±
0.80
7.72 ±
7.14
15849.57
±
18094.28
27.21 ±
17.92
18.62 ±
15.23
3.90 ±
3.47
9.08 ±
7.13
15.33 ±
7.98

3.04 ±
0.35
0.77 ±
0.13
9.09 ±
4.36
1833.41 ±
35.03
10.84 ±
0.28
1.45 ±
1.07
3.17 ±
0.33
7788.59 ±
3445.91
3.26 ±
0.20
14.43 ±
3.17
3.15 ±
0.40
3.89 ±
0.44
10.60 ±
1.50

3.07 ±
2.78 ±
1.38
1.40
1.80
0.93 ±
0.81 ±
0.64
0.31
0.61
126.25 ±
88.14 ±
27.06
126.89
150.94
1553.17
1788.03 ±
1768.63
± 495.29
67.87
11.05 ±
5.18 ±
15.34
7.45
2.28
2.22 ±
3.68 ±
2.15
1.25
1.36
2.55 ±
3.68 ±
5.66
0.69
3.11
15179.67
12830.33
±
2423.83
±
9134.72
17584.73
16.00 ±
127.82 ±
42.2
7.14
81.51
22.37 ±
54.38 ±
40.04
10.31
42.75
2.90 ±
4.36 ±
3.26
1.42
2.79
4.08 ±
10.14 ±
9.41
2.13
6.66
11.84 ±
17.58 ±
9
3.41
8.80
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2.60 ±
0.67
0.71 ±
0.30
25.72 ±
11.90
1831.01 ±
81.65
8.84 ±
3.19
3.23 ±
0.30
2.78 ±
1.45

3.91 ± 1.05

2.98

1.30 ± 0.22

1.17

265.24 ±
227.68
1807.54 ±
54.66
18.62 ±
7.35*

1871.41

6.02 ± 3.99

3.66

6.78 ± 4.31

2.49

7182.46 ±
4480.41

25594.50 ±
18607.97

6392.44

85.41 ±
5.18
25.50 ±
3.73
3.22 ±
0.81
8.60 ±
2.19
12.07 ±
2.02

151.07 ±
109.31
65.65 ±
32.53
6.33 ± 3.34
15.95 ±
8.10
32.59 ±
15.58*

75.68

18.17

284.61
67.04
3.69
9.6
16.38

MIP-1β
TARC

4.93 ±
3.19
2.99 ±
1.77

2.75 ±
1.33
1.76 ±
0.07

4.14 ±
2.22
2.60 ±
0.42

3.93
6.45

10.20 ±
2.41
10.74 ±
4.16

8.00 ±
2.17
10.79 ±
1.13

13.20 ±
6.28
13.79 ±
3.94

6.04
8.2

Table 4.1. Cytokines release in basolateral cell culture media. Values represents mean (pg/ml) ± standard
deviation (SD). N = 3 – 5 inserts/treatment/time point, n= 3 replicates. * Statistical Significance at the p < 0.05 level.
a - No SD was calculated, N = 1 insert/time point, n= 2 replicate.
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4.4.

DISCUSSION

In our previous two studies, we evaluated the toxicity of FFF 3-D printer emissions
using both in vitro [348] and in vivo methods [349]. In the in vitro study [348], small airway
epithelial cells (SAEC) were exposed in the submerged conditions to 3-D printer emittedparticle freshly collected in the culture medium. In the in vivo study [349], male SpragueDawley rats were exposed to emissions generated during real-time printing using a
whole-body inhalation exposure system. Considering the difficulty of translating
toxicological findings obtained in traditional submerged (2D) cell culture models or animal
models to human context, this study aimed to evaluate the toxicity of FFF 3-D printing
with ABS using a more relevant human ALI organotypic airway tissue model derived from
primary normal bronchial epithelial cells and use it as a potential screening tool for other
FFF 3-D printer emissions.
Functional characteristics of airway epithelial cells, such as TEER across the
epithelial layer [370], ciliary motion [371], and the formation of the junctional complex
[351] are essential and key endpoints universally evaluated to study the potential adverse
health effects of airborne toxicants or chemicals. Moreover, a change in one of these
parameters could be relevant to a variety of respiratory diseases [372].
A previous study [373] showed that ALI cultured airway epithelia from asthma
patients display a decreased TEER in comparison to epithelia derived from healthy
controls. In this study, the TEER values were lower but not significant in ABS-exposed
cells (673 - 680 Ω × cm2) compared to chamber and incubator control cells (691 - 741 Ω
× cm2). This finding is intriguing considering that in a case report study [264], a selfemployed businessman reported asthma-like symptoms after 10 days working with ABS
filament, and his symptoms slowly improved and eventually resolved after he replaced
ABS filament with a low emitter filament.
Abnormal ciliary function can lead to inadequate mucociliary clearance, which is
associated with various respiratory diseases such as cystic fibrosis, and chronic
obstructive pulmonary disease, among others [371]. In this study, light microscopy
observation of beating cilia was visualized with a Revolve microscope. However, due to
the unavailability of specialized equipment and software, the ciliary beat frequency was
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not quantified. However, rigorous observation of two entire inserts per treatment was
performed, and vigorous beating of cilia in an apparently coordinated manner was noted
as described in other ALI systems [374, 375], demonstrating that differentiated the
NHBEs’ have the potential for active mucociliary clearance. However, no noticeable
differences were observed between the ABS-exposed cells and the chamber and
incubator control cells.
The formation of junctional-complexes (which include tight junctions, adherens
junctions, and desmosomes) between neighboring epithelial cells seal off the paracellular
space between cells creating a physical barrier against inhaled particulates, pathogens,
and other xenobiotics from translocating into the interstitial compartment. The junctional
complex also forms a barrier against the movement of inflammatory mediators into the
circulation, thereby limiting the activation and recruitment of immune cells to sites of injury
[376]. Therefore, the evaluation of junctional-complexes structures presence is an
essential feature and important tool used in respiratory toxicity testing.
In the current study, the junctional-complexes were observed and localized by
immunofluorescence staining for E-cadherin and ZO-1, and by TEM. To obtain a clear
view of the ultrastructural arrangement, ALI cultures were sectioned, followed by TEM
imaging. The tight junctions were seen at the apicolateral borders of epithelial cells in the
differentiated NHBEs. In close proximity underneath of tight junctions are found adherens
junctions, emphasizing their interdependency, and the desmosome, localized more
basally. Studies looking at the impact of cigarette smoke, known to contain many types
of volatile components and particulates (heterogeneous mixture similar to 3-D printer
emissions in regard to its physical state and composition), showed that exposure to
cigarette smoke-induced TEER reduction and gene suppression of tight junctions and
adherens junction proteins in primary organotypic culture of human bronchial epithelial
cells [377], primary small airway epithelial cells [378] or a human airway epithelial cell line
(Calu-3) cultured at the air-liquid interface [379]. However, in this study, no noticeable
differences were observed between the ABS-exposed cells and the chamber and
incubator control cell at the conditions applied, which could be explained by the lower
delivered dose in our study.
176

The integrity of pseudostratified epithelium composed of ciliated and secretory
cells and basal stem cells is vital for the process of mucociliary clearance by which
multiciliated cells move mucus and trapped pathogens and particles out of the lung [371].
It was found that chronic exposure of primary HNBEs at ALI to cigarette smoke extract
impaired the cellular composition of the airway epithelium, reduced the number and the
length of ciliated cells, and increased the number of goblet cells [380]. In this study, the
major cell types normally associated with in vivo airway epithelium (i.e., ciliated, mucous
or goblet, and basal cells) were present within the differentiated NHBEs cultures, and
these were replicated in a pseudostratified morphology with ciliated cells interspersed
with goblet cells facing the apical side and basal cells spreading along the basolateral
membrane. The epithelium exhibited no evidence of major degradation or dedifferentiation between any of the treatments applied at the end of time points; there was
no noticeable reduction in the number of ciliated cells, no increase in the number of
epithelial vacuoles/gaps, and no adverse changes visible by H&E, PAS, and TEM.
Ultrastructural analysis of ciliated cells by TEM demonstrated that cilia associated with
differentiated HNBEs were of comparable morphology to those of ex vivo tissue, both in
terms of the structure of the basal bodies and the 9 + 2 arrangement of axonemes. In the
present study, evidence from PAS-stained histological sections and MUC5AC-labelled
cultures demonstrated the presence of goblet cells and the production of mucus from
differentiated HNBEs. The identification by TEM of mucus globules on the apical surface
of HNBEs cultures and goblet cells actively extruding mucus confirmed these findings.
Lastly, basal cells were identified from H&E-stained histological sections and TEM
images. These cells represent an important component of airway epithelia because they
function as progenitor (stem) cells which are involved in repair and regeneration following
injury [381].
Cytotoxicity testing is one of the first steps in the evaluation of toxicants. In the
current study, the applied treatments (except positive control) had no effect on cellular
viability. The LDH release into the media was slightly increased in ABS exposed cells.
However, significant increase in IL-12p70, IFN-γ, TNF-α, VEGF, IL-17A, and MIP-1α were
observed. Similar findings have been reported previously [382, 383] when it was found
that functional changes and oxidative metabolism occurs at concentrations that do not
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significantly affect the integrity of the cellular membrane and that the cellular function is
typically affected before membrane damage, thus making the cytokines responses a
more sensitive measure of cytotoxic effects resulted from exposure to 3-D printer
emissions.
The ability of NPs to induce inflammation in tissues is a key factor in determining
their toxicity and also a fundamental mechanistic paradigm in nanotoxicology [183, 186].
IL-12p70 is a pro-inflammatory cytokine which promotes induction of Th1 (IFN-γ, TNF-α)
and cytotoxic T cell responses [384]. Similarly, in this study, increased levels IL-12p70
was concomitant with increase in IFN-γ and TNF-α, which are well-known for their role in
the regulation of tight junction integrity [385]. TNF-α plays an important role in the
caveolin-1-mediated internalization of occludin, which increases epithelial barrier
permeability [386]. IFN-γ induces an increase in barrier permeability through the reduction
of ZO-1 and occludin expression in an adenosine monophosphate-activated protein
kinase (AMPK)-dependent pathway [387]. Therefore, the simultaneous presence of both
these cytokines could suggest that exposure to ABS emissions might have a detrimental
effect on epithelium barrier integrity through the disassociation of tight junction proteins
[388]. Indeed, in this study, the TEER were slightly decrease in cells exposed to ABS
emissions but did not reach statistical significance. TNF-α and VEGF have been reported
to be involved in the expression and secretion of MUC5AC [389], a major mucin
glycoprotein hypersecreted in asthmatic individuals [390, 391]. VEGF is also a potent
stimulator of inflammation, airway, and vascular remodeling [392]. MCP-1α was slightly
increased in ALI exposed cells. IL-17A, MIP-1α, and MCP-1α increase following exposure
to ABS emissions could promote generation of other pro-inflammatory cytokines and
chemokines, which might lead to the migration and infiltration of neutrophils and
monocytes/macrophages to the inflammation site, as has been previously reported [393395]. In addition, IL-17A can synergize with other proinflammatory cytokines such as
TNF-α and IFN-γ [396], which were found increased in our exposure model as well.
CULTEX® [397-399] and VITROCELL® [400-404] systems are commercially
available exposure systems largely used in the field of in vitro inhalation toxicology to test
a variety of airborne substances, such as NPs, gases, and complex mixtures. The air178

liquid interface cell exposure (ALICE) system [405-408] and VITROCELL/PARI BOY [409]
have been used for aerosolization of NP-containing liquid aerosols. he deposition rates
by these devices varied considerably. From the total aerosolized amount in nebulizers,
particle deposition ranged between 0.037% for aerosolized polystyrene particles/well in
the VITROCELL/PARI BOY system [409], 0.157% in the ALICE system [408], and 2.8%
in the optimized ALICE CLOUD system [410]. We also attempted to utilize the
VITROCELL® Cloud system in our study; however, due to the difficulty of delivering a
reliable dose, we utilize the exposure chamber developed for animal exposure, described
in Chapter 3, 3.2.1 paragraph, pages 112-113. Indeed, it has been found that in these
systems, the deposition is also particle-dependent [409].
Some advantages regarding the exposure method employed in this study are that
1) the cells were exposed to aerosols and gases via “dry” dispersion, which is comparable
to realistic exposure scenarios of the proximal airway exposure experienced by humans,
cell-chemical interactions, and faster uptake kinetics of the test articles [411] and 2) the
cells were exposed to emissions freshly generated during real-time 3-D printing avoiding
the “ageing” effect of long-term storage of NPs as previously reported [412]. With regard
to the toxicological effects, overall, the biological effects noted here resulted from the
exposure to the complex mixture composed of ultrafine particles and organic compounds.
The purpose of this study was to compare to some extent current findings with
outcomes observed under the submerged culture conditions (Chapter 2) or to in vivo
study (Chapter 3). However, the number of deposited ABS printer-emitted particles in this
study varied largely from 2.2 × 105 to 3.9 × 107 ABS particles per cm2 surface area of the
insert, making this comparison very challenging. One alternative is to conduct a repeateddose toxicity study. However, this paradigm could pose challenges as well as it has been
determined that performing repeat print runs of the same filament using the same 3-D
printer does not yield exactly the same results each time in terms of number of particles
or types and amounts of organic compounds [93]. Furthermore, to identify potential
threshold values and mechanistic studies, exposure to higher concentrations of ABS
emissions has to be performed. Exploring the effect of 3-D printer emissions in co-culture
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of epithelial cells with macrophages could provide more accurate insight into the interplay
of different cell types at the alveolar barrier.
This short-term exposure pilot study presented here should be considered as
preliminary. All results from the study are the findings of one experiment. The currently
used exposure chamber has the potential to successfully be used for testing the
respiratory toxicity of 3-D printer emissions by ALI approaches. For that, the exposure
chamber system requires structural changes to include more sample ports, optimized and
validated to ensure a uniform particle deposition throughout the chamber.

4.5.

CONCLUSIONS

At the concentration tested, exposure of differentiated NHBEs to ABS emissions
does not affect epithelium integrity, ciliation, mucus production, or induce cytotoxicity.
However, at the end of 4 hrs. exposure to ABS emissions, we observed increased IL-7
secretion, and at 24 hrs. after the exposure, IL-17A, VEGF, IFN-γ, IL-12p70, TNF-α, and
MIP-1α compared to chamber control cells. For the identification of potential threshold
values and mechanistic studies, exposure to higher concentrations of ABS emissions has
to be performed.
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4.6.

APPENDIX

Supplemental Figure 4.2. The NTA plate was placed in the exposure chamber
during FFF 3-D printing with ABS filament and used for particle collection and
characterization, and particle deposition estimation. The cell culture medium (0.5 mL)
added the three inserts corresponding to each of the four columns were combined and
marked as ABS1 throughout ABS4.

ABS1
ABS2

Mean diameter
(nm)
197.9 ± 6.9
177.3 ± 2.7

Mode diameter
(nm)
164.7 ± 15
157 ± 3.8

186.1 ± 7.2
165.2 ± 1.8

ABS3
ABS4

150.4 ± 2
158.9 ± 4.3

136.4 ± 6.2
130.7 ± 9.8

143.7 ± 2.7
142.1 ± 4.2

Sample

D50 (nm)

Supplemental Table 4.1. Characterization of ABS particles generated during a 4
hrs. print run: mean hydrodynamic diameter, mode diameter, and size of the particles in
the 50th percentile were measured using NTA.
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Sample
Culture
medium
(BKGD)
ABS1
ABS2
ABS3
ABS4

Average particle
concentration
(particles/mL)

Average
particle/mL
(after BKGD
subtraction)

Average
particle/insert
(0.5 mL, 1.12
cm2)

3.6 × 10⁷ ± 2.5 × 10⁶

0

0

0

7.7 × 10⁷ ± 4.5 × 10⁶
6.0 × 10⁷ ± 3.0 × 10⁶

4.1 × 10⁷
2.4 × 10⁷

2.1 × 10⁷
1.2 × 10⁷

1.8 × 10⁷

12.4 × 10⁷ ± 2.6 × 10⁷
3.7 × 10⁷ ± 2 × 10⁶

8.8 × 10⁷
5.0 × 105

4.4 × 10⁷
2.5 × 105

3.9 × 10⁷
2.2 × 105

Average
particle/cm2

1.1 × 10⁷

Supplemental Table 4.2. Calculation of average ABS printer-emitted particle
deposition per surface area. First, the concentration of “particles” measured in the cell
culture medium (background) was subtracted from the concentrations of the four ABS
samples (particle per mL, measured using NTA). These “particles” in the cell culture
medium are probably the proteins and other supplemental nutrients added into the ALI
complex culture medium to promote cells’ differentiation. Second, to calculate the number
of particles per insert, the particle concentration after background subtraction was divided
by two to account for the volume of culture medium added per insert (0.5 mL/ 1.12 cm 2).
Third, to determine the average particle per surface area (cm 2), the number of particles
per insert obtained previously were normalized per unit cm2.
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CHAPTER 5: GENERAL DISCUSSION
Currently, limited understanding is available on the health impact of FFF 3-D
printing exposures. The release of particles, particularly in the ultrafine size range, and
the complex mixture of toxic VOCs, prompted concerns regarding the possible health
implications of 3-D printing emissions. This is important, especially as 1) the use of AM
application is expected to increase in industrial workplaces, home-based businesses, and
educational settings and that 2) no occupational or consumer exposure limits have been
set up yet.
To address the knowledge gaps associated with pulmonary toxicity of FFF 3-D
printer emissions, this dissertation presents three studies with the following main goals:
1) To evaluate pulmonary toxicity of FFF 3-D printer emissions in in vitro submerged
monoculture model.
2) To determine pulmonary and systemic effects in rats resulting from whole-body
inhalation exposure to FFF 3-D printer emissions.
3) To study the pulmonary effects of FFF 3-D printer emissions using a relevant human
ALI organotypic airway tissue model to mimic the respiratory behavior upon exposure
to FFF 3-D printer emissions.

5.1. SUMMARY OF KEY FINDINGS
Initially, a rapid in vitro toxicity screening test (Chapter 2) of the two most used
thermoplastic filaments in FFF 3-D printing was carried out. This study is the first reported
in vitro study to evaluate the 3-D printer emission-induced cell toxicity. This first study
established that exposure to 3-D printer emissions collected in media induced dosedependent cytotoxicity in SAEC. Oxidative stress and inflammatory markers (Th1- and
Th2-type cytokines) were further investigated to explore the two main nanoparticleinduced toxicity mechanisms, and these analyses were also shown to provoke dosedependent toxicity. In this study, the dose-responsiveness (regression coefficients) was
determined based on the mixed model regression analyses performed on the measured
variables using particle number as the independent variable. It is important to emphasize
that the cells were exposed to the mixture of particles and organic compounds (styrene,
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BPA etc.) trapped in the culture medium during the sample collection. Therefore, it cannot
be excluded that the effects measured and their degree of toxicity could be in part due to
the specific types of organic compounds released by each individual filament; thus, not
solely a result of cell-particle interaction.
The second study (Chapter 3) aimed to evaluate the pulmonary and systemic
effects of ABS 3-D printer emissions in a rodent model. This study is the first published in
vivo study to evaluate the pulmonary responses from inhalation exposure to 3-D printer
emissions. The data indicated that the pulmonary toxic effects caused by exposure to
ABS emissions precede systemic toxicity. In detail, at the start of the exposure (day 1), a
predominant pro-inflammatory response was seen in BALF represented by an increase
in IFN-γ and TNF-α Th1-type cytokines, which was followed by a switch to an antiinflammatory response by day 15 of exposure represented by a rise in IL-10 Th2-type
cytokine. The Th1/Th2 switch could be responsible for the initial “delayed” influx of the
alveolar macrophages and its peak occurrence at 15 days of exposure, which
corresponded with a significant increase in blood monocytes and platelet counts. Other
systemic changes that were noted was that initially (day 1), a significant increase in both
hepatic and renal biomarkers (PHOS, AST, LDH) were found, however at day 15 of
exposure, only renal biomarkers (PHOS, BUN, URIC) were increased. At the longest
exposure duration (day 30), all the endpoints evaluated returned to the control levels.
Therefore, at the experimental conditions applied it was concluded that the ABS
emissions caused minimal transient pulmonary and systemic toxicity.
The mesentery from the animals used in the respiratory inhalation toxicology
studies was shared with our collaborators to evaluate systemic microvascular function
[413]. It was found that the ABS emissions significantly reduced arteriolar
responsiveness, causing systemic microvascular dysfunction, which was maximum at
day 8 of exposure, supporting the hypothesis that the pulmonary exposure to 3-D printer
emissions leads to systemic effects. Moreover, microvascular dysfunction can furthere
cause hypertension, diabetes mellitus, diabetic cardiomyopathy, rheumatoid arthritis,
systemic lupus erythematosus, and systemic sclerosis, among others [414, 415].
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Due to limitations of submerged cell culture models and challenging data
extrapolation from rodents to humans, along with ethical issues raised with animal testing,
human-relevant in vitro methods have been promoted. Therefore, the third study (Chapter
4) investigated the adverse effects of exposure to 3-D printer emissions using a relevant
human ALI organotypic airway tissue model of primary NHBEs. Although the exposure of
differentiated NHBEs to ABS emissions did not affect epithelium integrity, ciliation, mucus
production, or induced cytotoxicity, a significant increase in cytokines involved in the
induction of Th1 responses and regulation of tight junction integrity were significantly
increased. Similar to the in vivo study (Chapter 3), IFN-γ and TNF-α levels were also
increased

after

ABS

emissions

exposure.

Additionally,

the

migration

of

monocytes/macrophages into the lungs observed in in vivo study could be explained by
increased levels of IL-17A, MIP-1α, and MCP-1α observed in NHBEs exposed cells.
5.2. OVERALL DISCUSSION AND FUTURE DIRECTIONS
There are five main strengths of the studies presented here:
1) The toxicological effects of 3-D printer emissions were conducted using both human
primary cells and cell lines in vitro models in an attempt to identify the integrative
biomarkers or biological descriptors for human toxicity prediction as to the ultimate
goal.
2) The use of the ALI model, one of the most relevant in vitro models of primary human
bronchial epithelial cells, after human precision-cut lung slices, which closely
mimics in vivo and occupational human exposure.
3) The use of in vitro human cell models and in vivo rat model with the purpose to fill in
the translational knowledge gap from animal models to humans.
4) The exposures were conducted using real-time generated 3-D printer emissions, thus
avoiding the “ageing” effect of test material or other changes that could be induced by
the particle vehicle.
5) The emissions consisted of a relevant mixture of particles and organic compounds,
consistent with human occupational exposure.
In the first study (Chapter 2), using a submerged monolayer culture model, the in
vitro cellular dose or effective dose (particles concentration that reached the cells) was
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not determined (this topic is discussed in detail in the next paragraph). However, based
on MATLAB calculation, it was estimated that 1 x 107 ABS particles in suspension are
equivalent to 0.626 µg particle mass, or 0.189716 µg/cm2 mass per surface area of well
(surface area of well = 0.33 cm2, 0.100 ml of solution/well). This represents the nominal
concentration (particles concentration given to the cells) and it was shown to cause a
10% decrease in viability and 20% increase of LDH over control. This particle mass
concentration is approximately 60x higher than the lung burden estimated in the in vivo
exposure (Chapter 3) at the most extended exposure duration (30 days). Explicitly, the
ABS lung burden at 30 days of exposure, as estimated by the MMPD model with
clearance (Table 3.3), was 12.4 µg which corresponded to 0.0031 µg/cm2 after
normalizing to the surface area of rat lung (4,000 cm2). Therefore, the minimal respiratory
and systemic changes observed in the rodent study may be due to lower particle mass
deposition than that delivered in the in vitro study, as well as lack of clearance
mechanisms.
As mentioned above, the mass of 1 × 107 particles was estimated to be equivalent
to 0.626 µg. In the third study, human airway ALI model (Chapter 4), the particle number
per surface area at ALI was calculated for four samples (Supplemental Table 4.2) and it
found to be, from the lowest to greatest, 0.022 × 10⁷, 1.085 × 10⁷, 1.848 × 10⁷, and 3.924
× 10⁷ particle/cm2 which would correspond to 0.013772 µg/cm2, 0.67921 µg/cm2,
1.156848 µg/cm2, and 2.456424 µg/cm2, respectively, after normalized to the mass of 1
× 107 particles (0.626 µg). Although the calculated particle mass delivered at ALI is
greater than the particle nominal concentration in the submerged monolayer culture
model, considering that these results are based on one experiment, more research is
needed before making any further comparisons. Thus, the following in vitro to in vivo
biological effects comparisons are irrespective of the dose, as dosimetry was the most
challenging factor in this project and also acknowledged in the field of nanomaterial risk
assessment [416]. This topic and future directions are thoroughly discussed in this
chapter for each separate study.
In in vitro studies, evaluating toxicity in submerged monolayer culture (Chapter 2)
and human airway ALI models (Chapter 4), the biological effects were assessed at 24 hr.
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after exposure. For the ALI model, the biological effects were also measured immediately
after the exposure. In in vivo studies (Chapter 3), the toxicity was assessed at 24 hr.
following repeated exposure (4 hrs./day, 4 days/week) for five duration periods (1, 4, 8,
15, and 30 days). When possible, similar endpoints were selected to compare in vivo and
in vitro toxicity.
In both in vitro studies, the cytotoxic effects of 3-D printer emissions were
evaluated using similar analytical methods. The emissions collected in the cell culture
media used in the submerged cell culture study (Chapter 2) caused more pronounced
decreased cellular viability and LDH release than in the ALI exposure (Chapter 4). This
could be due to the mucus-producing ability of the differentiated NHBEs, which could
have impacted the particle uptake. Ji et al. [417] found that primary bronchial epithelial
cells exposed to palladium nanoparticles at ALI showed low uptake in contrast to 1 h after
addition to the cultures [418]. However, considering the complexity of 3-D printer
emissions, traditional submerged in vitro models are unreliable as the addition of gaseous
or vaporized constituents to the medium may alter their properties due to interactions and
binding with various components of the medium [419]. For this matter, at the moment, a
physiologically relevant ALI model combined with an advanced exposure system to
ensure accurate dosimetry and uniform delivery is preferred [351].
ROS production and TAC and GPx OS markers were evaluated in the submerged
cell culture model (Chapter 2). In the in vivo study, MDA and protein carbonyls, known
lipid and protein OS markers, respectively, were quantitated (Chapter 3). OS markers
were not investigated in the ALI study (Chapter 4). Exposure to 3-D printer emissions is
SAEC induced ROS production and decrease antioxidant defense capacity of the cells
as seen by decreases in TAC and GPx. However, the levels of MDA and protein carbonyls
in the ABS-exposed rats were not statistically significant compared to the air-control
animals.
After 3-D printer emissions exposure, in both in vivo and in vitro, inflammation was
the most sensitive parameter for the detection of biological responses. The dysregulation
of pro- and anti-inflammatory cytokines and chemokines is a central aspect in the
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promotion of inflammation [215, 420]. However, the distinction between pro- and antiinflammatory effects is not entirely clear mainly due to pathway interactions and their dual
pro- and anti-inflammatory effects [215]. Therefore, it is often difficult to use as diagnostic
tools.
Figure 5.1 represents the Venn diagram including the statistically significant
cytokines and chemokines increased following exposure to 3-D printer emissions in the
SAEC submerged cell culture model, in vivo whole-body inhalation exposure, and in the
ALI exposure model of differentiated NHBEs. In the in vitro submerged culture model,
pro-inflammatory cytokines such as IL-16, IL-1β, IL-1α, IL-12p70, IL-13, IL-6, IL-8, and
TNF-α significantly increased following exposure to 3-D printer emissions. In the in vivo
study, IFN-γ and IL-10 were significantly increased in BALF. In the ALI study, IL-12p70,
IFN-γ, TNF-α, VEGF, IL-17A, and MIP-1α cytokines were significantly increased in
differentiated NHBEs. As seen in the Venn diagram, there was no overlap or relationship
between the cytokines measured in all three studies altogether. The first explanation is
the time-dependent release of cytokines that were not considered in this study; second,
limited commercially available cytokines and chemokines kits for rats; third, additional
studies at higher concentrations are needed to establish an exposure-dose-response
relationship; fourth, could be due to species differences.
In the first study, among all cytokines, IL-16 increased at the highest slope value
compared to other cytokines. IL-16 is a mediator of inflammation by promoting the
secretion of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) [421] and also plays a
key role in asthma [422]. IL-16 has been shown to play a key role in airway hyperresponsiveness and up-regulation of IgE [423]. In our in vivo study, no differences were
observed in the IgE levels between the ABS-exposed and air-control animals throughout
the entire study. Another cytokine that recently has been found to be involved in asthma
pathogenesis is IL-17A [424]. In ALI study, IL-17A increased in the differentiated NHBEs
exposed to ABS emissions.
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Figure 5.1. Venn diagram showing the statistically significant cytokines and
chemokines increased following exposure to 3-D printer emissions in the SAEC
submerged cell culture model (Chapter 2), in vivo whole-body inhalation exposure model
(Chapter 3) and in the ALI exposure model of differentiated NHBEs (Chapter 4).
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The significant increase levels of macrophage inflammatory protein-1, MIP-1α, and
slight increase of monocyte chemoattractant protein 1, MCP-1α, in ALI study could justify
the migration and infiltration of monocytes/macrophages to the inflammation site
observed in in vivo study, as has been previously reported [393, 394, 425]. An increased
level of MIP-1α has been detected in BALF from patients with different lung diseases such
as allergen-mediated asthma [426], acute respiratory distress syndrome [427], and
pulmonary fibrosis [428]. It has been found that MCP-1 stimulates collagen synthesis and
production of the pro-fibrotic factor transforming growth factor β (TGF-β) in fibroblasts
[429]. MCP-1 levels were significantly elevated in BALF from patients with idiopathic
pulmonary fibrosis, interstitial pneumonia with collagen vascular disease, chronic
interstitial pneumonia, and sarcoidosis groups compared with normal healthy volunteers
[430].
IL-12p70 and TNF-α were found significantly increased in both in vitro studies.
TNF-α was also slightly increase in BALF in vivo study at day 1 of exposure. IL-12p70 is
a pro-inflammatory cytokine that promotes the induction of TNF-α [381]. TNF-α is a cellsignaling cytokine involved in acute systemic inflammation, the regulation of tight junction
integrity [382], and expression and secretion of MUC5AC [389]. TNF-α decreases the
protein expression of the tight junction proteins claudin-1, occludin, and ZO-1, as well as
to induce cytoskeletal F-actin rearrangement and the mislocalization of occludin and ZO1 [431, 432]. TNF-α levels were also found increased in the pulmonary sputum of cystic
fibrosis patients [433]. In this study, quantification of ZO-1 and MUC5AC following
exposure to ABS emissons was not possible, therefore no relationship can be established
at this time.
Like TNF-α, IFN-γ was found to disrupt the barrier integrity of epithelial and
endothelial cell both in vivo [434] and in vitro [435-439]. Ng et al. [437] suggests that p38
MAP kinase is activated in response to IFN-γ and causes actin rearrangement and altered
cell morphology, which in turn mediates endothelial cell hyperpermeability. Smyth et al.
[438] suggest that IFNγ stimulates the activity of the Src kinase Fyn, leading to the
formation of a complex containing STAT5b, Gab2 and the p85α regulatory subunit of
PI3K. The complex assembly results in PI3K activation and a consequent increase in the
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macromolecular permeability characteristics of monolayers of the human colon-derived
T84 epithelial cell line. In this study, IFN-γ was found significantly increased in the ALI
study and in the in vivo study, at the beginning of the exposure and decrease thereafter.
Disruption of epithelial barrier function triggered by the eleveated IFN-γ is accompanied
by reduced expression of the TJ proteins, zonula occludens ZO-1 and occluding [435,
439].
In order to properly characterize the correlated risk of 3-D printer emissions
exposure as a function of exposure, exposure-dose-response relationships should be
established.
In the first study (Chapter 2), a dose-response assessment was completed
applying serial dilution method in a neat culture medium. The particles and vapors in
chamber air were trapped in the collection medium as the air was drawn through
biosamplers's orifices into the collection vessel. The collection medium resulted from two
print runs were each delivered at three dilution levels: as undiluted (or 0% dilution), 25%
dilution, and 50% dilution, resulting in six doses. Therefore, the concentration ranges
obtained for each filament tested were from 1.42 × 106 to 4.72 × 106 average particles/cm²
for ABS, and from 1.95 × 107 to 5.42 × 106 average particles/cm² for PC filament. As a
note, the particle concentrations used in this study have different ranges for each filament
type, with no overlapping concentrations range. Future experiments should be
considered, with wider dilution ranges and including the same particle concentrations.
An essential detail in this study that should be considered as a future direction is
dosimetry. The average numbers of particles/cm² used for the dose-response analyses
were determined in the suspension and did not represent the dose of 3-D printer-emitted
particles that were effectively in contact with the cells during the assay or the internal
cellular dose. The determination of the cellular dose is essential for the development of
predictive numerical models and reliable in vitro screening methods [440]. Therefore,
printer-emitted NP-cell interactions studies should be addressed, including NPs
sedimentation velocity/fluid dynamics, particle density (g/cm3), NP uptake and adsorption
to the cell surface, and calculation of delivered dose as a function of exposure time. In
general, the impact of exposure to a test article using in vitro studies is observed at 24 191

48 hrs. after the particle suspensions are applied to cells. Recently it has been found that
estimated delivery of the entire administered dose of engineered SiO2 nanomaterials to
cells in culture can take up to hundreds of hours, indicating the importance of test article
interactions in physiological fluid, mass transport, and its subsequent toxic effect on cells
[441]. The interactions between the 3-D printer particle and the serum proteins contained
in culture media are noteworthy. These serum proteins affect the particle size and the
mass density due to the presence of the protein corona or of agglomerates which are
essential parameters affecting particle transport toward the cell monolayer. However, the
determination of the in vitro cellular dose is not trivial, and it can be time-consuming,
depending on the method chosen. To evaluate cellular uptake, the most used methods
are imaging techniques, such as confocal laser scanning microscopy, TEM, SEM, atomic
force microscopy, flow cytometry, inductively coupled plasma-mass spectrometry, live cell
imaging, high-content image analysis, X-ray adsorption near-edge spectroscopy [442]. 3D printer filaments that contain phosphorescent materials that glow in the dark after
absorbing light energy are available on the market. These types of filaments could be of
interest to pursue particle kinetics of deposition and transport studies.
In the second study (Chapter 3), the animals were exposed to a single
concentration which represented the maximum concentration obtained during
simultaneously printing of three desktop printers. With respect to inhalation as the main
route of exposure, a minimum of three exposure concentrations plus air-exposed controls
should be used. To advance this study, one alternative would be to modify the emissions
generation chamber to accommodate the installation of additional 3-D printers or printer
nozzles ports, and the second alternative would be to conduct nose-only exposures able
to provide reliable, uniform, and efficient aerosol delivery. The retained dose (lung
burden) at the end of exposure is essential for the evaluation of the results of inhalation
studies and deemed as a requirement by the OECD revised Test Guideline 413 [422] for
subchronic rodent inhalation in order to provide exposure-dose-response relationships
data for quantitative inhalation risk assessments. In this study, the particle deposition
mass for the head/nose region, tracheobronchial region, alveolar regions were estimated
using the MPPD model. At 30 days the alveolar deposition estimates were about 25 µg
and 12 µg, representing the model without and with clearance, respectively, which is
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about 30 times and 60 times lower, than in the first in vitro study (Chapter 2). Based on
the in vivo minimal effects, this single concentration tested here could be at most
classified at LOAELs. However, additional studies are needed to obtain a complete
hazard ranking, establishing no observed adverse effect levels (NOAELs) and confirm
LOAELs. Ideally, a positive and/or negative benchmark material should be selected,
against which the 3-D printer emissions can be compared. For example, laser printer
emissions which have been thoroughly tested and are similar to 3-D printer emissions in
the sense that the laser printers are known to generate particles and organic compounds,
however, these emissions also release fibers and inorganic gases [443].
The availability of robust lung burden data from in vivo inhalation studies is
important for the dosimetric integration of in vivo and in vitro responses based on in vivo
to in vitro dose extrapolations (IVIVE) methods [444] which involves normalization by the
metric “per cell surface area” or “per cell.”
Ma‐Hock et al. [444] proposed the following six steps for in vitro dose setting
(OBIV) based on nanomaterial in vivo organ burden data which could be applied to further
explore the toxicological effects of 3-D printer emitted-particles:
1)

Determine in vivo scenario to be reflected in vitro by establishing the target organ

(the lung), route of exposure (inhalation), and which in vivo exposure duration will be
reflected (short-term or long-term exposures).
2)

Identify in vivo organ burden at (or close to) LOAEC.

If in vivo organ burden data are not available, the next steps can be taken: 1) establish
LOAEC experimentally (measured), and 2) model lung burden using the MPPD model to
estimate the relative in vivo particle deposition in the airways at the LOAEC (the use of
MPPD estimations adds a further uncertainty in the order of a factor of two to the IVIVE,
Step 6).
3)

Extrapolate in vitro dose from in vivo organ burden.

At this step, the in vivo organ burden is extrapolated to in vitro effective dose (particles
concentration that reached the cells) by calculating 1) the lung burden per alveolar
surface area, which would represent the in vitro dose expressed as particle mass per
culture well surface area (µg/cm2) or particle surface area per culture well surface area
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(cm2/cm2), and 2) the lung burden per cell dose which would represent the in vitro dose
expressed as particle mass per single cultured cell (pg/cell).
4)

Extrapolate in vitro effective dose to in vitro nominal concentration (particles

concentration given to the cells).
At this step, the type of cell exposure model that will be applied is taken into account. For
example, in the case of the aerosol exposure of cells at ALI, the determination of nominal
concentration to effective dose is more straightforward, as it can be controlled by
equipment. If submerged exposure is used, the nominal concertation that is correlated to
the effective dose must be determined using models such as NANOGENOTOX protocol,
DG, or ISDD modeling, which are considering particle’s sedimentation and diffusion.
However, because the 3-D printer particle’s sedimentation and diffusion properties are
still unknown, as discussed in this chapter, in this situation, the in vitro effective dose to
in vitro nominal concentration should be determined experimentally using imaging
techniques, as presented above in the paragraph that discusses the dosimetry challenges
involving 3-D printer emitted-particles.
5)

Set in vitro dose range around LOAEC-equivalent dose to allow establishing a

dose-response relationship. The dose range should be at least two orders of magnitude
to account for uncertainties.
6)

Consider variability and uncertainties related to the organ burden data and the in

vitro test system specificity potentially affecting in vitro interpretation. For example, Ma‐
Hock et al. [444] determined that lung burden and alveolar surface area measurements
have <15% and 20 - 25% uncertainties, respectively. Also, the uncertainty for the alveolar
epithelial type I or II cells (AET-I, AET-II) were approximately 12% and 7.5%, and can be
accounted for using the pg/AET-I or pg/AET-II dose metrics [444]. It is essential to identify
the in vitro test system parameters that can affect the interpretation of measurements,
such as particle properties that are affected by the surrounding environment (in the lung
lining fluid, in vivo, versus different culture media, in vitro), possible interference of particle
with in vitro endpoint detection methods, and exposure duration and time dependency of
in vivo versus in vitro effects.
The development of a human 3D airway epithelial tissue-like culture system that
can be maintained in vitro is significant progress in the field of environmental air pollutant
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risk assessment. One significant experimental advantage is that these cultured primary
cells can be directly exposed to aerosols at the ALI, simulating the relevant physiologically
conditions of human or in vivo exposure. In the third study (Chapter 4), the ABS printeremitted particle deposition per surface area of inserts in the ALI study varied greatly from
0.022 × 10⁷ to 3.924 × 10⁷ average particle/cm2, which confirms the challenges related to
the aerosol dosimetry. However, it should also be emphasized that this study represents
a preliminary study in which only one experiment was performed. Therefore, additional
studies are needed for the identification of potential threshold values and mechanistic
studies. Especially important are the deposition efficiency and uniformity of deposition at
ALI. Oldham et al. [445], using Vitrocell® 24/48 ALI exposure system, which is able to
directly expose each insert through individual aerosol inlets, found that the deposition
efficiency decreases with particle size. For example, polystyrene monodisperse solid
fluorescent particles with mass median aerodynamic diameters of 1.1 µm and 0.51 µm
had a deposition efficiency of 0.06 and 0.013%, respectively. Next, characterization of the
3-D printer emissions at ALI are needed, as the aerosol delivered to the cell surface may
be different from the generated (parent) aerosol. Since the 3-D printing emitted particles
are mainly composed of semi-volatile organic compounds, if heating and dilution of the
aerosol with humidified air is used (to maintain the exposure chamber at 37 °C), attention
should be given to the particle to gas phase change of semi-volatile chemical
constituents.
The EDX analysis of particles collected in the culture media showed the presence
of Ni, Cr, and Fe, metals associated with health and environmental concerns [446].
Therefore, to further our understanding of the 3-D printer emitted particle's toxic effects,
comprehensive solubility/dissolution studies should be considered. Dissolution affects
particle biopersistence and biokinetics, including retention [416]. Two such methods can
be applied by 1) determining the equilibrium (or quasi-dynamic) solubility (μg/L) and 2)
determining dissolution rates (ng/cm2/day dissolved).
The first method is characteristic of a static system reflecting in vitro conditions,
which involves suspending particles in a medium, incubation, removal of remaining solids
by centrifugation or ultrafiltration, and measurement of the test analyte in solution [447].
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The second method is characteristic of a dynamic (non-equilibrium) system and mimics
more closely the in vivo situation, that uses culture media composition that simulates
extra- and intracellular lung environments, with both fluid phase and solid phase product
analysis. In these systems, dissolved ions pass through a membrane with a pore size that
excludes the test particles and are continually removed from the system using a “push
through” (ultrafiltration) or “double chamber” (macrodialysis), thus achieving nonequilibrium conditions over time course of the study [416]. The dialysate is collected in
separate volumes. The target analyte is quantitated in the collected fractions and the
waste that was not sampled. Because a large number of 3-D printer emitted particles are
in the nano-size range, an appropriate separation membrane should be carefully
considered in this situation.
The composition of the dissolution fluid is another critical factor with respect to
closely simulating in vivo conditions, e.g., intracellular conditions (pH ~4.5) or extracellular
conditions (pH ~7.4). The extracellular fluid determines the dissolution of inhaled particles
in the epithelial lining fluid. The intracellular fluid measures dissolution in the
phagolysosome of alveolar macrophages following phagocytosis of the deposited
particles [448]. Additionally, Stefaniak et al. [449] found that the dissolution rates can be
influenced by the variations in phagolysosomal fluid simulant composition and
emphasized the importance of a fluid simulant to mimic the chemical properties of the
fluid in the biological environment in which they are present.
Dynamic dissolution studies could be of interest pursue in the future for testing the
particles emitted from various thermoplastic filaments. The dissolution rates could provide
valuable information about their biopersistence, which will allow prediction of the overall
pulmonary clearance rate and associated overall retention halftime of particles of different
solubilities [450]. These results may be further considered as a grouping tool into high,
moderate, low, and insoluble particles or used as inputs into the MPPD model for
purposes of human risk extrapolation modeling. However, this work will require validation
and standardization. Also, the transformations of shape and size distribution of the
residual solids after testing can be further evaluated using electron microscopy methods,
supported by EDX.
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Although biocompatibility evaluation of the 3-D printed parts was not the focus of
this work, it is worthwhile to mention some research findings in this area as it might apply
to future studies. Because the use of 3-D printed parts as medical and dental devices is
a growing industry [451], biocompatibility studies of printed parts are currently being
undertaken [128, 452]. These studies focus on extractables that could cause allergic,
inflammatory, or other toxicological reactions in patients. Extractables are solvent or
thermal extracted chemical compounds that can be pulled from the primary product under
controlled laboratory conditions.
Nahan et al. [128] conducted a screening for volatile, semi-volatile, and nonvolatile extractables compounds in FFF ABS orthopedic casts and found that these
extractables included potentially-genotoxic isomers of the styrene-acrylonitrile trimer.
Rindelaub et al. [452] investigated the extractables profiles from FFF 3-D printed medical
devices using PC, PETG, PLA, and a PLA polymer advertised as “FDA-approved”. The
material marked as “FDA-approved”, corresponds to the use of an FDA compliant resin
(as per the manufacturer) and does not actually hold U.S. Food and Drug Administration
approval. It was found that the FDA-approved PLA polymer extracts had the greatest
concentrations of semi-volatile organics, which included L-lactide and phthalate
plasticizer (DEHP), and particulate matter, raising caution about the potential human
hazard of these extractables. Animal studies [453, 454] show that DEHP causes
reproductive and developmental toxicity. This could be in line with the results of Oskui et
al. [271], who studied the toxicity of STL and FFF ABS 3-D printed parts on the Zebrafish
embryo and found that exposure to parts from both types of printers caused hatching and
developmental abnormalities, with STL-printed parts being significantly more toxic than
FFF-printed parts. However, in this study, the extractable or leachable were not
measured. De Almeida et al. [272] also studied the toxicity of commonly used 3-D printing
polymers on bovine embryos and found toxic effects of the polymers on embryo
development. DEHP and polyethylene glycol were detected in the cell culture media.
Rindelaub et al. [452] also reported that annealing of FDA-approved PLA 3-D printed
medical devices reduced the extractable semi-volatile organic compound concentrations
by 43%, and particulate matter concentrations by a factor of 50.
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Overall, toxicological evaluation of FFF 3-D printer emissions was conducted in
three different conditions, 1) traditional submerged culture of human small airway
epithelial cells, 2) repeated whole-body inhalation exposure of rats to freshly generated
aerosols, and 3) advanced human ALI organotypic airway tissue model derived from
primary normal bronchial epithelial cells. At the experimental conditions applied, in both
in vitro conventional model and in vivo, 3-D printer emissions produced minimal to
moderate pulmonary toxicity. Furthermore, these findings were consistent with results
observed in the physiologically relevant in vivo-like in vitro model cultured at ALI. In
conclusion, these studies indicate that the FFF 3-D printer emissions could induce
moderate toxicological effects. These studies are significant as they are amongst the first
and comprehensive studies published to evaluate the pulmonary and systemic toxicity of
3-D printer emissions. Further studies are needed to establish a more comprehensive
exposure-dose-response relationships and integration of in vivo and in vitro responses.
This work is relevant to public health because it will help to develop and implement
evidence-based exposure limits and control strategies, as currently, no exposure limits
exist, and thus impact the health of 3-D printer users in both industrial and non-industrial
settings.
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SUMMARY
• Highly organized and expert on evaluating pulmonary toxicity using in vitro (submerged,
co-culture, and air-liquid-interface) and in vivo (rodents) models
• Analyzed and evaluated the risk associated with exposure to diesel/ biodiesel emissions,
crystalline nanocellulose, asbestos/asbestiform fibers, carbon nanotubes, laser printer
particles, surgical smoke, and 3-D printer emissions
• First-author of 3 peer-reviewed publications and co-author of 10 publications
• Seeking a position in toxicology and human health risk assessment
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“In vitro and in vivo toxicological evaluation of emissions from the fused
filament fabrication three-dimensional printing.”
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West Virginia University, College of Agriculture, Natural Resources & Design
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RESEARCH EXPERIENCE
07/02/2012 - Present
Centers for Disease Control and Prevention (CDC)
National Institute for Occupational Safety and Health (NIOSH), Morgantown, WV
Position: Regular fellow/ORISE fellow
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●

●

●

Designed, planned, and carried out experiments in order to investigate the adverse
effects of exposure to acrylonitrile butadiene styrene (ABS) and polycarbonate (PC)
emissions generated from 3-D printers using submerged culture of human small airways
epithelial cells (SAEC).
o Established that emissions released by both thermoplastic filaments induced
toxicological effects as seen by a dose dependent significant cytotoxicity, oxidative
stress, cell death, and production of pro-inflammatory markers.
o Measured variables: cell viability, lactate dehydrogenase activity (LDH), ROS
production, glutathione peroxidase, total antioxidant capacity, apoptosis, necrosis,
and several pro- and anti-inflammatory cytokines and chemokines.
o Determined dose-response relationship between the measured variable and the
numbers of the 3-D printer emitted particles based on mixed model regression
analyses (JMP).
Determined the subchronic inhalation respiratory and systemic toxicity of ABS and PC
filament emissions in rats based on procedures described in OECD and EPA Guidelines,
and National Toxicology Program studies.
o Established that the emissions from ABS and PC filament caused minimal transient
pulmonary and systemic toxicity, suggesting that the emissions elicited an adaptive
response in this exposure paradigm.
o Measured pulmonary injury, inflammation, and oxidative stress as well as markers of
systemic toxicity.
o Endpoints measured:
▪ Pulmonary injury: bronchoalveolar lavage cell differential, total protein, LDH,
surfactant protein A and D, Clara cell secretory protein, and pro- and antiinflammatory cytokines.
▪ Oxidative stress markers in lung homogenates: malondialdehyde and protein
carbonyls.
▪ Systemic toxicity: complete blood count, serum chemistry analysis (liver, kidney,
and muscle injury markers).
▪ Histopathological changes of the lung, and nasal passages.
Designed, planned, and carried out experiments in order to investigate the adverse
effects of exposure to ABS emissions using primary human bronchial epithelial cells
(NHBE) grown at air-liquid interface.
o The goal of this study was to recapitulate the in vivo inhalation exposure responses
and provide robust data for quantitative inhalation risk assessments for use in a
regulatory context of other types of 3-D printer filaments, as alternatives to animal
testing.
o Assessed the morphological changes of HBEpC 3D culture characteristics and
integrity, based on H&E and periodic acid-Schiff (PAS) staining, immunofluorescence
for α-tubulin, E-cadherin, MUC5AC, and ZO-1, trans-epithelial electrical resistance
(TEER), and cilia beating.
o Evaluated cytotoxicity, oxidative stress, tissue injury/repair, and inflammatory and
immune system regulation markers.
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Other research projects involved outside my dissertation work:
●
Performed in vitro and in vivo research to investigate the pulmonary toxic effects of
diesel/ biodiesel emissions, crystalline nanocellulose, asbestos/asbestiform fibers,
carbon nanotubes, laser printer particles, and surgical smoke.
●
Participated in hypothesis driven conceptual design of research direction.
●
Assisted in data compilation, data review, data interpretation, and manuscripts
preparation.
●
Optimized and performed assays to determine various experimental endpoints.
Managerial responsibilities:
●
Authored Animal Use Protocols (Topaz Enterprise system) complying with the
regulations and guidelines set forth by the Institutional Animal Care and Use Committee
(IACUC).
●
Amended the Animal Use Protocol to include microvascular, neurotoxicity,
nephrotoxicity, and reproductive toxicity studies of the 3-D printer emissions in
collaborations with three other groups of researchers.
●
Coordinated and supervised the animals’ conditions and procedures while hosted by the
Animal Facility and the Inhalation Facility.
●
Assigned and tracked specimens and samples generated during the experiments as per
CDC Specimen and Sample Management policy.
●
Developed and implemented laboratory SOPs.
●
Oversaw all equipment, performed weekly equipment calibration and preventive
maintenance, inventory, and ordering of reagents and supplies.
●
Trained and supervised the effective working of six new employees.
●
Prepared “sole source” procurement documentation for purchasing equipment,
technology, or services.
01/12/2009 – 05/11/2012
West Virginia University, Davis College, Morgantown,WV
Position: Graduate research assistant
Advisor: Alan Sexstone, Ph.D.
●
Developed a growth method of two strains of green microalgae, Chlorella vulgaris (UTEX
2714) and Chlamydomonas reinhardtii (UTEX 90), to increase CO2 capture and biodiesel
production.
●
Tested the effect of different culture media, pH, light intensities, and CO 2 concentrations
on C. vulgaris and C. reinhardtii growth.
●
Initiated and maintained a culture collection of algae isolated from Morgantown, WV
surroundings areas.
●
Prepared materials for scientific tests and collected experimental data.
●
Analyzed data in JMP and maintained accurate experimental records.
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RESEARCH SKILLS
Molecular Biology
•
Transcriptomics: DNA and RNA extraction and purification from cells and tissue, DNA
and RNA quantitation.
•
Proteomics: Protein extraction and purification from cells and tissues, protein
quantitation, gel-electrophoresis, western blotting, ELISA.
•
Cloning: Bacterial transformation, plasmid purification, PCR.
Tissue Culture
•
Primary cell and immortalized cell line maintenance, aseptic technique,
cryopreservation, in vitro exposures (monoculture, co-culture, air-liquid interface).
•
Cell-based assays: MTT proliferation assay, AlamarBlue cell viability assay, DCFDA
Intracellular ROS assay, multiplexing, high content analysis.
Microscopy
•
Immunofluorescent microscopy of fixed cells and FFPE tissue.
Flow cytometry
•
Tissue digestion, antibody labeling, FACS analysis.
Animal procedures (mice and rats)
•
Handle and restrain, weigh animals, anesthesia, euthanasia.
•
Pharyngeal exposure.
•
Collect blood and tissues (lung, liver, spleen, kidney, heart, brain, small intestine, seminal
vesicles, testes).
•
Collect bronchoalveolar lavage, and cytologic analysis.
•
Intraperitoneal and tail injection.
OTHER PROFESSIONAL EXPERIENCE
08/01/2004-01/10/2008
S.C. Ciprod-Pharm S.R.L., Bucharest, Romania
Position: Biochemist & Internal auditor
●
Prepared documents and obtained approval for good manufacturing practice in
manufacturing, packing, labeling, or holding operations based on European Union
recommendations for over 100 dietary supplements and nutraceuticals.
●
Analyzed microbiological and physicochemical properties of medicinal plants used in
manufacturing, according to the European Pharmacopoeia.
●
Conducted on-site independent evaluations to ensure that Good Manufacturing Practice
and Quality Management System are adequately implemented.
●
Prepare formal written reports setting forth recommendations for local and corporate
management to strengthen and improve operations.
●
Provided audit support for external audits and miscellaneous enhancement initiatives
as needed.
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